BioVisionAlexandria 2010 11–15 April Bibliotheca Alexandrina
Conference Booklet 2 BioVisionAlexandria 2010 Abdelwahab, Hala AbdelHamid, Riham Abdel El-Rassoul,Marwa Azab, Khaled Ammar, Sherif Allam, Mohamed Abouela, Dina Abdelrazek, Hanan Abdel Latif,Inas Abd Eltawab,Omnia Madkour, Magdy El-Faham, Mohamed El Beltagy,Adel Abdelhady, Layla Van Montagu,Marc(Belgium) Rook, Graham(UnitedKingdom) Rangel-Aldao, Rafael(Venezuela) Omi, Koji(Japan) Huanming, Yang(China) Gros, Francois(France) Elliott, Malcolm(UnitedKingdom) Desmarescaux, Philippe(France) Bouis, Howarth(USA) Alberts, Bruce(USA) (Physiology orMedicine1989) (Physiology orMedicine1993) Lehn, JeanMarie Roberts, Richard (Chemistry 2003) (Chemistry 2002) (Chemistry 1987) Varmus, Harold Wüthrich, Kurt Agre, Peter Director, BibliothecaAlexandrinaandConferenceChair Technical andLogisticsCommittee International ScientificCommittee BA Steering/ScientificCommittee Organizing Committee El-Deeb, Dahlia El-Badry, Dalia El- Sammak,Mohamed El Saadany,Aly El Amir,Radwa Bayoumi, Cherine Azzam, Cherouk Anas, Nagy Amin, Marwa Ali, Alyaa El-Wakil, Marwa Darwish, Omneya Soliman, Salah Maram, Heba Nobel LaureatesCommittee Ismail Serageldin Singer, Peter(Canada) Rios, Gilbert(France) Rabbinge, Raoelf(Netherlands) McConnell, David(Ireland) Hassan, Mohamed(Sudan) Grenier, Christian(France) Elias, Zerhouni(USA) Daar, Abdallah(Canada) Berg, Robert(USA) (Physiology orMedicine2005) Warren, JohnRobin (Economics 2007) (Chemistry 1991) (Chemistry 1999) (Literature 1986) Zewail, Ahmed Farouk, Mustafa Ezzat, Amira Essalmawi, Hala El-Shobaky, Sara El-Sherbiny, Ayman El-Shazly, Eman El-Mallakh, Lara El-Kourdy, Khaled El-Fayoumi, Israa El-Fadaly, Shaimaa Nakhla, Rafik Mansour, Yehia Halim, Yehia Soyinka, Wole Ernst, Richard Maskin, Eric Mahdy, Ashraf Magdy, Sally Magdy, Doha Maamoun, Yasmin Konswa, Nevin Kamel, Omneya Kamal, Islam Ibrahim, Shymaa Helmy, Mona Hamdy, Heba Hassan, Rasha Gafour, Olfat Gomaa, Mohamed Gad, Mohamed Ghazal, May Fathy, Hend Marton-Lefevre, Julia(Switzerland) Laporte, Ronald(USA) Derhak, Dianna(USA) Amman, Klaus(Netherlands) International SteeringCommittee Riad, Sherif Ragab, Esraa Omar, Noha Nofal, Khaled Nassar, Hadeer Nashaat, Karim Nafea, Mohamed Nabeel, Ghada Moustafa, Passant Mounir, Hanan Mossaad, Khaled Mohamd, Shaimaa Merzeban, Faten Mahdy, Nehad Mahdy, Marwa Mahdy, Khaled Nutti, Marilia(Brazil) Leisinger, KlausM(Switzerland) Greenfield, BaronessSusan(UnitedKingdom) Anhoury, Pierre(France) Zaki, Nihal Wassef, Mayada Soliman, Asmaa Soccar, Peter Sobhi, Mina Sobeih, Yousra Samir, Yasmin Salib, Mariam Saleh, Ayman Salah, Mohamed Sakr, Ashraf Said, Kholoud Saad, Ashraf Roushdy, Marian
3 BioVisionAlexandria 2010 4 BioVisionAlexandria 2010 Dear Participant, in serving as a platform for dialogue, exchange of ideas and creating ways to work to ways creating together. WealsowishyouaproductiveandpleasantstayinAlexandria! and ideas of exchange dialogue, for platform a as serving in us for the first time, welcome! We hope that this conference will continue its tradition For those who have attended BioVisionAlexandria before, and for those who are joining discoveries oftodaycouldcreateabetterworldforthecominggenerations. weaimto do only not discuss the novel discoveries and breakthroughs Therefore, in science, but humanity. also to examine of how the benefit the its channeling to of potential aim enormous the with sciences life in frontiers new discuss to together get will society civil and science industry, of fields the from speakers distinguished and This year at BioVisionAlexandria 2010, our aim is to explore the future. Policy makers applications. its of possibilities vast the to poor, the on impact its lives, change to capacity its from ranging Biotechnology, of aspects many the on views diverse exchanged have minds great conferences these During Sciences. Life New at of field fascinating the explore together to brought were leaders global and BioVision; whether BioVisionAlexandria scientists or the World Life esteemed Sciences Forum, BioVision, years, eight For Sciences Life World Forum, BioVision. the with partnership in organized 2010 BioVisionAlexandria conference international the to welcome and Alexandria of Library the to Welcome
Director oftheBibliothecaAlexandrina Librarian ofAlexandria Ismail Serageldin Alexandria,12April2010 In thispublication, youwillfindalldocumentsanduseful informationthatyoumayneedfor theBioVisionAlexandria2010Conference. Itis . oe Luets ...... Laureates Nobel 3. 2. SpeakersList...... Program Provisional 1. 5. Partners, Sponsors and Exhibitors ...... Exhibitors and Sponsors Partners, 5. 4. Speakers`Biographies...... prepared bytheconference organizingcommitteetoaccompany youduringyourstayinAlexandria. Index 103 49 45 29
7
5 BioVisionAlexandria 2010
BioVisionAlexandria April 2010 Provisional Program
7 BioVisionAlexandria 2010 8 BioVisionAlexandria 2010
Sunday, Tuesday, 13 April 2010 Monday, 12 April 2010 11 April Plenary Sessions Nobel Day 2010 17:30-19:00 17:00-17:30 15:30-17:00 14:30-15:30 13:00-14:30 12:30-13:00 09:00-10:30 11:00-12:30 17:30-19:30 17:00-17:30 13:30-15:00 12:30-13:30 11:00-12:30 10:30-11:00 15:30-17:00 15:00-15:30 08:30 08:00 08:00 BVA 2010ProgramataGlance The TheoryofBiorobs:TowardstheFuture(II) Genomics &MolecularBiology:TheBiological TheTheoryofBiorobs:TowardstheFuture(I) Biodiversity: NaturalWealthandWell-Being Water:The Global NeedandtheUniversal Session 1:ScienceandTechnology:TheWaytotheFuture (Featuring EminentInternationalandNationalFigures) Registration (ThroughouttheEntireConferenceDuration) Registration (ThroughouttheEntireConferenceDuration) Subject toChange Session 2:NewLifeSciences:Impacts Evening Event1:NobelRoundTable Plenary Session1 Plenary Session5 Plenary Session3 Plenary Session2 Plenary Session4 Networking Coffee/TeaBreak Networking Coffee/TeaBreak Management Networking Coffee/TeaBreak Networking Coffee/TeaBreak Networking Coffee/TeaBreak Conference OpeningSession Challenge Lunch Break Lunch Break Registration Development and Answering Water Answering Water Answering Water Geo-engineering: MEDA-MENA MEDA-MENA MEDA-MENA Cooperation for Technologies In Technologies In Technologies In for aHealthier Environment? Provisional Program International A NewHope Innovation Membrane Membrane Membrane Countries: Countries: Countries: Plenum Plenum 1 Plenum 2 Track 1 Track 3 Track 2 Track 1 Track 1 Issues: Issues: Issues: 3 BioVisionAlexandria April 2010
Wednesday, 14 April 2010 Parallel Sessions 13:30-15:00 12:30-13:30 09:00-10:30 17:30-19:00 17:00-17:30 15:30-17:00 15:00-15:30 11:00-12:30 10:30-11:00 08:00 and Prevention: Biotechnology Translational Cancer Care and Health: Approaches Panel A-1 The Global Panel A-2: Challenges Panel A-3 Panel A-4 Medicine (Health) Medicine Access to (Health) (Health) (Health) Novel Registration (ThroughouttheEntireConferenceDuration) Evening Event2:CEOPanel Global (Environment) (Environment) The Debate(II) TheDebate(I) Opportunities Environmental Environmental (Environment) (Environment) Clean Energy Networking Coffee/TeaBreak Networking Coffee/TeaBreak Networking Coffee/TeaBreak Panel B-1: Change: A Agricultural Agricultural Resources: Panel B-2 Emerging Panel B-3 Panel B-4 Safety and Safety and Climate Benefits: Benefits: Biotech, Biotech, Heritage Lunch Break Biotechnology Benefits from Technologies Green Wayto to Sustainable Agriculture) Agriculture) Agricultural Agricultural Challenge: A Challenge: A Global Food Agriculture Sustainable Agriculture) Agriculture) Panel C-1 Panel C-2 Delivering (Food and (Food and Green Way Agriculture Panel C-3 Panel C-4 (Food and (Food and Driving The21 Century Century Security The 21 st st
Industry: The Gap Industry: The Gap Brain Advancing: Brain Advancing: Countries Avoid Can Developing Health Dangers Innovation and Innovation and of TheWestern Lifestyle; How BrainAging- Brain Aging- Education, Education, Research, Research, Plenum 1 Plenum 2 Plenum 2 Plenum 1 Track 5 Track 4 Track 6 Track 6 Track 5 Them?
9 BioVisionAlexandria 2010 10 BioVisionAlexandria 2010 Thursday, 15 April 2010 09:00-10:30 13:30-15:00 12:30-13:30 11:00-12:30 10:30-11:00 15:00-15:30 15:30-17:00 08:00 Free time Tracks Theme C:Food&Agriculture Theme B:Environment Theme A:Health Plenary Sessions Evening Events Nobel Daysessions New Technologies in Health:New Panel A-5 (Health) Hope Registration (ThroughouttheEntireConferenceDuration) Science Supercourse Plenary Session6 Green Technology Better Prospects and Sustainable (Environment) Development: Networking Coffee/TeaBreak Networking Coffee/TeaBreak Panel B-5 Plenary Session8 Plenary Session7 Reporting Session Closing Session Lunch Break Food and Agriculture) Priorities in Panel C-5 (Food and Security Academy ofScientific Rethinking Science and Technologyin Technology- Egypt the 21stCentury Research and Provisional Program Track 8 Track 7 BioVisionAlexandria April 2010 13:00-14:30 12:30-13:00 17:30-19:00 17:00-17:30 15:30-17:00 14:30-15:30 11:00-12:30 Day 1 Day 1 Day 1 Day 1 08:30 Evening Event:NobelRoundTable(GreatHall) Welcome Note:IsmailSerageldin,Director,BibliothecaAlexandrina(Egypt) Ahmed Nazif,EgyptianPrimeMinister(Egypt) Christian Grenier,CEO,theWorldLifeSciencesForum,BioVision(France) Developing WorldandPresident,AfricanAcademyofSciences Hassan, Mohamed (Japan) Koji Omi, Founder and Chairman, the Science and Technology in Society (STS) Forum (France) Desmarescaux, Philippe Conference OpeningSession(GreatHall) John RobinWarren,PhysiologyorMedicine,2005(Australia) Kurt Wüthrich,Chemistry,2002(Switzerland) Richard Roberts,Medicine,1993(USA) Rapporteur: PierreAnhoury,SeniorVicePresident,KantarHealth(France) Fellow, Bill&MelindaGatesFoundation(USA) Chair: Session 2:NewLifeSciences:Impacts(GreatHall) Wole Soyinka,Literature,1986(Nigeria) Eric Maskin,Economics,2007(USA) Peter Agre,Chemistry,2003(USA) Rapporteur: PierreAnhoury,SeniorVicePresident,KantarHealth(France) IUCN (Switzerland) Chair: Session 1:ScienceandTechnology:TheWaytotheFuture(GreatHall) BioVisionAlexandria 2010,11-15April Fre Drco, ainl nttts f elh n Senior and Health of Institutes National Director, Former Zerhouni, Elias Julia Drco Gnrl te ol Cnevto Uin - Union Conservation World the General, Director Marton-Lefevre, Registration (ThroughouttheEntireConferenceDuration) Monday, 12 xctv Drco, WS te cdm o Sine fr the for Sciences of Academy the - TWAS Director, Executive Detailed Program (Subject toChange)
himn te ol Lf Sine Frm BioVision Forum, Sciences Life World the Chairman, April2010(NobelDay) Networking Coffee/TeaBreak Networking Coffee/TeaBreak 2010* Lunch Break
11 BioVisionAlexandria 2010 12 BioVisionAlexandria 2010 10:30-11:00 09:00-10:30 09:00-10:30 08:00- Day 2 Day 2
Rafael RodriguezRafael , CSIC-Coordinator, MIRAProject, EU(Spain) EOLSS (Jordan) ShatanawiMuhammad, Francois Guinot, Former President, French Academy of Technology (France) Chair: AlaaEl-Din Abdin, Director, Strategic Resources Unit, NWRC (Egypt) speakers. nologies to address today and tomorrow’s water challenges will be put tech- forward by new the for need strong The large. at context policy and administrative societal, geographical, its in examined be will water of question the session, opening this In “Sustainable Water inMEDA-MENACountries” (Prof. Gilbert Rios) Co-organized withtheEuropean Membrane House &SIMEV Water Issues: Plenum 1(Lecture Hall) TrackMembraneAnswering Technologies1: Countries: MEDA-MENA in Sciences andDirector, Huada Genomics Research Center (China) Yang, Huanming of Michigan (USA) Omenn, Gilbert Research Group, Genomic SciencesCenter, RIKEN(Japan) of Department Yoshihide Hayashizaki, Medicine, and Biochemistry Biochemistry, Stanford University (USA) of Professor , Brutlag Douglas and Former President, Merck Vaccines (USA) Adel Mahmoud, Projacs International (Egypt) : Rapporteur Chair: AlastairKent, Director, Genetic Interest Group (UK) in thesepromising fields. research, it is our aim during this biological breakout and session to medical focus modern on the of actual developmenttopics common most the are Biology Molecular functions of single genes is the main concern of the of study the is Genomics While Biological The Biology: Molecular & Genomics Challenge (Great Hall) 1: Session Plenary Registration (Throughout the Entire Conference Duration) Rafik Nakhla, Professor, Department of Molecular Biology, Princeton University Professor of Medicine, Genetics, and Public Health, University Health, Public and Genetics, Medicine, of Professor ietr Biig eois nttt, hns Aaey of Academy Chinese Institute, Genomics Beijing Director, Tuesday, 13 Project Director and Chief Scientist, Genome Exploration Networking Coffee/Tea Break Professor, University of Jordan and UNESCO Chair,UNESCO Jordanand Professor, of University Vice President, Human Resources and Administration,
April 2010 of organisms, studying the roles and roles the studying organisms, of genomes Molecular Biolog y . As Genomics and Provisional Program BioVisionAlexandria April 2010 12:30-13:30 11:00-12:30 11:00-12:30 Day 2 Day 2 Chair: manipulation. cussed while taking into account the effect of the new tools of and biotechnology gene dis- be will issues biodiversity These benefit. common global initiate will protection biodiversity towards collaboration global expanding thus now, needs pressing are diversity tems of a region which presents the three levels identifying biological variety: ness. Biologists usually define biodiversity as the «totality of genes, species, and ecosys- «Biological Diversity», or «Biodiversity», indicates (Great Hall) SessionPlenary 2:Biodiversity: Natural Wealth and Well-Being Michel Farcy, Vice-President, Pall Industry (France) Langlais,Senior Engineer,Chrystelle SUEZ Environment (France) Jörg Vienken, Vice-President, BioSciences-Fresenius (Germany) Damia Barcelo, Director, Catalan Institute on Water Research (Spain) (France) Chair: holders tounderstandtheirspecificconstraints. stake- and actors Mediterranean and East Middle the with dialogue a to devoted users have been taken into account from the start: the core of the session will thus be Membrane technologies are at their most effective when the specific constraintsgiven. of its be will worldwide development their of trends the of Reminders solutions. Membrane technologies represent today an extraordinary opportunity to develop new “Membranes forWater” (Prof. Gilbert Rios) Co-organized withtheEuropean Membrane House &SIMEV Water Issues: Plenum 2(Lecture Hall) TrackMembraneAnswering Technologies1: Countries: MEDA-MENA in Russell A.Mittermeier, President, International Conservation (USA) Administrator ofUSAID(USA) Nina Fedoroff, Nature (IUCN)(Switzerland) Jeffrey McNeely, (Belgium) VanMarcMontagu , dicinal Chemistry, SchoolofPharmacy, University ofKansas (USA) Barbara TimmermannBarbara , tion, Projacs (Egypt) Administra- and Resources Human President, Vice Nakhla, Rafik Rapporteur: (Egypt) Magdy, , Poesr Erpa Mmrn Isiue f Montpellier of Institute Membrane European Professor, Ayral, André species diversity Science and Technology Adviser to the Secretary of State and to the Madkour Senior Science Advisor, International Union for Conservation of President, the European Federation of Biotechnology- EFB Biotechnology- of FederationEuropean the President, , and Distinguished Professor and Chair, Department of Me- of Department Chair, and Professor Distinguished Professor, Faculty of Agriculture, Ain Shams University ecosystem diversity Lunch Break . Preserving nature and biodiversity species diversity and species rich- genetic
13 BioVisionAlexandria 2010 14 BioVisionAlexandria 2010 15:00-15:30 13:30-15:00 15:30-17:00 13:30-15:00 Day 2 Day 2 Day 2 Sami Sayadi, Director, Bio-processes Laboratory, University ofSfax (Tunisia) Jean-Christophe Schrotter, R&DManager, VEOLIA-Membrane (France) - Saudi Arabia (Germany) Suzana Nunes, Principal Research Scientist, KAUST Membranes Research Center Gilbert Rios,ChairEuropean Membrane House (France) Chair: LouisCot,Director, SIMEVandUNESCO Chair(France) the environment, orhow membranes organs. offernewpossibilitiesforartificial into species toxic most the of dissemination the stop can membranes how water: to This session will show how membrane technologies can help solve health issues related “Membrane Technologies forMEDA-MENAContext” (Prof. Gilbert Rios) Co-organized withtheEuropean Membrane House &SIMEV Water Issues: Plenum 3(Lecture Hall) TrackMembraneAnswering Technologies1: Countries: MEDA-MENA in Hiroshi Ishiguro, Professor, Osaka University (Japan) Paolo Dario, Professor, ScuolarSuperiore Sant’ Anna (Italy) MaisonnierBruno , CEO,Aldebaran Robotics (France) tion, Projacs International (Egypt) Rapporteur: Chair: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) novel Biorobs thatassisthumanbeingsinvarious aspects. should developingThis in result exceptionalperformance. ordertheir understand to and even Hence,entertainment. it is a major need to focus upon their biosystems in and ogy engineering. Their application varies from medicine and to biology industry Biorobots are now playing a progressively crucial role in bridging the worlds of biol- (Great Hall) SessionPlenary 3: Kevin Warwick, Professor of Cybernetics, University ofReading (UK) University Medical (USA) Duke Neuroengineering, for CenterCo-Director, and Sciences Brain and logical Miguel Nicolelis, tion, Projacs International (Egypt) : Rapporteur Chair: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) in developing novel Biorobs thatassisthumanbeingsinvarious aspects. their upon biosystems in order to understand Thistheir shouldexceptional performance. result focus to need major a is it Hence, entertainment. even and to industry biology and medicine from varies application Their engineering. of and worlds the biology bridging in role crucial progressively a playing now are Biorobots (Great Hall) of Session Biorobs:Plenary 4:TheTheory Towards the Future (II) , Vice President, Human Resources and Administra- and Resources Human President, Vice Nakhla, Rafik , Vice President, Human Resources and Administra- and ResourcesHuman President, Nakhla, Vice Rafik Professor Biomedical of Neurobiology Engineering and Psycho- The Theory of Biorobs: TheTheory Towards the Future (I) Networking Coffee/Tea Break Provisional Program
BioVisionAlexandria April 2010 17:00-17:30 17:30-19:00 15:30-17:00 Day 2 Day 2 (France) Schrotter, Jean-Christophe Development, Environment, andSecurity (USA) Gleick, H. Peter William Cosgrove, Founder, Ecoconsult Inc.(Canada) BOT Crop Diversity Trust (Canada) MargaretCatley-CarlsonFormer , Projacs International (Egypt) : Rapporteur Chair: tba utilization ofwaterresources shouldbeoneofourprioritiesinthe21 preserving of importance already demand water the while diminishing, sustainably is water fresh clean, of supply (USA) WalterAndresson, Research Scholar, International Institute forApplied Systems Analysis (Austria) Blackstock, Jason (UK) Girardet, Herbert Ulrich Cubasch, Dean, Geoscience Faculty, Freie Universität Berlin (Germany) Chair: issues? these in involved actively more be world environment. the of the parts major and all can How humanity between changes relationship profound force will change climate Indeed, challenge. major a be will deployments and research and adaptation fail to prevent climate catastrophe. Governing well geo-engineering world’s temperature. Geo-engineering solutions should be developed in case be geo-engineering, in which mitigation humanity manipulates the global climate to lower the have serious consequences for cities. The global emergency fallback solutionwill change mightclimate fromMoreover, impacts risk. well agricultural high at Alexandria storm surges, a phenomena likely to increase sharply in coming years, puts cities like Climate trends Solutions predict severe damage to coastal cities like Alexandria. New data on Associations Geo-Engineering Nations United Applied Systems Analysis(Prof. Robert Berg) of Federation World Possible the with Co-organized Alexandria: forCoastal (Lecture Hall) Like Implications Emergency: Climate Cities Coming The 2: Track uses require human all Almost recreation. and environment household, industry, agriculture, in vary uses its earth’sas the development, of human sustainable for and ecosystem Water is not only vital for living but is also is very essential for the healthy functioning (Great Hall) Plenary Session 5: Water: The Global Need and the Universal Management
in many parts of the world. Vital awareness of the global the of awareness world. Vital the of parts many in supply surpasses Tute Wrd cdm o At n Sine (USA) Science and Art of Academy World Trustee, Berg, J. Robert fresh water Rafik Nakhla, Vice President, Human Resources and Administration, Co-founder and President, the Pacific Institute for Studies in Studies for Institute Pacific the President, and Co-founder Fellow, Centre for International Governance Innovation and InnovationGovernance InternationalFellow, for Centre Co-founder and Director, Programs,Council WorldFuture Director, and Co-founder President Emeritus, the World Academy of Art and Science and Art of AcademyWorld the Emeritus, President . Fresh water is a Networking Coffee/Tea Break n mn apoce t te aaeet and management the to approaches many and water & Mngr VOI-ebae House VEOLIA-Membrane Manager, R&D Chair,Global WaterChair,Partnershipand renewable resource. Nevertheless the world’s st century.
15 BioVisionAlexandria 2010 16 BioVisionAlexandria 2010 17:30-19:00 Day 2 Codntr n Assat E Sine Counsellor Science EU (Cyprus) Assistant, and Coordinator Papageorgiou, Kyriaki Fraunhofer-Institute forMechanics ofMaterials (Germany) Implants”, and Materials “Biomedical Group Research Head, Jäger, Raimund Program, ofHigher Ministry Education andScientific Research (Egypt) Innovation and El-Zoheiry,Coordinator,DevelopmentHamid ResearchAbdel Christian Hülshörster, Director, DAADofficein Cairo (Germany) Chair: tba Innovation and Development (Lecture Hall) for Cooperation International 3: Track Provisional Program BioVisionAlexandria April 2010 9:00-10:30 9:00-10:30 Day 3 Day 3 Projacs International (Egypt) (Venezuela) Polytechnic University -Hebron (Palestine) players. their by given examples hands-on specific with policies such of execution the with do to has other the and companies; start-up or institutes public either by wellness, of translation and care the health to engineering and sciences facilitate of host a from knowledge and cutting-edge foster to policies of formulation the with do to sector private has section One Europe). the and America, (Africa, and/or continents different from coming public the both from initiatives of variety a comprise that sections consecutive two in divided is session The name. same journal very that new with a launched recently Magazine Science that vibrant so is Medicine field. emerging this of view broad a Translational have to is panel this of aim The Co-organized withtheSimon Bolivar University (Prof. RaphaelRangelAldao) Panel A-1: Translational Medicine -Health (Great Hall) Chair: binding dealisapressing need. legally global a scenarios, climate future terrifying the of Thinking examples. just economic dangers are yet to come; the greenhouse effect and the global warming are the is change and health social, Climate Environmental, planet. end. our encountering threat an global greatest to come not do worries global the yet continue, Negotiations 2009: Conference Change Climate Copenhagen the Protocol, Kyoto The 1992 UN Framework Convention on Climate Change (UNFCCC), the 1997 (Small Theater) Panel B-1:ClimateChange:AGlobal Heritage -Environment Anthony Bunn Ashhab, Yaqoub Rafael Rangel-Aldao, Maritha Kotze, Lazdins-Helds, K. Janis Francois Franceschi, Chair: Herbert Girardet, (Egypt) Barry Barry Worthington, Robert J.Berg, Gregor C.Leckebusch , : Rapporteur Co-Chair : University, (Venezuela) : Rapporteur (USA) Diagnostics (Italy) Raphael Raphael Rangel-Aldao, WalterAndresson, Anthony Bunn
aa Soliman, Salah Rafik Nakhla, Rafik Senior Advisor, World Federation ofUnited Nations (USA) Associations , Director, MRC Innovation Centre (SouthAfrica) CEO,Knowmix Cape Biotech Trust (SouthAfrica) Co-founder andDirector, Programs, World Future Council(UK)
Wednesday, 14 ietr Boehooy riig n Rsac Ui, Palestine Unit, Research and Training Biotechnology Director, Executive Director, United Association States Energy Senior Director, Technology Rib-X,Inc. (USA)
Associate Professor,Associate Freie Universität Berlin Professor, Digital Molecular Medicine, Simon Bolivar University Head, Novartis Vaccines Academy, Novartis Vaccines and VaccinesNovartisAcademy, VaccinesNovartis Head, President Emeritus, the World Academy of Art and Science Science and Art of Worldthe Academy Emeritus, President , Director, MRC Innovation Centre (SouthAfrica)
ie rsdn, ua Rsucs n Administration, and Resources Human President, Vice rfso, aut o Agriculture, of Faculty Professor,
Professor, Digital Molecular Medicine, Simon Bolivar
April 2010 lxnra University Alexandria (Germany) (USA)
17 BioVisionAlexandria 2010 18 BioVisionAlexandria 2010 11:00-12:30 10:30-11:00 9:00-10:30 9:00-10:30 Day 3 Day 3 Day 3 Chairman, Egyptian Seed Industry(ESIA)(Egypt) Association Egyptian Chairman, Deputy International. and Director,SeedsManaging Fine and Adel Yaseen, Chairman EU andInternational Affairs(Spain) Farmers-Spain Young of Association Representativefor ASAJA and Seville ASAJA and AndalusiaPresident, ASAJA (ASAJA), Agriculture President, Deputy Serra , Ricardo François Traoré, CottonGrower (Burkina Faso) Research, Alexandria University (Egypt) : Rapporteur Chair: tba Co-organized withMonsanto Company Agriculture (Lecture Hall) Panel Agricultural C-1: TechnologiesDriving Sustainable Agriculture – Joel Nobel, Founder andProfessor Emeritus, ECRIInstitute (USA) Werner Christie,Former Norwegian Minister ofHealth (Norway) Philadelphia of Hospital Children’s(USA) the Health, Global of Director Finalle, Rodney Forum, OECD(France) Michael Oborne, Director, the International Futures Programme and the Global Science Projacs International (Egypt) : Rapporteur Chair: Dianna Derhak the for framework positive a create tofosterforthe goodofoneandall. industry and together sit to alike governments and companies catapulted has style life and health human areaof the in biotechnology health challenges. ofglobal of crisis benefits apparent can’tThe we anything. science do and the biotechnology Without than forhumanity test no bigger is There Panel A-2:Biotechnology andHealth: The Global Challenges-Health (Great Hall) Charité University Medical Centre (Germany) Matricardi, Paolo Graham Rook, Professor ofMedical Microbiology, University CollegeLondon(UK) Nottingham (UK) of UniversityPharmacy, of School ParasiteImmunology, of Professor Pritchard, David (UK) Chair: happen, andwhatcanbedonetoprotect developing countriesfrom thisfate. The session will explain the changes in patterns of disease, why we think the changes disease and others) increase dramatically, as do some cancers and mood decline, disturbances. diseases infectious autoimmunity, disorders (allergies, inflammatory chronicbowel but Many inflammatory disease. of patterns in change a is there cities, modern of lifestyle the to existence ruraltraditional a from change populations As Co-organized withtheUniversity CollegeLondon(Prof. Graham Rook) Avoid Them?(Delegates Hall) Track 4: Health Dangers of the Western Lifestyle; How Can Developing Countries Graham Rook, Graham Vc Peiet Hmn eore ad Administration, and Resources Human President, Vice Nakhla, Rafik aa Hassouna, Salah rfso, eatet f eiti Pemlg ad Immunology, and Pneumology Pediatric of Department Professor, , Director, Business Development, EPOS(USA) Professor of Medical Microbiology, University College London College University Microbiology, Medical of Professor Networking Coffee/Tea Break rfso, ih nttt o Gaut Suis and Studies Graduate of Institute High Professor, Provisional Program Foodand BioVisionAlexandria April 2010 11:00-12:30 11:00-12:30 11:00-12:30 Day 3 Day 3 Day 3 (Delegates Hall) University (Egypt) SalahHassouna, Technical Design, Urban and ArchitectureUniversity (Germany) Darmstadt in Professor Assistant Hesse , Christoph João Paes deCarvalho,Principal, BiznessBrazil (Brazil) Hani El-Nokraschy, CEO,Nokraschy Engineering GmbH(Germany) (Egypt) : Rapporteur (USA) converting to renewable energy sources inorder torenewableconverting tobemore energy environment-friendly. renewableis also energy known as green or clean energy, much of the world today is oil high with increases. coupled legislation As towards government support Thus prices. energy renewable always are they increase, concerns change climate While renewables. from came consumption energy final global of 18% about 2006, In (Small Theater) Panel B-2:CleanEnergy Resources: Emerging Environment Opportunities- odcr & soits oslig Dmgahc Info Demographic Consulting, Biotechnology, Cincinnati Area Associates (USA) & Fondacaro President, Fondacaro, Joe Prabuddha Ganguli, CEO, Vision-IPR (India) Industry (France) Gillespie, Iain Morris andManaging Director, Berrie, Co-Chairman Tech Investor Ltd(UK) Chair: Morris andManaging Director, Berrie,Co-Chairman Tech Investor Ltd(UK) andresearch?industry education, between bridges such build to ideas possible the are what we And stand? do where So, essential. means all by is innovation example. linking another and Encouraging is education continuing for programs Funding industry. and university binding in role important very a play should researchers and research industrialized and developed countries, strong links between in industries and universities are being Accordingly,set. Sponsoring escalating. is gap the bridging importance of the evident, between is gap industry the a and of universities especially existence education the the countries developing and developed both in As 5: Track Rural Development andForestry (Nigeria) Diran Makinde, African Agricultural Technology Foundation (AATF) (Nigeria) Oikeh, O. Sylvester M’MbijjeweKinyua , Monsanto Corporate AffairsLeadinAfrica(Kenya) : tba Rapporteur Chair: Hassan Moawadhe, Professor, National Reserach Center (Egypt) Co-organized withMonsanto Company -Food andAgriculture (Lecture Hall) Panel C-2:Delivering Benefits from Agricultural Biotechnology Chair: ar Worthington, Barry Research, Education, Innovation and Industry: The Gap: The Industry: and Innovation Education, Research, aa Soliman, Salah Head, Biotechnology Division, Directorate for Science, Technology and TechnologyScience, for Directorate Division, Biotechnology Head, Professor of Animal Science and Former Dean of the School of Agriculture, Professor,HighInstitute Graduateof Studies Research,and Alexandria Project Manager, Water Efficient Maize for Africa (WEMA), for Africa Maize Efficient Water Manager, Project rfso, aut o Agriculture, of Faculty Professor, Executive Director, United States Energy Association Association Energy States United Director, Executive lxnra University Alexandria lnm 1 Plenum
19 BioVisionAlexandria 2010 20 BioVisionAlexandria 2010 13:30-15:00 13:30-15:00 12:30-13:30 Day 3 Day 3 finance foraffordable drugs. andeffective sustainable providing and systems, regulatory drug regional or domestic building effective legislation, property intellectual domestic enabling access, constructing through medicines to systems, access delivery care health strengthening for means It practices. business responsible needs people’s poor meeting life: for Investing Panel A-3:Access toMedicine -Health (Great Hall) : Rapporteur Chair: Huanming Yang, Co-Vice EAGLES Chairman, (China) progress. booming achieving is field this in research the also but years, recent in intensified create has a dilemma. Thus, the public debate about the use of plant biotechnology and the environment, while others view them as a basic threat. These opposing views Many Biotech tools are considered a “powerful and safe» way to improve agriculture – Environment (Small Theater) (I) Debate The Benefits: Agricultural and Safety Environmental Biotech, PanelB-3: (Canada) Peter Singer, Professor of Medicine, University Health Network and University of Toronto Sustainable Development (Switzerland) Venture Leisinger, Malaria M. Klaus for Medicines CEO, and (Switzerland) President Hentschel, Christopher Jane Morris, Director, AfricanCentre forGene Technologies (SouthAfrica) Projacs (Egypt) : Rapporteur (Egypt) Chair: eerhr Ntoa Rsac Cne o Fo Tcnlg, Embrapa Technology, Food (Brazil) on Center Research National Researcher, Nutti, Marilia College ofAgriculture andLife University Sciences, Cornell (USA) Shotkoski, Frank Biljana Papazov, BotanicalGarden, theUniversity (Netherlands) ofBern (Egypt) Yehia Zaky, Salah Soliman, Salah Vc Peiet Hmn eore ad Administration, and Resources Human President, Vice Nakhla, Rafik Head, Academic and Cultural Affairs Sector, Bibliotheca Alexandrina ietr Arclua Boehooy upr Poet AS) II, (ABSP) Project Support Biotechnology Agricultural Director, rsdn ad xctv Drco, oats onain for Foundation Novartis Director, Executive and President rfso, aut o Arclue Aeadi University Alexandria Agriculture, of Faculty Professor, Lunch Break Provisional Program BioVisionAlexandria April 2010 13:30-15:00 15:00-15:30 13:30-15:00 Day 3 Day 3 Development (USA) and Agriculture Food, for Institute International Cornell Professor, Uphoff, Norman Adel El-Beltagy, Chair, Global Forum onAgricultural Research (Egypt) (India) Datta, Swapan Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) Research, Alexandria University (Egypt) : Rapporteur Improvement (UK) Chair: “A Tribute toNorman Borlaug” (Prof. Malcolm Elliott) Co-organized withtheNorman BorlaugInstitute forCrop Improvement Agriculture (Lecture Hall) Panel C-3: The 21 The C-3: Panel Claire Elizabeth Cockcroft, Head, Relations, External theBabraham Institute (UK) Anatole Krattiger, Research Professor, Arizona State University (USA) Brian F.C. Clark, Vice President, European Federation (Denmark) ofBiotechnology Amir Dossal, Executive Director, theUnited Nations Officefor (USA) Partnerships Chair: Morris andManaging Director, Berrie,co-Chairman Tech Investor Ltd(UK) andresearch?industry education, between bridges such build to ideas possible the are what we And stand? do where So, essential. means all by is innovation example. linking another and Encouraging is education continuing for programs Funding industry. and university binding in role important very a play should researchers and research industrialized and countries, strong links between developed industries and universities are being set. Sponsoring in Accordingly, escalating. is gap the bridging importance of the evident, between is gap industry the a and of universities especially existence education the the countries developing and developed both in As Gap: (Delegates Hall) The Industry: and Innovation Education, Research, 5: Track acl Elliott, Malcolm aa Hassouna, Salah euy ietr eea, nin oni o Arclua Research Agricultural of Council Indian General, Director Deputy st Century: A Green Way to Global Food Security - Security Food Global to WayGreen A Century: xctv Drco, h Nra Brag nttt fr Crop for Institute Borlaug Norman the Director, Executive Networking Coffee/Tea Break rfso, ih nttt o Gaut Suis and Studies Graduate of Institute High Professor, lnm 2 Plenum Food and Food
21 BioVisionAlexandria 2010 22 BioVisionAlexandria 2010 15:30-17:00 15:30-17:00 Day 3 Day 3 detection ofthatserioushealthproblem. Various survivors. cancer preventionworldwidefor objectivesnational developedhaveearly institutions and all for life of quality the improve and rates mortality incidence, cancer reduce to aim efforts these All service. and advocacy education, research, through cancer from suffering diminish to worked have institutions and societies Many 2030. in deaths million 12 deaths estimated an with rising, million continue to 7.4 nearly for accounting worldwideareprojectedcancer from Deaths problem 2004. in deaths) all of 13% (around health major a is Cancer Co-organized withKantarHealth (Prof. Pierre Anhoury) Panel A-4:Cancer Care andPrevention: Novel Approaches -Health (Great Hall) PepsiCo (Mexico) Rivero, Carmela Effat Badr, Professor Emeritus, Faculty ofAgriculture, Alexandria University (Egypt) Villoo Morawala Patell, Founder andCMD,Avesthagen Limited (India) Biotechnology National of Federation Companies (Uruguay) American Latin Director, Pagliano, Daniel ) (Egypt : Rapporteur Chair: Huanming Yang, Co-Vice EAGLES Chairman, (China) progress. booming achieving is field this in research the also but years, recent in intensified views opposing These create has a dilemma. Thus, the public debate about the use of plant biotechnology threat. basic a as them view others environment, the and Many Biotech tools are considered a “powerful and safe» way to improve agriculture (II) –Environment (Small Theater) Debate The Benefits: PanelAgricultural and SafetyEnvironmentalBiotech, B-4: Pierre Bey, Former Director, Institut Curie (France) (UK) David Kerr, Centers (Egypt) Establishment andDevelopment ofOncology ElZawawy, Ahmed Clet Niyikiza, Vice President ofGlaxoSmithKline (USA) Pierre Anhoury, Senior Vice President, KantarHealth (France) Projacs International (Egypt) : Rapporteur Chair: Farha Abd El-Aziz,Vice President, Mansoura University (Egypt) Rhodes Salah Soliman, Salah ie rsdn, ua Rsucs n Administration, and Resources Human President, Vice Nakhla, Rafik ie rsdn, eerh n Dvlpet Ltn mrc Foods, America Latin Development, and Research President, Vice Professor of Clinical and Pharmacology Cancer, University of Oxford rsdn ad is Fudr Itrainl apin for Campaign International Founder, First and President rfso, aut o Agriculture, of Faculty Professor, lxnra University Alexandria Provisional Program BioVisionAlexandria April 2010 17:00-17:30 15:30-17:00 15:30-17:00 17:30-19:00 Day 3 Day 3 Day 3 Panel C-4: The 21 Haskell Sears Ward, Senior Vice President, Government Relations, SEACOM (USA) James Geraghty, Senior Vice President, Genzyme (USA) Paul Herrling, Head, Corporate Research, Novartis International AG (Switzerland) Clet Niyikiza, Vice President ofGlaxoSmithkline (USA) Jacques-François Martin, President andCEO,Parteurop (France) Chair: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) Evening Event: CEOPanel (Great Hall) Athens (Greece) of UniversityPsychiatry, of Department Consultant, Special and Houston of University PeriklisKtonas, (FORTH), (IMBB)(Greece) Institute andBiotechnology ofMolecular Biology Kafetzopoulos Dimitris, Principal Researcher, Foundation for Research and Technology Psicología, de Facultad University ofSeville (Spain) Laboratory, Neuropsychology Human León-Carrión, José Evangelos M.Mylonas, R&DDirector, DAEDALUS INFORMATICS Ltd(Greece) Chair: tba related other among presenteditems. be will Interfaces Machine Brain and Cognitive Sciences, Modeling, Brain like Issues Neuroengineering. and Neurosurgery, Neuroprosthetics concerning topics discuss will which Advancing», Brain - Aging brain-related«Braingeneralof theme advancementsthe research, related to under the of framework the BIOVISION 2010, are within proud to co-organize Alexandrina,a focused session on a Bibliotheca state-of-art issue the and DAEDALUS Co-organized withDaeDalus Track 6:Brain Aging-BrainAdvancing: Plenum 1(Delegates Hall) Magdy Madkour, Professor, Faculty ofAgriculture, AinShams University (Egypt) Clive James, andFounder, Chairman ISAAA(Cayman Islands) Klaus Ammann,Guest Professor, Delft University of Technology (The Netherlands) Nottingham (UK) Cocking, Edward Research, Alexandria University (Egypt) Rapporteur: Improvement (UK) Chair: (Prof. Improvement Crop for Malcolm Elliott) Institute Borlaug Norman the with Co-organized “A TtributetoNorman Borlaug” Food andAgriculture (Lecture Hall) acl Elliott, Malcolm Poesr Hg Isiue f rdae tde and Studies Graduate of Institute High Professor, Hassouna, Salah Professor Emeritus, Electrical and Computer Engineering Department, Department, Engineering Computer and ProfessorElectricalEmeritus, st Century Challenge: Century A Green Way to Sustainable Agriculture ietr te ete o Co Ntoe Fxto, nvriy of University Fixation, Nitrogen Crop for Centre the Director, xctv Drco, h Nra Brag nttt fr Crop for Institute Borlaug Norman the Director, Executive Networking Coffee/Tea Break -
23 BioVisionAlexandria 2010 24 BioVisionAlexandria 2010 17:30-19:00 Day 3 cecs ad ri Mcie nefcs il e rsne aog te related other among presenteditems. be will Interfaces Machine Brain and Cognitive Sciences, Modeling, Brain like Issues Neuroengineering. and Neurosurgery, Neuroprosthetics concerning topics discuss will which Advancing», Brain - Aging brain-related«Braingeneralof theme advancementsthe research, related to under the of framework the BIOVISION 2010, are within proud to co-organize Alexandrina,a focused session on a Bibliotheca state-of-art issue the and DAEDALUS Co-organized withDaeDalus Track 6:Brain Aging-BrainAdvancing: Plenum 2(Delegates Hall) Texas Medical School(USA) Andrew C. Papanicolaou, Nitish V. Thakor, Technical University ofCrete (Greece) Zervakis, Michalis Evangelismos Hospital (Greece) Sakas, E. Damianos Chair: tba Professor of Biomedical Engineering, Johns Hopkins University (USA) ietr te iia Iae n Sga Poesn Laboratory, Processing Signal and Image Digital the Director, rfso o Nuougr, nvriy f tes Mdcl School Medical Athens, of University Neurosurgery, of Professor Director, Center for Clinical Neurosciences, the University of Provisional Program BioVisionAlexandria April 2010 9:00-10:30 9:00-10:30 Day 4 Day 4 what are itsnewest implications? and offer technology new does what So, diseases. of lot a for treatments promising certainly donot They provide to technologies effective and compelling diseases? are they yet wand, magic a supply to all incurable treatment to finding hope offer discoveries in the medical and pharmaceutical field. But, do new technologies really and researchmore and more to door the open Biotechnology and technology Gene Panel A-5:New Technologies inHealth: New Hope -Health (Great Hall) Tobias Wagner, Research Associate, Technische Universität München (Germany) Philip Wexler, Technical Information Specialist, National Library ofMedicine (USA) João Paes deCarvalho,Principal, BiznessBrazil (Brazil) (Egypt) Soliman, Salah : Rapporteur of Nature (IUCN)(Switzerland) : Chair to order in environment sustain thisdevelopment our inpresent andinthefuture. save to need the with development economic and are social for people of environment need the equilibrating about whole all is Concisely,it needs. the pressing of continuity the finding threatening toward problems approaches to development, solutions sustainable of backbone the as serves environment the that Considering this. do to Greenhope only methods, our indeed conservation Technologyis simple by planet our save to act can all we While Environment (Lecture Hall) - Prospects Better Development: Sustainable TechnologyGreenand B-5: Panel Patterson AirForce Base (USA) Laboratory, Research Wright Force Air Directorate, Effectiveness Human Biotechnology, Saber Hussain, Scientist—Group Lead, Biological Interaction of Nanomaterials Applied Vienna (Austria) Gabain , von Alexander Alexandria University (Egypt) Medicine, of Faculty Center, Genomics Clinical Director, , Kassem Heba (Egypt) Hassan , Azzazy Projacs International (Egypt) : Rapporteur (Egypt) Chair: Yehia Zaky, Jeffrey McNeely , Vc Peiet Hmn eore ad Administration, and Resources Human President, Vice Nakhla, Rafik Chairman, Chairman, Department of Chemistry, the American University in Cairo Head, Academic and Cultural Affairs Sector, Bibliotheca Alexandrina Thursday, 15 April 2010 rfso, h Mx . euz aoaois te nvriy of University the Laboratories, Perutz F. Max the Professor, SeniorAdvisor,Science International Union Conservation for rfso, aut o Agriculture, of Faculty Professor, lxnra University Alexandria
25 BioVisionAlexandria 2010 26 BioVisionAlexandria 2010 10:30-11:00 9:00-10:30 9:00-10:30 Day 4 Day 4 Nadia, Technical Alansary President Assistant, Office,ASRT (Egypt) (Egypt) Sector,InnovationDevelopmentASRT the Tarek and InventionSupervisor, the , Kapiel of theInvention andtheInnovation Development Sector, ASRT (Egypt) Shabrawy, El Mervat Mahmoud Sakr, Vice President, ASRT (Egypt) (Egypt) how canwe enhancethequalityforimproved nutrition. and food in priorities the are what know to important is it Therefore, nutrition. and security food for implications intense have which areas in research support to significance global of is it So, big. is practice into research the translate quickly to need the escalating, continuously is food of demand global the As century. this of challenge greatest the is food safe and adequate for source sustainable a Creating (Small Theater) Panel C-5:Priorities inFood andFood Security -Food andAgriculture Tarek Chair: tba of Youth (EAY). presented.be In ASRTsession, this President Academy introduceEgyptian will the will plan future and assessment impact achievements, its including biotechnology and engineering genetic for strategy national the of Moreover,overview detailed a agreements. international and programs ongoing ASRT for the and fund studies ASRT scientific prizes, state the showcase also will It innovators. and inventors to support monetary and grants research Ph.D. and M.Sc. programs,its facilities, fellowship (ASRT), and Technology Research Scientific of Academy Egyptian the about details know to chance the have will attendees the session, the During Co-organized withASRT (Prof. Tarek Hussein) (Delegates Hall) Track 7:Academy ofScientific Research and Technology - Egypt (ASRT) : Rapporteur (USA) Chair: Vivian Lowery Derryck, the and Agriculture Food, for Vision Environment Initiative (USA) 2020 IFPRI’S Head, Pandya-Lorch, Rajul (Belgium) Marc Van Montagu, Elected and Acting president, the European Federation of Technology Research, Alexandria University, (Egypt) Development (USA) and Agriculture Food, for Institute International Cornell Professor, Uphoff, Norman for Educational Development (USA) Hussein, Robert J. Berg, Senior Advisor, World Federation of United Nations Associations aa Hassouna , Salah President, Egyptian Academy of Scientific Research & Technology Research Scientific of Academy Egyptian President, Professor, Faculty of Medicine, Suez Canal UniversitySupervisor Canal Professor, SuezMedicine, Facultyof Senior Vice President and Director, Public Policy, the Academy Networking Coffee/Tea Break rfso, ih nttt o Gaut Suis and Studies Graduate of Institute High Professor, Provisional Program BioVisionAlexandria April 2010 12:30-13:30 11:00-12:30 11:00-12:30 Day 4 Day 4 Dianna Derhak, Director, Business Development, EPOS(USA) University (Egypt) Mona K. Marei, Head, Tissue Engineering Laboratories, Faculty of Dentistry, Alexandria John, President, Kilama Global Bioscience Development Institute (USA) Claudio Carlone Hypothesis, Chairman, (Italy) Affairs, Harvard University (USA) Science, Technology, and Globalization Project, Belfer Center for Science and International Calestous Juma, of Toronto (Canada) Chair: 21 the for technology and science Rethinking Alexandrina (Egypt) Adly,Noha of University Celaya Obstetrics, and Guanajuato (Mexico) Nursing of School Professor, Padilla, Nicolas for theEastern Mediterranean (Egypt) Shorbaji, El Najeeb Jianshi Huang President,, Assistant ChineseAcademy ofMedical Sciences(China) Francois Sauer , CEO, Trans Am Group (USA) of Medicine (USA) School Pittsburgh, UniversityMedicine,of Professor of Faina ResearchAssistant Linkov, Novosibirsk Medicine, Internal (Russia) of Institute Scientist, Research Shubnikov, Eugene of Pittsburgh (USA) Ronald , Laporte Professor of Epidemiology, Graduate School of Public Health, University Key Note Presentation: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) Administration, and Projac International (Egypt) Resources Human President, Vice Nakhla, Rafik Rapporteur: University ofPittsburgh (USA) Chair: SessionPlenary 6:ScienceSupercourse (Great Hall) Track 8:Rethinking Scienceand Technology inthe21 and new technology innovations are implemented. and newtechnology throughincreasingsustained be rateonly the discoveriesnew which arewith made can is innovation.this But technology and do discovery scientific of support the through we rate the at resources Earth use to way only The technology. and science , Professor of Medicine, University Health Network and University and NetworkHealth University Medicine, of ProfessorPeter Singer, Professor of Epidemiology, Graduate School of Public Health, Public of School GraduateEpidemiology, of Professor , Laporte Ronald Deputy Head, Information Communication TechnologySector,BibliothecaCommunication Information Head, Deputy Professor of the Practice of International Development and Director, the Coordinator, Health Information Support, WHO Regional Office Regional Support,WHO Information Coordinator,Health Lunch Break st etr: oit i dpnet on dependent is society Century: st Century (Delegates Hall) Century
27 BioVisionAlexandria 2010 28 BioVisionAlexandria 2010 15:30-17:00 15:00-15:30 13:30-15:00 Day 4 Day 4 Francois Gros, Permanent Honorary Secretary, Académie desSciences (France) Ismail Serageldin , Director, Bibliotheca Alexandrina (Egypt) Richard Roberts, Medicine 1993(UK) SessionPlenary 8:ClosingSession (Great Hall) Studies andResearch, Alexandria University (Egypt) FoodAgricultureand Stream: Projacs International (Egypt) Stream:Health University (Egypt) Stream: Environment Projac International (Egypt) Plenary Sessions: SessionPlenary 7:Reporting Session (Great Hall) , Vice President, Human Resources and Administration, and Resources HumanPresident, ViceNakhla, Rafik Rafik Nakhla, Vice President, Human Resources and Administration, aa Soliman, Salah Networking Coffee/Tea Break Salah HassounaSalah, rfso, aut o Agriculture, of Faculty Professor, Professor,GraduateInstituteHighof Provisional Program Alexandria BioVisionAlexandria April 2010 Speakers List
29 BioVisionAlexandria 2010 30 BioVisionAlexandria 2010 A Track 7 Technical President Assistant, Office,Academy ofScientific Research and(Egypt) Technology Alansary, Nadia Session 6 Plenary Deputy Head, Information Communication Technology Sector, Bibliotheca Alexandrina (Egypt) Adly, Noha Track 1Plenum 1 Director, Strategic Resources Unit, NWRC (Egypt) Abdin, AlaaEl-Din Panel A-4 Vice President, Mansoura University (Egypt) Abd El-Aziz,Farha Session 2,ClosingSession Economics 2007(USA) Chemistry 2003(USA) Chemistry Medicine 1993(USA) Roberts, Richard Maskin, Eric Agre, Peter Session 1 Session 1 Nobel Laureates Speakers Physiology orMedicine 2005(Australia)Physiology Chemistry 2002(Switzerland)Chemistry Literature 1986(Nigeria) Warren, John Robin Wüthrich, Kurt Soyinka, Wole Session 1 Session 2 Session 2 Speakers’ Biographies &Abstracts BioVisionAlexandria April 2010 B Track 2 Applied Systems Analysis (Austria) Fellow, Centre forInternational Governance Innovation and Research Scholar, International Institute for Blackstock, Jason Panel A-4 Former Director, Institut Curie (France) Bey, Pierre Track 5Plenum 1, Track 5Plenum 2 andManaging Director,Co-Chairman Tech Investor Ltd(UK) Berrie, Morris Track 2,Panel B-1,Panel C-5 Senior Advisor, World Federation ofUnited Nations (USA) Associations Berg, Robert J. Track 1Plenum 2 Director, Catalan Institute on Water Research (Spain) Barcelo, Damia Panel B-4 Professor Emeritus, ofGenetics, Department Faculty ofAgriculture, Alexandria University (Egypt) Badr, Effat Panel A-5 ofChemistry, Department Chairman, theAmerican University inCairo (Egypt) Azzazy, Hassan Track 1Plenum 2 Professor, European Membrane Institute ofMontpellier (France) Ayral, André Panel A-1 Director, Biotechnology Training andResearch Unit, Palestine Polytechnic University (Palestine) Ashhab, Yaqoub Session 1,Session 2,Panel A-4 Senior Vice President, KantarHealth (France) Anhoury, Pierr Track 2,Panel B-1 President Emeritus, World Academy ofArt andScience(USA) Anderson, Walter Truett Panel C-4 Guest Professor, Delft University of Technology (The Netherlands) Ammann, Klaus Session 6 Plenary Director, Knowledge Management andSharing (Switzerland) Al Shorbaji, Najeeb e
31 BioVisionAlexandria 2010 32 BioVisionAlexandria 2010 C D Director, Centre forCrop Nitrogen Fixation, University ofNottingham (UK) Cocking, Edward Track 5Plenum 2 Head, Relations, External theBabraham Institute (UK) Cockcroft, Claire Elizabeth Track 5Plenum 2 Vice President, European Federation (Denmark) ofBiotechnology Clark, Brian F.C. Panel A-2 Former Norwegian Minister ofHealth (Norway) Christie, Werner Session 5 Plenary Chair, BOT Crop Diversity Trust (Canada) Catley-Carlson, Margaret Track 8 HypothesisChairman, (Italy) Carlone, Claudio Panel A-1 Director, MRC Innovation Centre (SouthAfrica) Bunn, Anthony Session 1 Plenary Professor andMedicine, ofBiochemistry ofBiochemistry, Department Stanford University (USA) ,DouglasBrutlag Plenary Session 3 Plenary Professor, ScuolarSuperior Sant’Anna (Italy) Dario, Paolo Track 2 Dean, Geoscience Faculty, Freie Universität Berlin (Germany) Cubasch, Ulrich Track 1,Plenum 3 Director, SIMEVandUNESCO Chair(France) Cot, Louis Session 5 Plenary Founder, Ecoconsult Inc. (Canada) Cosgrove, William Panel C-4
Speakers’ Biographies &Abstracts BioVisionAlexandria April 2010 F E Track 1Plenum 2 Vice-President, Pall Industry (France) Farcy, Michel Track 3 Scientific Research (Egypt) Coordinator, Research Development andInnovation Program, ofHigher Ministry Education and El-Zoheiry, Abdel Hamid Panel A-4 Centers (Egypt) President andFirst Founder, International Campaign forEstablishment andDevelopment ofOncology ElZawawy, Ahmed Panel B-2 CEO, Nokraschy Engineering GmbH(Germany) El-Nokraschy, Hani Panel C-3,Panel C-4 Executive Director, theNorman Borlaug Institute forCrop Improvement (UK) Elliott, Malcolm Panel C-3 Chair, Global Forum onAgricultural Research (Egypt) El-Beltagy, Adel Track 5Plenum 2 Executive Director, theUnited Nations Officefor (USA) Partnerships Dossal, Amir Track 6Plenum 1 (IMBB)(Greece)and Biotechnology Principal Researcher, Foundation forResearch and Technology (FORTH), Institute ofMolecular Biology Dimitris, Kafetzopoulos Opening Session the Chairman, World Life SciencesForum, BioVision (France) Desmarescaux, Philippe Panel A-2, Track 8 Director Business Development, EPOSUSA(USA) Derhak, Dianna Panel C-3 Deputy Director General, Indian CouncilofAgricultural Research (India) Datta, Swapan
33 BioVisionAlexandria 2010 34 BioVisionAlexandria 2010 G Panel A-1 Senior Director, Technology Rib-X,Inc. (USA) Franceschi, Francois Track 5Plenum 1 President, Fondacaro Consulting,Demographic &Associates Info Biotechnology, Cincinnati Area (USA) Fondacaro, Joe Panel A-2 Director ofGlobal Health, theChildren’s Hospital ofPhiladelphia (USA) Finalle, Rodne Session 2 Plenary Science and Technology Adviser totheSecretary ofState andtotheAdministrator ofUSAID(USA) Fedoroff, Nina Track 1Plenum 1 Former President, French Academy of Technology (France) Guinot, Francois Closing Session Permanent Honorary Secretary, Académie desSciences,France (France) Gros, François Opening Session CEO, The World Life Sciences Forum, BioVision (France) Grenier, Christian Session 5 Plenary (USA) Co-founder andPresident, thePacific Institute for Studies in Development, Environment, and Security Gleick, Peter H. Track 2,Panel B-1 Co-Founder andDirector, Programs, World Future Council (UK) Girardet, Herbert Track 5Plenum 1 Division,DirectorateHead, Biotechnology forScience, Technology andIndustry, OECD(France) Gillespie, Iain CEO Panel Senior Vice President, Genzyme (USA) Geraghty, James A. Track 5Plenum 1 CEO, Vision-IPR (India) Ganguli, Prabuddha y Speakers’ Biographies &Abstracts H BioVisionAlexandria April 2010 Track 7 President, Academy ofScientific Egyptian Research and (Egypt) Technology Hussein, Tarek Panel A-5 Effectiveness Directorate, Air Force Research Laboratory, Wright Patterson Air Force Base (USA) Scientist—Group Lead,Biological Interaction ofNanomaterials Applied Biotechnology, Human Hussain, Saber Track 3 Director, DAAD,Cairo Office (Germany) Hülshörster, Christian Session 6 Plenary PresidentAssistant ofChineseAcademy ofMedical Sciences(China) Huang, Jianshi Panel B-2 ProfessorAssistant inArchitecture andUrban Design, Technical University (Germany) Darmstadt Hesse, Christoph CEO Panel Head ofCorporate Research, Novartis International AG (Switzerland) Herrling, Paul Panel A-3 President andCEO,Medicines forMalaria Venture (Switzerland) Hentschel, Christopher Opening Session Minister ofHigher Education andScientific Research (Egypt) Helal, Hany Session 1 Plenary RIKEN (Japan) Project Director andChiefScientist,Genome Exploration Research Group, Genomic SciencesCenter, Hayashizaki, Yoshihide Panel C-1,Panel B-2,Panel C-3,Panel C-4,Panel Session C-5,Reporting Professor, High Institute ofGraduate Studies andResearch, Alexandria University (Egypt) Hassouna, Salah Opening Session Academy ofSciences Executive Director, TWAS-the Academy ofSciencesfortheDeveloping World; andPresident, African Hassan, Mohamed
35 BioVisionAlexandria 2010 36 BioVisionAlexandria 2010 J I K Track 8 Globalization Project, Belfer Center forScienceandInternational Affairs, Harvard University (USA) Professor ofthePractice ofInternational Development andDirector, theScience, Technology, and Juma, Calestous Panel C-4 andFounder,Chairman ISAAA(Cayman Islands) James, Clive Track 3 Materials (Germany) Head, Research Group “Biomedical Materials andImplants”, Fraunhofer-Institute forMechanics of Jäger, Raimund Session 3 Plenary Professor, Osaka University (Japan) Ishiguro, Hiroshi Joh Kilama, n Panel A-4 andCancer,Rhodes Professor ofClinicalPharmacology University ofOxford (UK) Kerr, David Session 1 Plenary Director, Genetic Interest Group (UK) Kent, Alastai r Panel A-5 Director, ClinicalGenomics Center, Faculty ofMedicine, Alexandria University (Egypt) HebaKassem, Track 7 and Technology (Egypt) Supervisor, Invention andtheInnovation Development Sector, Academy ofScientific Egyptian Research Kapiel, Tarek Panel A-1 CEO, Knowmix Cape Biotech Trust (South Africa) Kotze, Maritha Track 8 President, Global Bioscience Development Institute (USA) Speakers’ Biographies &Abstracts L BioVisionAlexandria April 2010 M Plenary Session 2 ,PanelPlenary C-4 Chairman, Technical Committee,Agricultural Research forDevelopment Fund-ARDF (Egypt) Madkour, Magdy Panel C-2 Monsanto Corporate AffairsLeadinAfrica(Kenya) M’Mbijjewe, Kinyua Panel C-5 Senior Vice President andDirector, Public Policy, theAcademy forEducational Development (USA) Lowery Derryck, Vivian Session 6 Plenary Research Professor Assistant ofMedicine, University ofPittsburgh School ofMedicine (USA) Linkov, Faina Track 6Plenum 1 Human Laboratory Neuropsychology Facultad dePsicología, University ofSeville (Spain) León-Carrión, José Panel A-3 President andExecutive Director, Novartis Foundation forSustainable Development (Switzerland) Leisinger, KlausM. Panel B-1 Professor,Associate freie Universität Berlin (Germany) Leckebusch, Gregor C. Panel A-1 Head, Novartis Vaccines Academy, Novartis Vaccines andDiagnostics(Italy) Lazdins-Helds, Janis K. Session 6 Plenary Professor ofEpidemiology, Graduate SchoolofPublic Health, University ofPittsburgh (USA) RonaldLaporte, Track 1Plenum 2 Senior Engineer, SUEZEnvironment (France) Langlais, Chrystelle Track 6Plenum 1 ofPsychiatry,Consultant, Department University ofAthens (Greece) Professor Emeritus, Electrical andComputerEngineering University Department, ofHouston andSpecial Ktonas, Periklis Track 5Plenum 2 Research Professor, Arizona State University (USA) Krattiger, Anatole
37 BioVisionAlexandria 2010 38 BioVisionAlexandria 2010 R &DDirector, DAEDALUS INFORMATICS Ltd(Greece Mylonas, Evangelos M. Panel A-3 Director, AfricanCentre forGene Technologies (SouthAfrica) Morris, Jane Panel C-2 Professor, National Research Center (Egypt) Moawadhe, Hassan Session 2 Plenary President, International Conservation (USA) Mittermeier, Russell A. Session 2,PanelPlenary B-5 Senior ScienceAdvisor, International Union ofNature-IUCN forConservation (Switzerland) McNeely, Jeffre Track 4 (Germany) Professor, ofPediatric Department andImmunology, Pneumology CharitéUniversity Medical Centre Matricardi, Paolo Session 1 Director General, the World Union-IUCN Conservation (Switzerland) Marton-Lefevre, Julia CEO Panel President andCEO,Parteurop (France) Martin, Jacques-François Track 8 Head, Tissue Engineering Laboratories, Faculty ofDentistry, Alexandria University (Egypt) Marei, Mona K Panel C-2 Forestry (Nigeria) Professor ofAnimal ScienceandFormer Dean oftheSchoolAgriculture, Rural Development and Makinde, Diran Session 3 Plenary CEO, Aldebaran Robotics (France) Maisonnier, Bruno Panel C-2 Director ofScientific Publications (France) Mainguy, Gaël Session 1 Plenary (USA) Professor, ofMolecular Department Biology, Princeton University andFormer President, Merck Vaccines Mahmoud, Adel Track 6Plenum 1 y ) Speakers’ Biographies &Abstracts N BioVisionAlexandria April 2010 O Opening Session Founder theScienceand andChairman, Technology inSociety(STS)Forum (Japan) Omi, Koji Session 1 Plenary Professor ofMedicine, Genetics, andPublic Health, University ofMichigan (USA) Omenn, Gilbert Panel A-2 Director, theInternational Futures Programme andtheGlobal ScienceForum, OECD(France) Oborne, Michael Panel C-2 Foundation (AATF) (Nigeria) Project Manager, Water EfficientforAfrica(WEMA),African Maize Agricultural Technology O. Oikeh, Sylvester Panel B-3 Researcher, National Research Center onFood Technology, Embrapa (Brazil) Nutti, Marilia Track 1Plenum 3 Principal Research Scientist,KAUST Membranes Research Center (Germany) Nunes, Suzana Panel A-2 Founder andProfessor Emeritus, ECRIInstitute (USA) Nobel, Joel Panel A-4,CEOPanel Vice President, GlaxoSmithKline (USA) Niyikiza, Clet Session 4 Plenary Co-Director, Center forNeuroengineering, DukeUniversity Medical Center (USA) Professor Biomedical ofNeurobiology Engineering andPsychological andBrain Sciences;and Nicolelis, Miguel Opening Session PrimeEgyptian Minister (Egypt) Nazif, Ahmed Rapporteur Vice President, Human Resources andAdministration, Projacs International (Egypt) Nakhla, Rafik
39 BioVisionAlexandria 2010 40 BioVisionAlexandria 2010 P R Track 4 Professor ofParasite Immunology, Schoolof Pharmacy, University ofNottingham (UK) Pritchard, David Panel B-4 Founder andCMD,Avesthagen Limited (India) Patell, Villoo Morawala Panel B-3 Botanical Garden, University (Netherlands) ofBern Papazov, Biljana Track 6Plenum 2 Director, Center forClinicalNeurosciences, theUniversity of Texas Medical School(USA) Papanicolaou, Andrew C. Track 3 Coordinator EUScienceCounsellor(Cyprus) andAssistant, Papageorgiou, Kyriaki Panel C-5 Head, IFPRI’S 2020 Vision forFood, Agriculture andtheEnvironment Initiative (USA) Pandya-Lorch, Rajul Panel B-4 Director, LatinAmerican Federation (Uruguay) CompaniesAssociation ofNational Biotechnology Pagliano, Daniel Panel B-2,Panel B-5 Principal, BiznessBrazil (Brazil) Paes deCarvalho,João Session 6 Plenary Professor, SchoolofNursing andObstetrics, Celaya University ofGuanajuato (Mexico) Padilla, Nicolas Panel B-4 Vice President, Research andDevelopment, LatinAmerica Foods, PepsiCo (Mexico) Rivero, Carmela Track 1Plenum 3 EuropeanChairman, Membrane House (France) Rios, Gilbert M. Panel A-1 Professor, DigitalMolecular Medicine, Simon Bolivar University (Venezuela) Rafael Rangel-Aldao, Speakers’ Biographies &Abstracts S BioVisionAlexandria April 2010 Track 1Plenum 1 Professor, University ofJordan andUNESCO Chair, EOLSS(Jordan) Shatanawi, Muhammad Track 7 Professor, Faculty ofMedicine, Suez Canal University (Egypt) Shabrawy, Mervat Panel C-1 Deputy President, Agriculture of Association Young Farmers-Spain (ASAJA)(Spain) Serra, Ricardo Closing Session Opening Session, Session Plenary 3,Plenary 4,Panel C-3,CEOPanel, Session Plenary 6, Director, Bibliotheca Alexandrina (Egypt) Serageldin, Ismail CEO Panel Senior Vice President, Government Relations, SEACOM (USA) Sears Ward, Haskell Track Session 5 1Plenum 3,Plenary R&D Manager, VEOLIA-Membrane House (France) Schrotter, Jean-Christophe Track 1Plenum 3 Director, Bio-processes Laboratory, University ofSfax(Tunisia) Sayadi, Sami Session 6 Plenary CEO, Trans Am Group (USA) Sauer, Francois Track 7 Vice President, Academy ofScientific Egyptian Research and (Egypt) Technology Sakr, Mahmoud Track 6Plenum 2 Professor ofNeurosurgery, University ofAthens, Medical SchoolEvangelismos Hospital (Greece) Sakas, Damianos E. Track 4 Professor ofMedical Microbiology, University CollegeLondon(UK) Rook, Graham Track 1Plenum 1 CSIC-Coordinator, MIRAProject, EU(Spain) Rodriguez, Rafael
41 BioVisionAlexandria 2010 42 BioVisionAlexandria 2010 Kansas(USA) V U T Rapporteur Professor ofPesticide & Chemistry Toxicology, Faculty ofAgriculture, Alexandria University (Egypt) Soliman, Salah Panel A-3, Track 8 Professor ofMedicine, University Health Network andUniversity of Toronto (Canada) Singer, Peter Session 6 Plenary Research Scientist,Institute ofInternal Medicine, Novosibirsk (Russia) Shubnikov, Eugene Panel B-3 UniversityCornell (USA) Director, Agricultural Support Project Biotechnology (ABSP)II,CollegeofAgriculture andLife Sciences, Shotkoski, Frank Track 1Plenum 2 Vice-President, BioSciences-Fresenius (Germany) Vienken, Jorg Session 2,PanelPlenary C-5 President, theEuropean Federation EFB(Belgium) ofBiotechnology- Van Montagu, Marc Panel C-3,Panel C-5 Professor, International Cornell Institute forFood, Agriculture andDevelopment (USA) Uphoff, Norman Panel C-1 Cotton Grower (Burkina Faso) (Burkina Faso) Traoré, François Session 2 Plenary Distinguished Professor andChair, ofMedicinal Department Chemistry, School ofPharmacy, University of Timmermann, Barbara Track 6Plenum 2 Professor ofBiomedical Engineering, Johns Hopkins University (USA) Thakor, Nitish V.
Speakers’ Biographies &Abstracts
W BioVisionAlexandria April 2010 Z Y Track 6Plenum 2 Director, Digital Image andSignal Processing Laboratory, Technical University ofCrete (Greece) MichalisZervakis, Session 2 (USA) Former Director, National Institutes ofHealth andSenior Fellow, Bill andMelinda Gates Foundation Zerhouni, Elias Panel A-3,Panel A-5 Head, Academic andCultural Affairs Sector, Bibliotheca Alexandrina (Egypt) Zaky, Yehia Panel C-1 Industry (ESIA)(Egypt) Association andManaging Director,Chairman Fine Seeds Seed andInternational. Egyptian Deputy Chairman, Yaseen, Adel Session 1,PanelPlenary B-3,Panel B-4 Research Center (China) Director, Beijing Genomics Institute, ChineseAcademy ofSciencesandDirector, Huada Genomics Yang, Huanming Panel B-1,Panel B-2 Executive Director, United (USA) Association States Energy Worthington, Barry Panel B-5 Technology Information Specialist, National Library ofMedicine (USA) Wexler, Philip Session 4 Plenary Professor ofCybernetics, University ofReading (UK) Warwick, Kevin Panel B-5 Research Associate, Technische Universität München (Germany) Wagner, Tobias Panel A-5 Professor, Max F. Perutz Laboratories, University of Vienna (Austria) Von Gabain, Alexander
43 BioVisionAlexandria 2010 44 BioVisionAlexandria 2010 Nobel Laureates BioVisionAlexandria April 2006 Nobel Laureates
45 BioVisionAlexandria 2010 46 BioVisionAlexandria 2010 Society. causa, honoris Theory Game President-elect, Doctorate Cambodia; of University College; and Budapest Bardof University Corvinus Letters, Humane of Doctor Sciences; of Academy of School NationalMember, Sciences; Economic in Higher Prize Nobel University; Shenzhen Moscow and Economics, University, Tsinghua University, Wuhan Professor, Academy; British Honorary Fellow, Corresponding 2007; Economics, Environmental Award, Kempe Cambridge; College, Jesus and John's Fellow,St Honorary 1992-; Letters Economics Editor, Fellow, American Academy of Arts and Sciences; Fellow, Econometric Society (President, 2003), 1981; Sloan Foundation Fellow, 1983-85; Editor, Quarterly Journal of Economics, 1984-1990; 2000-; Study,Director, Summer Advanced School in Economic for Theory, Hebrew Institute Professor,University, Hirschman 2008-; Guggenheim Fellow, O. Albert 1997-2000; Harvard, Technology,Professor,1981-84; BerkmanLouis Harvard,Professor1985-2000, Economics,of Agre becamePresident oftheAmericanAssociationforAdvancement ofSciences. for which he was chairman and on serves the Committee on Human Rights. In February 2009, Medicineof Institute the and Sciences Nationalof Academythe of member a is Agre America. of Merit from King Harald V, and the Distinguished Eagle Scout Award from the Boy Scouts of other honors including 15 honorary doctorates, Commandership in the Royal Norwegian Order physiological processes in humans and is implicated in multiple clinical disorders. Agre received numerous for responsible is which naturethroughout found proteins channel water of family a Publicof Health. In 2003, Agre School shared the Nobel PrizeBloomberg for in DiscoveringChemistry Aquaporins, the at Institute Research Malaria the of Director and University the at Professor became he where 2008, January in HopkinsJohns to Biology.returned AgreCell of Jesus College, Cambridge, 1976-77; Professor, Massachusetts Institute of Institute MassachusettsProfessor, 1976-77; Cambridge, College, Jesus Fellow, Research 1976; Harvard, Ph.D, 1972; University, Harvard A.B, to game theory, political economy and, contract theory, among other areas. 2007 Nobel Memorial Prize in Economics. He has also made contributions of mechanism design. For laying the foundations of this field he shared the Eric Maskin is an economic theorist best known for his work on the theory 2007 Economics Eric MASKIN, as Vice Chancellor for Science and Technology and James B. Duke Professor moved to the Duke University School of Medicine where he was appointed of rank Professorthe of Biological Chemistry to and Professor rose of Medicine. In and 2005, Agre 1984 in Medicine of School Hopkins joined Johns Agre the 1974). (M.D. Hopkins Johns at medicine and 1970) (B.A. College Augsburg at chemistry studied Agre Peter Minnesotan, native A 2003 Chemistry Peter AGRE,
Nobel Laureates annotation ofsequencedbacterialandarchaeal genomes. functional improvethe to workingnow also Heis focus. research major a is systems restriction new find to genomes microbial of studies Bioinformatic flipping. base of discovery the to led methyltransferase HhaI the for structures restriction-modification crystal first the and interest active of of also are systems components as methyltransferases, DNA area. this in computers of application the pioneered Adenovirus-2 laboratory his the and essential of became tools sequencing computational genome the During 1993. in Medicine in Prize Nobel the received he which for 1977, in splicing mRNA and genes split of discovery the to led Adenovirus-2 in haveenzymes these researchand major 1972 a in been enzymes Studiestheme. transcription of restriction discoveredType II newly the on work began Watson.He J.D. asapostdoctoral Laboratory, eventually becoming Assistant Director for Research under Dr. moved then and SpringHarbor Cold at worked he 1992, Fromto Harvard. 1972 to fellow University Sheffield from 1968 in New England at Officer Scientific Biolabs, Beverly, Chief Massachusetts. He received a the Ph.D. in Organic Chemistry is Roberts J. Richard Dr. 1993 Medicine Richard ROBERTS, BioVisionAlexandria April 2006 1986 Literature WoleSOYINKA,
47 BioVisionAlexandria 2010 48 BioVisionAlexandria 2010 honorary degrees. honorary and awards other of number a by and Chemistry, in Prize NobelTechnology, Advanced the in PrizeKyoto the Médecine, de Jeantet Louis Prix the by recognized been have achievements KurtWüthrich’s species. of variety a from proteins prion and system, regulatory transcriptional the immunosuppression system cyclophilin A/cyclosporin A, the homeodomain–operator DNA including acids, nucleic and proteins of structures NMR of number large a solved have groups The Wüthrich solution. in acids nucleic and proteins of determination structure dimensional biological macromolecules, where with he Spectroscopy contributed (NMR) the Resonance NMR Magnetic method Nuclear of is three- specialty His genomics. structural in and biology, structural molecular in are interests California, USA, where he is a Professor of Structural Biology. His research Switzerland, Zürich, ETH where he is a Professor the of Biophysics, and The Scripps Research Institute in between time his shares Wüthrich Kurt 2002 Chemistry WÜTHRICH, Kurt 2005 Physiology orMedicine WARREN, John Robin Nobel Laureates BioVisionAlexandria April 2010 Speakers’ Biographies
49 BioVisionAlexandria 2010 50 BioVisionAlexandria 2010 presented invarious conferences andpublishedinprofessional journals. articles and papers research 80 over of author the is He informatics. health and management information in specialized associations and societies professional international and national of knowledgenetworks, eHealth, and HeCenters. Collaborating WHO number a of member a is in 1986. Dr Al-Shorbaji’s portfolio covers WHO publishing activities and programs, library and Eastern Mediterranean Region until August 2008. He obtained his PHD in Information Sciences and Coordinator for Knowledge Management and Sharing for the WHO the for Sharing Telecommunicationand Management Knowledge for Coordinator and and Management Information Health for Advisor Regional Scientist, Information of September posts the held since he that to Prior Geneva 2008. in (WHO/HQ) the Headquarters at Organization Director as working been Department of Knowledge Management and Sharing at the World Health has citizenship, Jordanian Najeeb, Director, Knowledge Management andSharing (Switzerland) Al Shorbaji Abd Vice President, Mansoura University El-Aziz, , Najeeb
Farha
Speakers’ Biographies &Abstracts Bibliography.crops GM of Assessment Risk Biodiveristy; Conservation, Plant Projects Research Initiative, Regulation and Research Public PRRI: Committee Steering EFB. Biodiversity Section Biotechnology,Chair of Federation European Board Executive Committees; Istanbul and Delft in Prof.GuestZürich; ETH PollutionMosses;Air at and Lichens Lichens with Biomonitoringof and Evolution, Vegetation Ecology, Biogeography at University of Bern, Taxonomy and Ecology University, of Istanbul, February 2009–June 2009; Universityteaching Plant Systematics Delft Sabanci Professor Professor Visiting 2006-2008; Dept. VisitingTechnology, Botanic Biotechnology 2006; and February University from Bern, retiredGarden, 2000; since Professor 1996–2006; Honorary Berne of University Garden, Botanic Director curriculum: Klaus Ammann, Prof. Emeritus, University of Bern, Switzerland. Academic Guest Professor, Delft University of Technology Ammann BioVisionAlexandria April 2010 Group System onEarth Preservation (IESP),Munich. Expert International the of member a and Governance, Stability Climate Civilization”.Hethe currentlyof is co-chair World Academy’s programon Politicalthe of Animal”,“All and Now:Connected Firstthe in Life Global and author of 17 books including, “To Govern UniversityEvolution: of Southern California) is a political Furtherscientist, futurist, journalist psychology,Adventures social and science (political Ph.D., Anderson, TruettWalter President Emeritus, World Academy andScience ofArt ANDERSON, Walter Truett , Klaus
51 BioVisionAlexandria 2010 52 BioVisionAlexandria 2010 el et, n ivsiaig irba gnmc i odr o eeo nvl igotc and diagnostics novel develop to vaccines. order in genomics microbial investigating and death, cell programmed of mechanisms molecular the studying are: areas research bioinformatics two His countries. developing in models research and training bioinformatics developing for network a Biology and Director of Biotechnology Training and Research Unit. His Molecularmain interest of Professoris Associate to build currently is He WorldBank. the and Commission European the by funded been has that unit research biotechnology first the of establishment the lead to PalestineHebron, in PolytechnicUniversityPalestine joined he 2004 In centre. research same “Inhibitor of Apoptosis Proteins” family. From 2002-2004 he became a research associate in the his postdoc, he discovered and characterized the BIRC7 gene that codes for a new member of the Hebrew University to do his Postdoctoral research in the field of programmed cell death. During disease. In 1999 he joined the laboratory of Prof. Dina Ben-Yehuda at Hadassah Medicalthyroid autoimmune in Centre, role their and family gene chemokines CC the investigated he Borrell, Health SciencesinChicagoandaDegree inClinicalOncology. M.P.H.Universitythe fromof management Nancyrisk from Universityin France M.S. in and health health, public in roles economics, teaching and healthcare management. Dr. Anhoury’s multiple academic credentials include M.D. and and Organization, Health World the with affiliated center collaborating non-profit a Institute, ECRI the with year a include experiences 1998, respectively. During his work in the laboratory of Prof. Ricardo Pujol- MolecularBiology from Autonomous University Barcelonaof and 1994 in TechnicalUniversity, in Ph.D. and M.Sc. Turkeyhis receivedHe 1990. in East Middle from Honours Class First with degree biology undergraduate Yaqoub Ashhab was born and grew up in Hebron, Palestine. He received his University Director,Biotechnology TrainingResearchUnit,and Palestine Polytechnic ASHHAB, Yaqoub Anhoury’s Dr. consulting, to addition In manufacturers. pharmaceutical and organizations, governmental providers, to consultant management a as years’experience 20 nearly with innovativedrugs, for access market and pricing, and reimbursement planning, strategic has hospital in Anhoury expertise deep Dr. KantarHealth). (Now Business Europe MattsonJack and of President Leader Vice Senior is M.P.H., M.D., Anhoury, Pierre Senior Vice President, KanterHealth ANHOURY, Pierre Speakers’ Biographies &Abstracts (since 2008). 2 MontpellierUniversity the at Recherche) Formation(Pôle Chemistry of committee, Department executive the of the of member and Education, of charge in director, Deputy - (2007) researchthe centre:of European education, and InstituteMembranes on Montpellierof (IEM) research of charge director,in Deputy - (2004-2007). IEM in membranes hybrid and ceramic the at Chemistry of on Department team research a of Leader (2006-2008). University the Montpellier2 the of FacultySciences of of relations, international of and masters of charge in CEA « Chimie Séparative, Matériaux et Procédés » (CSMP) » Administration - Deputy director,/ ENSCM / UM2 master research the of Head - e-learning and program exchange inter-universities international of the of and 2 Montpellier Physicochimie University the - PROMATat » « Matériaux des master appliquée professional the Chemistry of of Head School - Higher (ENSCM). National Montpellier Graduate of the at and levels) Master and (Bachelor 2 Montpellier University the at Science Membrane and chemistry Material Chemistry,Teaching Analytical MaterialsPorous Teaching- of of Journal scientific multifunctional international membranes, in Board: Editorial of Member - 120, patents. and books books, chapter and journals, than more layers Publications: - thin membranes hybrid and inorganic sol-gel-derived of characterisation and Synthesis topics: -Main Research Professor, European Membrane Institute ofMontpellier A BioVisionAlexandria April 2010 a fellow oftheNational Academy (FACB), ofClinicalBiochemistry Washington, DC,USA. Registry, the American Society for Clinical Pathology (ASCP), Chicago, IL, USA. Dr. is Azzazy of Board (SC), Chemistry Clinical in Specialist a as certified also is He and diagnostics. molecular chemistry clinical specializations: two in USA DC, Washington, Chemistry, Clinical of AUC 2010 Excellencethe in Teachingand Award Award.Endeavors He is ascertified Creative a diplomate of the American Board & Research in Excellence 2008 AUC the being latest which the of awards and honors numerous received has Azzazy Dr. conferences. and textbooks, over published journals, international in all monographs and abstracts, conference has chapters, book articles, 120 Azzazy Dr. journals. Medicine Laboratory Chemistry Clinical and Acta, University Maryland College, USA. He of is a member Universityof the editorial Biotechnology,boards of the Clinical of Biochemistry, Clin Chimica School Graduate the at Professor Adjunct an also is Azzazy Dr. AUC. at Center Research & & Technology Science the Diagnostics Yousef-Jameel at “Novel group research Therapeutics” of leader the and Program Graduate the Chemistry of director the also is He (AUC). Cairo In University American the at Department Chemistry the of Chairman and Professor a is Dr.Azzazy ofChemistry,Chairman, Department theAmericanUniversity inCairo Azz yral azy , André , Hassan
53 BioVisionAlexandria 2010 54 BioVisionAlexandria 2010 Honorary Award ofAppreciation, AlexandriaUniversity 2008. present. – 2008 Universities,Egypt of SupremeCourt Chemistry,Genetics. and Microbiology scientific of Award Agricultural of Committee UniversityScientific environment.Alexandria the distinction, of Chairman 2006. the and society with concerned NGOs several of board of the On editorial board of 1984. the Egypt. J. – of Genetics and the 1978 Arab J. of Center Biotechnology.Research Member / Alexandria member of University Unit, Biology Molecular of present. PI of Several Joint Scientific Projects with American and Sector French Universities. Education Chairman High the of Committee of Member Genetic Engineering and 2001. Biotechnology, Supreme – Council of Universities 1999 1998 – University Harvard at Development National Egyptian of Encyclopedia the Figures in 1989. Member Listed of the Task 1976. Egypt Force Committee on Class, Biotechnology, 1st Center for International Arts, and Sciences of Medallion 1974. Egypt Sciences Agricultural University,Awardin NationalHarvard 1984. from anumberofuniversities. Director, also is he Graduate boards,Fellows NGO Program, and United Nationseducation Association, of involving doctoral number and masters a students of member A change. climate of the UN expert group on the economic and governance implications of implications governance and economic the on group expert UN the of Committee and founding director of evaluation for USAID. Assistance HeDevelopment OECD is the a for member evaluation of chair Hefounding Nations.was United the of parts of number a to advisor senior been has Nations United He Science. of & Art a TrusteeWorldof is the AcademyHe of Federation Associations. World Advisor, Senior is Berg J. Robert Senior Advisor, World Federation ofUnited Nations Associations Berg the Board, 1978 – 2008. Fulbright2008. Award,– Board,1978 the Research,EngineeringGenetic of member and 1998 – 1995 Universities, of Council Supreme Genetics, – Alexandria 1984, 2001 – 2007. Chairman of the Genetics, Permanent Scientific Committee of of Dept University Chairman, 1991 – 1994. Vice President, present. Egyptian Society of Genetics 1979 – 1977 Alexandria University Genetics, of Prof. 1963. USA University, Columbia D. Ph. Agriculture, of Faculty Genetics, Alexandria University of Department Emeritus, Professor Badr , Robert J. , Robert , Effat Speakers’ Biographies &Abstracts Strategy, Publishing andAwards CommitteesoftheSociety ofChemicalIndustry. Business the at seat a holds also He London. College, Imperial at Ph.D. his completing upon Royal Society of Chemistry and was the recipient of an European DG the Post-Doctoral of Fellowship Member a Chemist, Chartered a is AG, Schering at worked has He Reuters. Thomson Science patent and drug registry content of the Investigational Drug database (IDdb) owned by Development for Nature Publishing Group and before that the Compound Director of the Life he worked with prestigious clients. Prior to that he was Chief Head of Global Intelligence the and Business was Investment “Biotechnology the of Group” Today where Editor-in-Chief he and Officer Executive Previously raising. capital and development strategic business i.e. science”, of business “the on sector biotech the throughout governments, companies advises and and regions aids specifically latter the whilst sector biotech stage/SME early the in flow deal facilitates and globally Ltd. Summit Transfer Tech of Co-Chair Managing Director of Tech is Investor Ltd. The former Berrie is an organization that S. Morris Dr. Co-Chairman, TTS Ltd.andManaging Director, Tech Investor Ltd BERRIE, Morris BioVisionAlexandria April 2010 Sudan (since2009). in 2002), (since Syria 1987), (since China cooperations 1976), (since in Morocco mainly oncology of different field the in involved was He centers. cancer comprehensive of organization the in and oncology in networks therapy,of radiation building and the oncology in of practice Radiation clinical in experience of special obtained He Professor 2007. to 1980 was from Oncology He 2001). to 1991 (from region, Nancy,Lorraine in Center Cancer Comprehensive Regional the of Director and 2009), to 2002 (from Paris in Curie was previously Institut of He Hospital the of Director cancer. against fight the help to countries emergent with relationships develop Paris,France,to in Curie, Institut of President Oncology,the Professorbyof EmeritusBey, commissioned Pierre is MD, Former Director, Institut Curie BEY, Pierre
55 BioVisionAlexandria 2010 56 BioVisionAlexandria 2010 2006), andhisMaster ofPublic Administration (Harvard, 2008). his PhD in Physics (Alberta, 2005), his Graduate Certificate in International Security (Stanford, was alsoawarded the1992Computerworld-Smithsonian Award inScience. University,HeKeio Japan. at Bioinformatics of Professor Honorary and Informatics; Medical of College American the Fellowof Science; of Advancement the for Association American the of FellowFellowship; GuggenheimFellowship, Fogarty Senior NIH include: Brutlag’shonors the Infrastructure Advisory Group (IAG), and the Senate Committee on Libraries (C-LIB). Dr. Information Systems (C-ACIS), distributed Information and and Computer EnvironmentsComputing (DICE), Academic on Committees Senate the chaired Brutlag Professor Stanford, At Institute. Planck Max the and Medicine of Library National the including organizations and Brutl ag
, Douglas Biology. He has served on the scientific advisory boards of many firms ofmany boards advisory scientific the on served has He Biology. Computational for Society International the co-founded he 1997 in and founder of IntelliGenetics, one of the first firms involved in bioinformatics, application of computer science to molecular biology. In 1979 he was a co- since 1974. His research helped develop the field of bioinformatics and the Stanford University in 1972 and has been a Professor of Biochemistry there from DistinctionGreat with Ph.D. his received Brutlag ProfessorDouglas Biochemistry, of Stanford University Department Medicine, and Biochemistry of Professor focus on scientific and socio-political implications ofgeo-engineering 2001), implications (Edinburgh, Physics of Master his received Jasonhas technologies. socio-political and scientific on focus broadly research His explores the intersection of science and international affairs, with a current (Canada). for Innovation Centre the Governance at Fellow International a and (Austria) Analysis Systems Applied for Institute International the at Scholar Research a Dr.is Blackstock JasonJ. Research & Innovation Scholar, Governance International Institute forApplied Systems Analysis International for Centre Fellow, BL ACKSTOCK, Jason Speakers’ Biographies &Abstracts Association (SARIMA) and actively participates inthenationalinnovationAssociation (SARIMA)andactively participates agenda. He is also a co-founder and member of the Southern African Research & Innovation Innovationinvolved in Managementcapacity development in technology transfer in Southern and East Africa. Health for ProgramMIHR, TonyAfrican organization, the international co-founded the with IP.critical securing on Together based all companies, start-up successful four of formation the meetings. Tony’sinternational to and lead national has and researchboth own at entrepreneurialissues innovation transfer, technology on speak to invited frequently is He postgraduates. PhD and MSc numerous supervised and journals peer-reviewed in extensively published has He university. the with position honorary an holds currently and Town head of the department of biomedical engineering at the University of Cape discovery. He was previously (1988-1994) an associate professor and acting research MRC from opportunities innovation manages that and 2004 in established he (MRC)which Council MedicalResearch African South the Tony Bunn PhD, MSc, UED. Tony is Director of the Innovation Centre of Director, MRC Innovation Centre BUNN, Anthony BioVisionAlexandria April 2010 (1993-1996). He speaksEnglish, French andSpanish. 2002) and coordinated the Committee for Science and Technology (CAST) of the City of Milan for the recovery plan for the former Falck industrial area in Sesto San Giovanni (Milan) (2001- Advisory Commerce’scommission the of Secretary Innovationthe Hethe was Project Centre2005). of Boardfor (since Chamber Milan the of Coordinator the as acting include activities Carlone’sExchange’sStockfirms). Italian hi-tech (the Italiana other of Borsa index Mercatoof Nuovo the of partner a as and companies listed of boards the on serving sectors, financial and In 1989, he founded Hypothesis. Since 1992, he has worked as a strategic advisor in the hi-tech society.and enterprise between relationship the on focusing communications, and journalism in career a launched Carlone Italian1982, NationalInthe Research Council. at biotechnology in research conducted later and (1977) biology and engineering chemical in degree a received Carlone organizations. international and manufacturing institutions financial companies, to consultant and entrepreneur an as works he 1952, in Born Government). (Italian Innovation and Technology for Agency the projects, January Sinceat relations special public and communications for relations. responsible been has he 2010 institutional services, and public advisory and communications image, strategic corporate Hypothesis–a in of specialized President the company is Carlone Claudio Chairman, Hypothesis CARL ONE, Claudio
57 BioVisionAlexandria 2010 58 BioVisionAlexandria 2010 an Officerofthe Order ofCanada. Health and Welfare of Canada, 1989-1992. Ms. Catley-Carlson has ten honorary degrees and is of Department the of Minister NewDeputyYork, in and PopulationCouncil 1993-1998; the of President 1981-1983; York, New in UNICEF of Director Executive Deputy 1983-1989; Agency,Development International Canadian the Presidentof was She Alexandria. of Library the Development), and Environment of Institute (International IIED of member Institute, Board and Management Water (International IWMI Council), Research Development (Int’l Dry Areas, CABI (Center for Agriculture and Biosciences). She was also Vice Chair of the IDRCin Development Agricultural for Center (Int WaterICARDA Partnership,Global the chaired Prize,SyngentaBoardsthe Foundation,the of (FertilizerIFDC the and Management). She has FoodWorld the of Advisors of Council the in serves Trust,Diversity and Crop the of Board consultant away from his company‘World Health Connections’. independent an as works now He issues. reform health and welfare as well as technologies and his work was mainly focused on energy, environment, building, medical, marine and bio-science where Embassy,Beijing,Norwegian Royal the Technologyfor and Counselor Science the was UN International Ecological Safety Cooperative Organization. From May 2004 to Jan 2009, he member ofEduMonde SA,aneducationalmediaventure, andmemberofthePresidium ofthe Advice Public of member board a Internationalbecame Foundation and Chair of PAhe Asia’s2007, China operations. In 2008 he became a board In Francisco. San in function that in advisor inmedical-andbio-technologyfortheNorwegian Trade twoyears Council,andserved special a as years 5 for worked He networks. Biotech of network ScanBalt and Biotechnology of Federation European including start-ups, and investors providers, care health numerous of boards the on served and consulted has He care. health primary of management and planning officer and hospital manager in and has Norway done research and published a textbook on the health public a as worked farmer.has He part-time a as experience years 13 than more has He aie, etme 19- eebr 95 ad omr hi o the private partnership. He of is a Medical Doctor also educated in Social chair Science. former and WHO’spublic- and “StopNorway TB” of Board Advisory Biotechnology 1995, December 1992- September Cabinet, Werner Christie is a former Minister of Health of Norway in Norwegian Dr. Brundtland’s the of Chairman Norway, Biotechnology Board. Advisory Health, of Minister Former & Beijing Embassy, Norwegian Royal Counselor, Technology and Science CHRISTIE,Werner and Patronand Network;Globalthe of Chair past and Water WaterPartnership. She the chairs Canadian the Forum; Rosenberg the Water; on Board Suez Environment, and a member of the UN Secretary General’s Advisory Agenda Council on Water, of the Foresight Advisory Committee for Group and rural development. She is Chair of the World Economic Forum Global water resource management and the twin issues of agricultural productivity Margaret Catley-Carlson operates at the Board level in support of improved Chair, BOT Crop Diversity Trust Catley -Carlson , Margaret Speakers’ Biographies &Abstracts 6th formers, undergraduates andMasters students. for schemes research summer up set has She research. biomedical of issues scientific/ethical the includes Conferences for 6th formers, after-school science clubs, careers events and This workshops exploring science. about people young excite and inspire to activities enrichment science Society& ProgrammeScience successful Babraham.a at Claireestablished has deliveringnovel in scientists and students through business plan competitions and knowledge exchange initiatives Bioincubator, home to 30 life science companies. She also encourages an entrepreneurial outlook media liaison, public engagement events and PR/marketing for the campus including its vibrant communications, corporate with deals Claire Relations, External of Head As communication. science and engagement public in opportunities and culture entrepreneurial the by attracted – InstituteBabraham – an the institute of the joined Biotechnology and Claire Biological Sciences 2005, Research JuneCouncil (BBSRC)In entrepreneurs. aspiring and sector science life the of leaders future at aimed Programme, Enterprise Bioscience the directed and designed Claire Claire 2001, in Recognising a need coat for a biotechnology-focused business course in the lab UK, her up hanging pioneered a cross-disciplinary Masters After Programme at writer.Cambridge with MIT. freelance a as Science British the by Association, working fellowship with Tim MediaRadford at The Guardian and a subsequently awarded was she PostDoc a While Cambridge. of University the from Biotechnology Plant in PhD a and Oxford of The University from Biochemistry in degree a holds Claire Head, External Relations, theBabraham Institute PROTEOMAGE inEurope involving 19partners andChina. (1985); protein ProjectIntegrated EU of Coordinator (1995). aGTP-binding complex ternary the of determination of structural structure first the of determination (1983) PLC Senetek of Co-founder (1968); tRNA of crystallization first (1965-66); coding protein of start hence and synthesis protein for codon initiation the of discovery Achievements: books. five including Emeritus 2006 Professor. 2006, publications, PLC 200 Senetek Officer Publications: Scientific Brenner. Sydney & 1974-2006 , ProfessorCrick of bio-structural at chemistry FrancisThe University of Aarhus,of Denmark. Chief direction the under biology cell of division of Member Cambridge; Biology, Molecular of Member Laboratory Council, 1964-74, Research Medical USA. Staff, Scientific Maryland, of Bethesda, N.I.H., Institute, Heart National Genetics, Biochemical of M.W.Dr.Nirenberg’sSection in Fellow Visiting 1962-64, USA. Cambridge, and age-relatedCareer:diseases. Research 1961-62, M.I.T. at Division in Associate Biochemistry of cancer including disease of mechanism Molecular proteins. mutant phage of Use characterize to and agiing. expression gene cellular differential of identify to display mechanism cellular and of3d Molecular synthesis. interms protein function of mechanism molecular and of mimicry Macromolecular structure. Explanation fields: Main (Cantab). Sc.D Ph.D., MA, BA, background: professional and Academic citizen. British Vice President, European Federation ofBiotechnology CL BioVisionAlexandria April 2010 C ockcroft ARK, Brian F.C , Claire Elizabeth
59 BioVisionAlexandria 2010 60 BioVisionAlexandria 2010 of Toledo (USA). Fellow(Rothamsted), World Innovation Foundation,AchievementAward, Lifetime University Leverhulme Sciences, TrustLawes of Member of Sciences, Agricultural AcademyTrustFellow, Academy IndianResearch Fellow Hungarian of Member Europaea, Academia of Member Nitrogen Crop Fixation, for University of Nottingham Membership and Distinctions: Fellow Centre of the Royal Society, Director, 1997); Professor, (Emeritus Nottingham of University Dean,Faculty ProfessorScience of Head andPlantGeneticManipulationBotany ofGroup,of protoplasts. Facultyisolated ViceDean, of fusion Purethe byof plants crop Science; other and Biological of cereals of hybridization SomaticGroup: DirectorResearch Council Research Agricultural HeadStudies sometime and Nottingham; of University Botany, of Department of the World Water Council. Presidentof Honorary World the Formeris PresidentHeof ViceBank.A (2005). al et Rogers and ‘Water for Growth and Security in World Water Crisis: Myth or Reality?’, edited by Peter P. Waterand Ethics Transparency (2009) al et Llamas Waterin Ramón M. Ethics’,by and edited Peace Process” (UNESCO). Other recent publications include: ‘Public Participation to Promote n Pae A ytei o Suis rprd ne te CPWtr for PCCP-Water the under Prepared Studies of Synthesis A Peace: and Security “Water of and (2000)” Water“WorldVision the of co-author is Worldthe He of Water(2009). edition Report thirdDevelopment the for Coordinator Content was he l’environnement sur publiques d’audiences resources management. Following his term as President of Quebec’s Bureau water of field the in experience of years many has Cosgrove(Bill) William Founder, Ecoconsult Inc. COSGROVE, William Institute for Medical Research, Göttingen; Professor of Botany and Head and Botany of Professor Göttingen; Research, Medical for Institute Planck Max and Zurich ETH, the at Fellowships Research; Nottingham of University Botany, of Department Reader, then nitrogen Lecturer, Chemistry and biology cell Plant Bristol; metabolism. Career: Civil of Service Commission UniversityResearch Fellow DSc in Bacterial, barley, in synthesis protein and acid Amino Bristol; of University University PhD Chemistry,Bristol; of Biological Honours Class First BSc, Education: Director, Centre forCrop Nitrogen Fixation, University ofNottingham C ocking , Edward Speakers’ Biographies &Abstracts ResClim, Norway.of board evaluation the of member (2009); Gesellschaft”, Meteorologische “Deutsche the of Chairman committee; advisory technical GKSS the of member DFG-Geokommission; the of member 313; FK DFG-Forschungskommission the of member KLIWAS; program; research BMV the of committee advisory the of member Germany;IIASA-Support organization, the of member CAWSES/SCOSTEP;committee; the of EuropeanTransport member and Systems); Scientific Board Advisory EU-Project QUANTIFY (Quantifying the Climate Impact of Global (NobelPeaceIPCC FAR,PrizeWG1author 2007); lead TAR,committees: international AR4 1978-1986 Germany Hamburg, & national in Meteorologie, ECMWF,Cooperation/consultancy Analyst, UK; Scientist/NumericalReading, für Max-PIanck-Insitute Scientist, Senior 1987-1999, Modelfrom Germany; the Hamburg, Klimarechenzentrum, of Deutsches Group, Leader Application 1991-1999, from Hamburg; Meteorologie, für Max-PIanck-Institute Freien der MeteorologischesGroup, Data and Model Facultythe of the Head 1999-2002, from FreienBerlin;Universität, der Institut at Geoscience Professor Full the 2002, since of Berlin; Universität, Dean 2007, Diploma, since 1977; experienc: Germany, nat.) Hamburg, rer. Meteorology, Christian-Albrechts-Universität, Kiel, Germany. Universität (Dr. Professional Meteorology, Dissertation 1984; in Germany, Hamburg, Meteorology,Universität in Habilitation 1993 training: Academic Climate. Urban Research Interests: Climate Variability, Climate Modeling, Global Change, Dean, Geoscience Faculty, Freie Universität Berlin Cubasch BioVisionAlexandria April 2010 is alsoamember oftheBoard ofthe International Foundation ofRobotics Research (IFRR). Tokyo, and a recipient of many honors and awards, including the Joseph Engelberger Award. He MedicalBiologicalFellowand Engineering,a Universitythe Engineeringof of School the of of on Society European the of Fellow Fellow,a IEEE an is Dario Prof.(ICRA’07). Automation EMBS BioRob’06 Conference and of the 2007 IEEE International Conference on Robotics and and Robotics IEEE the RAS- IEEE the of Chair General of the Hebeen Automation2002-2003. yearshas the Society in President as served has mechatronics Dario bio-robotics, Prof. robotics, micro/nanoengineering. medical and of fields the in are interests researchTechnology. of main Institute His Italian the of Sant’Anna Superiore Scuola Center at established Micro-BioRobotics newly of the of coordinator the been has Dario Professor 2009, September Since Sant’Anna. Superior Scuola the of Valdera Sant’Anna Polo the Directorof as serves also He students. PhD 70 over including researchers, of 140 about Laboratory of team a supervises Microengineering), he where Sant’Anna, Superior Scuola in the Research the for (Center the of CRIM coordinator the is He China. University, Zhejiang at and Japan,University, Waseda at Professor Visiting a also is He Pisa. in Sant’Anna SuperioreScuola the at Robotics Biomedical Professorof a is PaoloDario Professor, ScuolarSuperior Sant’Anna Dario , Paolo , Ulrich
61 BioVisionAlexandria 2010 62 BioVisionAlexandria 2010 in Washington, DC. internationally renowred asaleadingplantbiotechnologist. is He issues. Regulatory Biotechnology,Policy,and Crop AgricultureBiosafety with and Food dealing committees National many in Member professional a is He Journal. Plant Breeding, including Nature, Nature Biotechnology, MGG, TAG, Plant Molecular Biology andMolecular Policy and Management. He has published more than 120 research papers in reference journals Science Agricultural IPR-International analysis, Food-safety and Field in Transgeniccrops of contributions in Plant Biotechnology, Molecular Breeding, Regulatory aspects and Deployment significant has He (2009). Medal Memorial Brouhl JohnnesPaulAwarded and (2006) Medal Research PanchananRecipientof CropLeader(1993-2005); Rice Maheshwari Rice Institute)andHarvestPlus (International IRRI at Biotechnologist Plant & Scientist Senior (1989); USA UC-Davis, at Professor VASwitzerland; ETH-Zurich, at Scientist Senior and Leader Group Fellow,Institute) (FriedrichMiecher Switzerland;FMI Basel, Germany; Gruenbach, Genetics, D (DBT, GOI). He was awarded DAAD Fellow at Institute for Resistance for Institute at Fellow DAAD awarded was He (DBT,GOI). Professor Chair at University Ghosh of Calcutta, RB Kolkata, Former TATAIndia. Sciences of Innovation Academy Fellow National 2006 in elected Fellow,Sciences; Agricultural IRRI. of Academy at National CGIAR 2005, elected of Fellow leader Crop Rice HarvestPlus and Scientist Senior Prof. Swapan Datta, FNAAS, FNASc, DDG (Crop Science), ICAR, Former Deputy Director General, Indian CouncilofAgriculturalResearch project design, launch, implementation, field operations management, operations based is Derhak Ms. dialogues. level policy and monitoring and evaluation field implementation, launch, design, project in all facets of international development work including strategic planning, public health, law and business management. Dianna Derhak is experienced attorney and MBA with 15 years of international development experience in Founder and Chief Executive of DNA International Consultancy. She is an Founder/Chief Executive ofDNAInternational Consultancy DERHAK, Dianna atta , Swapan Speakers’ Biographies &Abstracts (SEB Group, Auriga, Innate Pharma, Eurotab…). de Chimie (French company of chemistry). Chairman and board member of various companies also is Desmarescaux Philippe Chevalier de la Légion d’Honneur (Legion of honor medal). Chairman of the Société Française2007. October till 1998 from chaired has he which Lyon, of Sciences Forum, BioVision since 1998 and he is now vice-president of the Scientific Foundation Normale Supérieure de Lyon from 1994 to 2000, Philippe Desmarescaux chairs the World Life he became President of the Rhône-Poulenc Group in 1992. Chairman of the board of the Ecole Group’sthe of Chairman 1997), Rhône-Poulenc1997, to 1986 subsidiary fromInc. American (1991- Sector Chemicals of Chairman (1980-1996). company the of Sector Agrochemical the of Chairman later and President been –PoulencGroup’shas Rhône He Committee. Executive of the Agrochemical Division in 1979. In 1980, Philippe Desmarescaux became Member of the was then Director of Marketing He and Exports (1977) Rhône-Poulenc.before being President of Division Agrochemical the in Director Research became he 1974 In PROGRIL. of Department Research the in engineer 1961 (CNRS, France). He joined the Rhône-Poulenc Group in 1963 as an started as a research attaché at the National Center for scientific research in of Parisnational school of chemistry and is a Doctor in physics. His career Julyon Born Philippe1938. Desmarescaux16, fromhigher graduated the Chairman, The World LifeSciences Forum, BioVision DESMARESCAUX, Philippe BioVisionAlexandria April 2010 son. undertakes regularly He America. speaking engagements, and North serves on the boards and of several non-profits. Amir East, is married with one Middle Europe, Caribbean, the Asia, in UnitedNations in 1985, he worked the in the business world for over 15 years. joining Amir has lived and worked to Prior 1975. in London Sells, & Haskins Deloitte, with trained having democratic governance or restored in new democracies. Amir is a Chartered Accountant (FCA) enhance and institutions strengthen to 2005, in established he the which Fund, of Democracy management UN oversees also Amir partners. other numerous from million $560 over of health, women and population, climate change, and biodiversity. This includes social investments media mogul Tedwith partnership Turner’sthe for RepresentativeUN’s $1 billion donation, the covering 450 is programs and projects Amir in children’scauses. humanitarian of support in industry,technology, entertainment including and media, pharmaceutical, Goals.He UN’sthe spearheaded has sectors of number a with engagement foundations and philanthropists in achieving the Millennium Development guides the for development Office of strategic Nations alliances He Partnerships. for Unitedwith Liaison UN’sChief governments, the the is Dossalcorporations, Amir Partnerships. of Director Executive Dossal, A. Amir Executive Director, theUnited Nations Officefor Partnerships DOSSAL, Amir
63 BioVisionAlexandria 2010 64 BioVisionAlexandria 2010 the sustainable enhancementofglobal agriculturalproduction enable will that improvementprograms crop in techniques science plant edge cutting applying by wealth of creation and security food of delivery the facilitating Normanas Institute Borlaug the of role the Professorsees Agriculture.Elliott of AcademyBulgarian the of Causa) (Honoris Sciences Biological for Medal Gold JanDSc Evangelistathe the ExceptionalMerit Purkyne(1993), and Researchof Medal (1994) Mendel Gregor the the awarded (1992), was Medal He University improvement. Charles cereal to approaches biological with molecular publications on research hundred emphasis several of author the is Elliott Professor date). to (1994 Improvement Crop for Institute Borlaug Norman The of Director Founding then (1989–93) 140 sciencepublications. than more of co-author and author the (AWC).is WWC, He Sci, Hort for Society Egy U.K; Plant Physiology, Int’l Society of Hort Sci, US Society for Hort of Sci, Society for Societies Experi Biology,EU of Federation Assoc, Substances Growth Plant Int’l AAAS, Group, Regulator Growth Plant British the of member Founding a and 1798, in founded d’Egypte l’institut of member Elected 2006, In Egypt. Science, in Prize Recognition State 2008 awarded been also Science & Arts for his contribution to the Development of Agriculture in the Dry Areas. He has Culture, for Order Class First Qaboos Sultan the awarded also was HeJordan. of II Abdullah Council in 2009. A native of Egypt, he has been awarded. Al-Istiklal Medal by His Majesty King Central Asia and the Caucasus of CWANA; and a Fellow of TWASTask-ForceCDC Chair, for and Board; an elected Assessment member of Ecosystem its Millennium the of Member Board CDC ICWG - Climate Change; Member of the CGIAR Genetic Resources Policy Committee; Khartoum; of UnivChairman of (CDC) the for the fromInt’l Ag Science Res centers of of the CGIAR. Doctorate Chair of Honorary INRM; Member an of the holds He ACSAD. Board, Exec of Wales,Chair of Univ the of FellowEGY; of Reclam. Land for State the of Secretary EGY,of Sci. Center the ResTech. for Ag Chair of Under- Chair 1st Int’lSSO, the of Council ShamsUniversity. Most recently, HeICARDA. of DG the as Director/Boardwas served has he by the Prime Minister of EGY; and a Prof of Ag, Arid Lands Res Inst, Ain Inst,Res Lands Arid Ag, Profof a EGY; and of PrimeMinister the by of the Alex. Bib; Member of the Supreme Council of Science & Tech chaired GDTF, Chair the of the of Ag Res Board & Co-Chair,Dev Council EAGLES,(ARDC), EGY; of Board MemberMember IDDC; Chair, MDGs. of world: implementation the addressing agri HLC,FAO the of MemberChair, the GFAR; in positions many holds currently El-Beltagy Adel Prof. Chair, Global Forum onAgriculturalResearch El-Bel (1971–94). Chairman of The College of Deans at De Montfort University University,Montfort De at Leicester Sciences Life of School The of Head in Plant Biochemistry Lecturer at The University (1967–69). of Leicester (1969–71). University Professor Yale and at Fellow Research and inplant Scholar PhD his Fulbright a was He 1966. in and received of Wales University The from biochemistry (1963) Sciences Wales Plant of in University The Honors from Class First with graduated Elliott Malcolm Founding Director, The Norman Borlaug Institute for Crop Improvement ELLIOTT, Malcolm tagy , Adel Speakers’ Biographies &Abstracts board. supervisory the of Chairman Vice & Foundation DESERTEC the of Co-founder 2009; RE, in Course Masters Bi-cultural REMENA for Board Advisory the of MemberGermany, 2008; in Businessmen Egyptian of Association 1999; applications, energy renewable and protection in Membership Power. Trans-Mediterranean Solar Renewable Energy Co-operation, a network TREC, of 2002, scientist Concentrating devoted Energy;to climate Sustainable for with Council Business European 2003:2005, Desalination organizations: Seawater and Europe to ElectricityTransmission Mediterranean, the Around Demand Electricity Potentialand Energy Conference”, Energy Renewable North-Africa “Middle-East 2004-2007; member of the study teams MED-CSP, series TRANS-CSP and AQUA-CSP, conference Renewable the for org. www.menarec.technology,site and web science the of of year administrator Creatorand 2006; Consulting 2007; 2007 Junemember to 21-24 the German the Damascus, Expert Team in of for 4 renewable energies MENAREC in Member the for frame of Committee the 2007. German Executive Egyptian teams: Study/Work in Membership Germany. 2003; Owner and CEO of Nokraschy Engineering since GmbH in Holm (Hamburg), (SOLAREC), Center” Research Solar “Egyptian of partner Darmstadt, Germany, PhD, 2005. He is the managing director and owner University Technical 1968; Germany, Darmstadt, University Technical 1963; University,Egypt, Cairo Engineering of Faculty 1958 Education: 28JuneDate andplaceofbirth: 1935inCairo, Egypt CEO, Nokraschy Engineering GmbH El-Nokraschy BioVisionAlexandria April 2010 around theworld. in reviewer a cancer fields to “Surgicalin related consultant a activities: Otherinternational UK. Oncology “ & USA Oncology”, Surgical of Journal activities:”World editorial review Peer Oncology Clinical of Society BreastHealth.of Society American Medical(ESMO), Oncologyof European society (ASCO), American in member societies: international of Membership Radiotherapy,in studies France.graduates Oncology; post of accomplishment 1981, In Egypt. University,Alexandria Medicine, of Faculty CH.B, M.B. 1975: November MD., Education: Canal University & Chairman of Al Soliman Radiation Oncology Department, Port Said, SuezMedicine, FacultyEgypt.of Department, MedicineNuclear and Oncology Clinical of Professor & Chairman present; at Egypt, in www.AORTIC.org.(AORTIC)Locally cancer Training in and Research for Organization African the of council executive the oncology.info.in Member www.semco- SEMCO. Oncology of College Mediterranean East and South of Co-President ORG. WWW.ICEDOC.USA. Borders, Without Cancer in ICEDOC’s Experts & (ICEDOC) Centers Oncology of Development And Establishment for Campaign International the of President Positions: International Egypt). Professor Dr. Ahmed Elzawawy, Professor of Clinical Oncology (Port Said, Development ofOncology Centers(ICEDOC) and Establishment for Founder,Campaign FirstPresident& International ELZ AWAWY, Ahmed , Hani
65 BioVisionAlexandria 2010 66 BioVisionAlexandria 2010 absence from Pennsylvania State of leave on currently Fedoroff is scientists. US to awarded honor highest the Science, Medalof National 2006 a is awards her Among journals. scientific in papers 130 than more and books two published FedoroffFe has Institute.Santa the Facultyof External the of member a as well has included extensive work inHaiti, the Dominican Republic, BotswanaandSouth Africa. and medical school at the University of Pennsylvania School of Medicine. His Children’sinternational The Philadelphia, work of at Hospital training pediatric his completed He Health. Child International on Section AAP the on Pediatricsserves (FAAP)of he Academy American the of Fellow a As Philadelphia.West in Creek Cobbs the at Center of Children’sCare Hospital’sDirector Primary Medical former and pediatrician, a is Finalle Dr Medicine. International for Philadelphia’s Children’s of Alliance The Hospital of Director Executive and Founder the was Finalle Dr. Finalle. Dr. by atthe supervised and Health Fellowship supported are Global Philadelphia of N.Pincus Children’sHospital David the including efforts, Health Global All the strategic vision to the critically important area of global child health. child global of area important critically the to vision strategic the Dr.institution. the throughout Healthactivities GlobalFinalle of provides of Professor Dr.variety wide a Finalleto guidance overseesprovidesand and leadership Clinical Associate position his In Medicine. of PennsylvaniaSchool of University Philadelphia.Pediatrics, The at of Health Hospital Global Children’s of F.A.A.P. Director M.D., Finalle, R. Rodney Director ofGlobal Health, TheChildren’s Hospital of Philadelphia FINALLE, Rodney Fedoroff Professor of the Life Sciences and an Evan Pugh Professor at Penn State, as the founding Director of the Huck Institutes of the Life. She is and Institute Biotechnology the the Stateof DirectorUniversity, the was Willamanshe where Pennsylvania the and University Hopkins Johns the Washington, of Institution Carnegie the of faculties the on served has University,and Nina V. Fedoroff received her Ph.D. the in to Molecular Biology and from State the of Rockefeller Secretary Administrator ofUSAID the to Adviser Technology and Science , Nina Speakers’ Biographies &Abstracts Education. and Research Biomedical for Foundation Cincinnati the and Incubator Biomedical BioStart Trusteesof of Boards the on serves and Medicine, of College Cincinnati, of University the at Transfer. He is President of Fondacaro & Associates Consulting, Emeritus Professor of Pediatrics in topics Technologyon chapter book a and articles several published has HeBrazil. and Chile International Technologyat lectured TransferFrance,Germany,Canada, in Spain,conferences Vice President including for group Professional both Development for and the offices Board various of held Trusteeshas meetings, for AUTM AUTM: regular and Dr.LES a at Fondacaro is speaker has He (LES). Society Executive Licensing the and (AUTM) Managers Technology University of Association the in active is He event. monetization royalty a and companies up start- active 5 agreements, license active 50 over had disclosures, 90 overreceived program the 2007, In program. transfer technology recognized a nationally into office the transformed He Children’s Hospital Medical Center as founder and director of the Office of Technologymany Transfer.national and international conferences. In 1996, he joined at Cincinnati talks scientific delivered and chapters book and articles research review in the pharmaceutical industry. Dr. Fondacaro has published over 150 peer at Physiology of Professor University Associate of an Cincinnati, is College of Ph.D Medicine, Fondacaro, and a D. Drug Joseph Discovery scientist Info Demographic Consulting, Associates Biotechnology, CincinnatiArea & Fondacaro President, Fondacaro BioVisionAlexandria April 2010 drug-resistant bacterial infections. developmentand design rapid the novelto of essential is activeclasses antibiotic serious against Ribosome of Targetingand that toolkit Technology,assay an on focused team a leads he where Director Senior the Noller.Currently,is François Harry and Jorgensen William Moore,Peter of antibiotics. Among Rib-X co-founders are: Tom Steitz (2009 Chemistry Nobel Prize winner), classes new of design based structure the on focused company development and discovery drug ribosomal subunits. In 2002 he joined Rib-X Pharmaceuticals, a product driven small molecule that and crystallized solved structures of the small (T. thermophilus) and large (D. radiodurans) consortium, headed by Ada Yonath (2009 NobelChemistry Prize winner), At the Max-Planck Institute his group was a pivotal part of an international and function at the Max Planck Institute for Molecular Genetics in Berlin. structure ribosome on focused group research a of Investigator Principal Biochemistry in was he 2002 Ph.D. and 1991 Between 1989. Freiin UniversitätBerlinthe from a and Venezuela, Caracas, in Bolivar Simon of University from 1983 in degree Biology his obtained FranceschiFrançois Senior Director, Technology Rib-X,Inc. FRANCESCHI, Francois , Joe
67 BioVisionAlexandria 2010 68 BioVisionAlexandria 2010 ulse b WlyVH Gray (09; n “egahcl niain-t evolving Indications-its “Geographical and contours”, released in2009. (2009); (Germany) Wiley-VCH by published Khanna, Rita Dr PrickrilPerspective”and BenGlobal Dr A with Biotechnology-- co-edited in “Technology issues Transfer UNIDO-WIPO-IMTMA(2005); Future”, the “Shaping (2001); (1998); “Intellectual Property Rights--Unleashing the Knowledge Economy”, Press Universities Scenario” Tata Indian Patents--The McGrawHill for up “Gearing books: 5 published also He Patent Information. He has over 50 publications in technical fields, over 60 publications in IPR. Institute of India;a of Fashion Technology, NationalIndia; of a Government member Senate of the the Internationalof Adviser; MemberEditorial Washington;a BoardIIPI, of the Scientific “Worldof Board the Advisory Principal the of of member Office the to matters IPR and factory management and business planning. He is Honorary Scientific Consultant for Innovation roles including R&D, technology assessment, forecasting and transfer, knowledge management, of Pennsylvania andaBachelor’s Degree from Georgetown University. Journal, Health Affairs, and other publications. He holds a Masters Degree from the University the of Yalethe graduate BIO-India.in YaleA of and articles published has he School, Law Law Forum,Health Global for Partnering the of member Board Advisory an as and 2007 committee BIO for executive the of Co-Chair as served He India’sICGEB. with and Institute, Cruz Genzyme’s partnerships with The Broad Institute and MMV,structured has withHe DNDi,basis. with non-commercialBrazil’s a Oswaldo on programs therapeutic innovative develop helps Genzyme which under program, Diseases Neglected for Assistance Genzyme’sHumanitarian supervises also Geraghty Mr. Inc. Pharmaceuticals, Genetix and SA, Myosix of boards the of President and C.E.O starting from its founding in 1993. He is also a member Transgenics Corporation), where he was Chairman from 1998 to 2001, and Genzyme (formerly Biotherapeutics GTC/ of Director the currently is He business. cardiovascularGenzyme’s of Manager General became at Genzyme 2004 in Officer an and and 1998-2002, PresidentfromEurope Genzyme President of was He Corporation. Vice Senior is Geraghty James Senior Vice President, Genzyme Geraghty research, he worked in industry for 2 decades holding diverse managerial academic diverse holding decades in 2 for industry years in worked he research, several After Sciences. of Academy Maharashtra the of Fellow elected an and governments several for policy IPR in expert an to the World Intellectual Property Organization for IPR capacity building, Knowledge and in management Security Management. He Information is a leading international expert in IPR services and a Consultant Rights, offering Property “VISION-IPR” Intellectual of of CEO the is He CEO, Vision-IPR GANGULI, Prabuddha , James A. Speakers’ Biographies &Abstracts Renewable World –Energy, Ecology, Equality,’ whichwaspublishedby Green Books,UK. ‘Acompleted, recently has He Earthscan. by published Challenges,’Global other and Change Development and Climate Change’. In 2007 he edited ‘Surviving The Century – Facing Climate Urban – People,Planet ‘Cities, book his published Wiley-Academy 2004 In WestEngland. of the of University at Professor Visiting a and UK, Association, Soil the of patron a Architects, British of TV Institute Royal 50 of Fellow Honorary and an is He books broadcasters. major 12 for documentaries of co-author and author is Herbert Shanghai. Island, Chongming on strategies for South Australia. He has also been a senior adviser to the Dongtan Eco-City project Vienna. In 2003 he was ‘Thinker in Residence’ in Adelaide, developing sustainableand development London as such cities major for policies sustainability developed has and UN-Habitat and UNEP to consultant a been Hehas ecologist. urban leading world’s the called often is and development urban sustainable challenges of the on mainly focused has he years environmentalmany For outstanding achievements’. ‘for Award 500 Global UN a of recipient a and development sustainable on consultant leading is HeFuture Council. Prof. Herbert Girardet is co-founder and director of programs of the World Co-Founder andDirector, Programs, World Future Council Girardet BioVisionAlexandria April 2010 (Washington, D.C.) seven books, including the Biennial Water Report. The World’s Water, published by Island Press boards and papers scientific many of author numerousthe of is and organizations, and journals Yale from B.S. a received University Gleick andanM.S.Ph.D. from theUniversity ofCalifornia,Berkeley. D.C. He inthe serves Washington; Sciences, of Academy National the by elected was he 2006, in Norway; Oslo, Academy,Waterin International the of Academician an elected was “Visionary Gleick 1999, In BroadcastingCorporation. British Environment”the bythe a on dubbed was Gleick 2001, In work. his for 2003 October nominated in Fellowwas MacArthur he expert, water recognized internationally an is Gleick Dr. resources. water over conflicts international and globalization, and privatization use, water sustainable change, climate of impacts hydrologic the health, human water and between connections critical the address writing and research His Studies in Development, Environment, and Security in Oakland, California. Dr. Peter H. Gleick is Co-Founder and President of the Pacific Institute for Environment, andSecurity Co-founder and President, the Pacific Institute for Studies in Development, Gleick , Peter H. , Herbert
69 BioVisionAlexandria 2010 70 BioVisionAlexandria 2010 and ason. theoretical include areas research plasma His physics, physics of Sciences. wind erosion and of sand transport. He Academy is married and Pakistan has and two daughters the Sciences, of of Fellow Academy Foreign Overseas Royal Belgian the of member corresponding also is He AcademyColombian Exact,NaturalPhysicalthe ofand of member Honorary wellas Sciences. Scientific Merit of Brazil. He is a fellow ofTWAS, of AAS, andof Dean theorder Islamicthe Academyreceived and ofHe Sciences, Khartoum. as of ProfessorUniversity the at former Sciences Mathematical of was School the He (1974). UK Oxford, of University the from Physics companies andisalecturer intheentrepreneurship program ofHECbusinessschool. biotech European in positions member board numerous Mr.holds Grenier2009. in company pharmaceutical major a to sold he which disorders urology in specialized company biotech a Christian Grenier is a successful biotech entrepreneur. He was co-founder in 2000 of UroGene, event. the attend participants 1500 and speakers 120 About Egypt. BioVisionAlexandria, with organizations. He was born in Sudan in 1947, and holds a Ph.D. in Plasma Issues (IAP), he also serves in a number of committees in other international International PanelInterAcademyon the of Co-Chair and (AAS) Sciences of Sciences for the Developing World, President of the African Academy of Academy of the TWASDirectorExecutive - an is Hassan H.A. Mohamed World; andPresident, AfricanAcademy ofSciences Developing the for Sciences of Academy TWAS-the Director, Executive Hassan BioVision takes place every 2 years in Lyon, France and has strong links strong has and France Lyon, in years 2 the every place takes BioVision concerns Dialogue issues. global to solution the Representatives.and discoveries sciences life major of impact NGOs and Commissioners, leaders European Agencies, Business UN of Heads society: dialogue social scientists with prominent other and Laureates Nobel where Forum Christian Grenier, MBA, is the CEO of BioVision, the World Life Sciences CEO, The World LifeSciences Forum, BioVision GRENIER ,Christian , Mohamed Speakers’ Biographies &Abstracts the understandingofbiologicalphenomenaassystemsatamolecularlevel. advance to meant is This pathways. and networks molecular to subdisciplines omics of variety a link to established was center The Center. Science Omics the of Director appointed was he 2008, In RNA. as transcribed is — exons protein-coding are that fraction ~1.5% the just not network and The analysis. FANTOM activities revealed — moregenome that the of 63% than transcriptome to expanded consortium, subsequently and aninternational cDNA of by number large out a annotate to originally is carried project This project. cDNA) Mammalian of cDNA full-length large clone banks, which was followed established by the organization of the FANTOM (Functional Annotation he approach, this With technologies. of cDNA series full-length a including technologies unique developing by transcriptomes in 1995. ProjectSince then he has taken Genome a transversal data-driven approach to RIKEN analyze the for Director Project appointed was and Medical School in 1982 and 1986, respectively. In 1992, he joined RIKEN, Yoshihide Hayashizaki received his M.D. and Ph.D. from Osaka University, Genomic SciencesCenter, RIKEN Project Director and Chief Scientist, Genome Exploration Research Group, Hayashiz BioVisionAlexandria April 2010 constituency. CEOofMMVsince2000 butsteppeddown in2010. development product the representing Committee, ExecutivePartnership (RBM) Malaria Back Roll the of Member alternate an as serves He USA. focused on basic biomedical research, including as a Fogarty Fellow career at Early NIH, London. King’sBiochemistry,College, in Doctorate sectors. and technology transfer management experience in both private and public A bio-pharmaceutical executive with more than 25 years international R&D President andCEO,Medicines forMalaria Venture Hentschel aki , Christopher , Yoshihide
71 BioVisionAlexandria 2010 72 BioVisionAlexandria 2010 President oftheETHBoard (Swiss Federal Institutes of Technology). the Vice- also is Neglectedhe for InitiativeDiseases2008 JanuarySince(DNDi).Drugs the of Committee Advisory Scientific the and BaselUniversity of the of UniversityInstitute,Council Research Scripps Trusteesof The Board of notably most boards, several on serves he activities, DrugDiscovery Universitythe at Science Basel,of Switzerland. In editing scientific to addition of Professor a also is He Research. Corporate of Head 1994, in and, Pharma Sandoz for Basel Research Preclinical of Head made Research was he CNS 1992, Preclinical In Basel. the in Pharma of Sandoz at Head Department and Bern in Institute Research Sandoz the of Headbecame he 1985, In Switzerland. Bern, in Wanderand Switzerland Basel, in Sandoz both at research in positions various held and 1975 in Pharma Sandoz joined HerrlingPaul Novartis. of the research organizations of Sandoz and Ciba-Geigy following their merger in 1996 to form member of the Pharma Executive Committee (PEC). In this capacity, he directed the integration a and NovartisPharma of Research Global of Head institutes, aforementioned the supervising Novartisin Research Corporate of Head was PaulHerrling position, current Italy.his to Prior Siena, in (NVGH) Health Global (GNF) for VaccinesInstituteNovartis Foundation the and Research USA NovartisCalifornia, in the of Institute Genomics the Switzerland, Basel, in Sponsor: Federal ofResearch Ministry andEducation Germany). Mega City Research Project, Ho Chi Min City, (Saigon), Vietnam (Coordinator: BTU Cottbus, University;Harvard Design,Research: of GraduateSchool at Architecture in StudioInstructor at TechnicalInternational BuildingGermany, Universityand Darmstadt, TeachingFellowand uih atr f rhtcue hn.. ecig oiin: Assistant Planning of Positions: Department at Teaching Design Urban and (hons.). Architecture of Professor Architecture of Master Zurich of Technology Institute Federal Swiss - Zurich Eth City’ the and Theory Technology‘Social of Institute Massachusetts Distinction with (MAUD) Design Urban in Architecture of Master University, Harvard Education: Darmstadt Assistant Professor in Architecture and Urban Design, Technical University Hesse funding. In addition, he oversees the Friedrich Miescher Institute (FMI) Institute Miescher Friedrich the oversees drug-research he addition, little In funding. received have historically which diseases, infectious tropical in research medical advance to endeavor long-term in a Singapore, (NITD) DiseasesTropical for Institute Novartis the of Board the Chairman of also is He 2010. February Research in assumed Biomedical he position a for (NIBR), Institutes Novartis in (NIDWMR) Research Paul Herrling is Head of Novartis Institutes for Developing World Medical Head ofCorporateResearch, Novartis International AG Herrling , Christoph , Paul Speakers’ Biographies &Abstracts published productively media. inpeerreview journalsandinnews Huang Dr Canada. and StatesUnited the in years of 17 spent UniversityDr.has Huang1997. USA Ashland Ohio, from (MBA) Administration Business of in Master specialized a (1990) and Health epidemiolog), Public of Master and (1988) Education Professions Health of (Master USA Chicago, at Illinois Universityof the from degrees master two and 1983, China, received his Medical Degree from the Sun Yet Sen University of Medical Science at Guangzhou, of Journal Chinese the Health Management for and the Editor in Chief for Chief the Health Management magazine. in Dr. Huang Editor Deputy Chinese the the Medicine, of Preventive Committee of Control Association and Assessment Risk Health the of Chairman Vice the DoctorAssociation, Chinese of HealthInsuranceCommittee the Health Managementand the of Chairman Vicethe MedicalAssociation, China the Association, ManagementHealth the of Chairman Vice the is he Currently coverage. radio and throughTV person-times million 100 than more and directly others and professionals management health to 30,000 than more of He has given 171 talks on health management between 2005-2009 with accumulated audiences area. management health the in books several and papers dozen a than more published has He for textbook official the for chief in editors two the of Health Management China. in Specialist one also is He Specialist. Management Health for standard occupation national the setting in “Healthnamed Managementoccupation Specialist”. leader team Hethe is new certified government a of establishment and planning the in role key a played He practice. and theory management health promoting China in scholars earliest the of one is Huang Dr College. Medical Union Peking for Sciences/ Medical of DeanAcademy Chinese the at PublicHealth of School and the Epidemiology of Professor a MBA, MPH, MHPE, MD, Assistant President ofChineseAcademy ofMedical Sciences Huang BioVisionAlexandria April 2010 of theDAADinEgypt andtheregion aswell asextensive businesstravel intheregion. personnel (18 employees), financial management, overall program responsibility, representation for responsible is he where – Africa) East North Middle (Region: Egypt Office, Branch DAAD the of Head the is Hülshörster Dr.Christian 2005, Since Germany”. in Research and “Study DAAD headquarters in Bonn where he was responsible for the worldwide marketing campaign, became head of the unit - International University marketing for 5 years at was Head of the DAAD Office in Bangkok. After returning to Germany he years as a DAAD Guest Professor at Chulalongkorn University Bangkok and the Westfälische Wilhelms-Universität Münster in 1996, he at literature worked German for in studies four Doctorate his of completion After Office. Cairo DAAD the of Director the currently is Hülshörster Christian Dr. Director, DAAD,Cairo Office Hülshörster , Jianshi , Christian
73 BioVisionAlexandria 2010 74 BioVisionAlexandria 2010 the tribologyofbiomedicalmaterials. and science biomedical in techniques manufacturing generative of use the non-wovens), spun electro- (e.g. structures fibrous of mechanics the and include also materials activities research biomedical the implants, conventional investigating to addition In implants. and materials biomedical of performance and reliability the study orderto in simulations and of experiments of Mechanics combination for a typically employs Institute group research The Fraunhofer (Germany). Freiburg in the IWM Materials at Implants” and research Materials the of “Biomedical head group is he 2002, Since (1998–2002). technology packaging for coordinator the Agro-technological Research Center ATO in Wageningen (The Netherlands) as programme Netherlands) at the Department of Chemical Technology and was followed by an employment at i rsac itrss nld dsrbtd esr ytm, neatv rbtc, n android and robotics, interactive systems, science. sensor distributed include interests research His Adaptive Machine Systems in the Graduate School of Engineering Science at Osaka University. of Department the in (2002-2009) professor a also WakayamaUniversity.at was HeSciences Professor Associate was He USA. (2000–2001) and Professor Diego, (2001–2002) in San the Department of Computer California, and Communication of University the at (1998–1999) 2000) in the Department of Social Informatics at (1998– KyotoProfessor University.Associate and HeUniversity was also Osaka Visiting at Scholar Science Engineering of School Graduate the in (1992–1994) Associate Research previously was He (1999–2002). Researcher Visiting eeomnctos eerh nttt, hr h peiul wre as worked previously he where Institute, Research Telecommunications the Intelligent Robotics and of Communication Laboratories at the Advanced (2002–) Leader Group at Visiting also Science is He Engineering (2009–). University of Osaka School Graduate the in Innovation Systems of Department of Professor a currently is He 1991. in University,Japan Osaka the from engineering systems in HiroshiD.Eng.Ishiguro receiveda Professor, Osaka University Ishiguro pro a Ps-o (9619) t h Uiesti Tet (The Twente Universiteit the at (1996–1998) Post-Doc as period A 1995. in chemistry physical University in PhD his the obtaining TorontoCanada, of in at student graduate was he “Diplom-Physiker”, as 1991 in in graduating Universität After physics. Albert-Ludwigs polymer in specializing the (Germany) Freiburg at physics studied Jaeger Raimund Institute forMechanics ofMaterials Implants”,and GroupResearchMaterialsHead,Fraunhofer-“Biomedical Jä ger , Raimund Raimund , Hiroshi Speakers’ Biographies &Abstracts organizations onissuesconcerningpolicy, development anddisabledpeople service incurable currently conditions. Prior of to treatment joining GIG, the Alastair worked for for into a number support knowledge of voluntary and new services this improved of transfer speedy the see to and disease, and health in play factors genetic that part the and genetics of understanding scientific the of development the promote to is mission GIG’sdisorders. genetic by affected people for groups support and charities of alliance UK the - (GIG) Group Interest Genetic the of Director the is Kent Alastair Director, Genetic Interest Group KENT, Alastair BioVisionAlexandria April 2010 Genetics) andhascontributedmanybooksoncancer. in articles peer-reviewed journals (including New England Journal of Medicine, Lancet, 350 Nature than more published has He innovation. for award Nye-Bevan NHS first the and prizes international several awarded was He pathways. biochemical key novel of inhibitors involve and biomarkers which treatment cancer to approaches new developing currently is He cancer. is internationally renowned for his contributions in the treatment of and research into colorectal has he where Medicine Hospital.HeMedicineCancer Cancer and Institutefor new a build to colleagues Cancer with worked of Professor as Oxford to contributes and Hospital’ Cancer in Amal medicine ‘Al practices Qatar’seffectively cabinet, Health, Health of Council Supreme improvingto contribute and Global Health. He the to appointed been has build a collaborative biomedical research network through the Middle East to plans he Fromthere, Institute.Qatar’s Research Biomedicalof national Director and billion, 8 $ with endowed (www.sidra.org) Centre Science Health academic an SIDRA, for Scientist Chief the become to Oxford of University the from absence of leave year 5 a given been has Kerr David Director ofQatar Biomedical Research Institute KERR, David
75 BioVisionAlexandria 2010 76 BioVisionAlexandria 2010 Council and was partly funded by the IndustrialCouncil and was partly Development Corporation ofSouth Africa. ResearchMedical African South the was of InnovationCentre the of auspices system the under developed Gknowmix The lectures. accredited CPD of facilitator and and meetings presenter regular scientific a international is and national numerous at speaker invited Maritha an chapters. been book has and articles peer-reviewed 100 than more include publications Her Africa. in South Biomedicalfield the in publishers active ranking highest 20 the of one as USA the in Information Scientific for Institute the by time this during identified was and 2005 in for Research Excellence in 1999. She received a patent incentive award for Research Innovation she has moresupervised than 10 PhD post-graduates. She has been awarded the Rector’s Award 1990, in degree PhD her obtaining SinceStellenbosch. Universityof the at laude cum degrees the InternationalinDevelopment Organization(IOCD),Belgium. forChemistry The Children Hospital of Philadelphia, Scientific Advisor to Institute of One World Health and is currently a member of Board of Directors of Pytica Inc., and is an Advisor to Global Health at SwitzerlandPublicand Interest Intellectual Property Advisors, Inc., WashingtonHeUSA. DC, Geneva, Research, Health for Forum Global (PPPH) Health for PartnershipPrivate Public of Research Chemist and is the holder of several patents. Dr. Kilama was on the Board of Directors a and Kentucky, of Bachelors Universitydegree in Chemistry from the Berea. Dr.from Kilama worked in degree DuPont as Pharmacy a Senior Medicinala Arizona, of University the from Chemistry Medicinal in PhD his receivedDr. Uganda,Kilama in Born nations. developing in public) and (private institutions and corporations multinational between partnerships effective several their facilitated Kilama Dr. for countries. developing regulations of trade development economic international the on and impact assistance technical of evaluation in expert an idvriy Boehooy n Lw riig urcl ue t train to also used is Kilama Dr. countries. developing curricula other and Africa in professionals training Law of and healthcare, Founder Biotechnology a Biodiversity, on is He development GBDIs’ developed He (GBDI). chemistry.Institute Development Bioscience Global policy agrochemical and in pharmaceutical in expert an biotechnology,property.intellectual and bioprospecting is Heexperience has Kilama Dr. President, Global Bioscience Development Institute KIL lncas D Mrta oz otie hr S, S hnus n MSc and honours BSc BSc, her obtained Kotze Maritha and Dr clinicians. scientists students, among innovation research genome promoting Stellenbosch,University of the at Researcher Senior as appointed is academia she as with links close maintains She system. delivery service testing clinical of integration for process assessments, laboratory analysis and reporting through a web-based business genetic a developed that company healthcare a Gknowmix, of CEO and founder the is Kotze Maritha Prof CEO, Knowmix CapeBiotech Trust K otze AMA, John , Maritha Speakers’ Biographies &Abstracts Practices’. ‘Intellectual Property Management in titled, Health and Agricultural Innovation:publication A Handbook recent of Best the to Editor-in-Chief as served Today,Strategy and Innovation of Law Pierce Franklin the Editor-in-Chief of Association; Biotechnology Sea BoardBlack the of Member Advisory Board Center,founding the of member a is He Rice. Golden for Board Humanitarianthe to Executive as served and years, seven for ISAAA of DirectorExecutive the was He CGIAR. the of centers the of one Mexico, in CIMMYT the at worked He England. University,Cambridge from breeding/genetics plant in PhD and degree a became masters a agronomy.obtained studied He He he whereSwitzerland in farmer consultant. world-wide a considered also He University. Arizonaat StateLaw Dayof College O’Connor University, Cornell at and government, science, businesses, and philanthropy. He teaches at the Sandra to Agri-biotechnology and Global Health at the crossroads of development, Anatole Krattiger works on strategic and intellectual property aspects related Adjunct Professor, Arizona State University KRATTIGER, Anatole BioVisionAlexandria April 2010 awarded Prix Hallopeau by theInternational Ozone Associationforheroriginal PhD research. she 1999 in information: Additional applications. Reuse Wastewaterand in expert as 2009 in Environment Cirsee-Suez the joined She lines. treatment different these in membranes wisely with membranes technologies applications and operations with a special emphasis on how to use dealing 2008, to 2005 from Water,Degrémont of department researchReuse and desalination of Degrémont in 1998 as project engineer then as Director of the Drinking career in Russia for Safège Consulting. She joined the Research department in been has working for Suez 1998, Environment she since 1997. She experience: began Rennes,her professional Professional Water. and of Microbiology Poitiers and of Chemistry Universities French the from thesis degree PhD her received Langlais Chrystelle Dr background: Educational Senior Engineer, SUEZEnvironment l Lang ais , Chrystelle , Chrystelle
77 BioVisionAlexandria 2010 78 BioVisionAlexandria 2010 R&D. He isFluent inSpanish, English andItalian. vaccine of area the in programs accreditation for academia and industry between collaboration Africa and Asia. Currently he is the Director of the Novartis Vaccines Academy which addresses America, in researchers several conducted has He Organization. WorldHealth the of Bulletin the AdviserEditorialfor the and GuidelinesCommittee, the ReviewWHO of member Hea is Property.Intellectual and Innovation Health, Public on resolution WHO diseases; neglected Dengue fever. He was a member of several WHO working groups addressing product R&D for Onchocerciasis of Control Lymphatic filariasis, for African and American trypanosomiasis, Schistosomiasis, Programs Leishmaniasis and African the for Unit Evaluation and Development Product the of Director the became he where TropicalTrainingin and Diseases Research for ProgramSpecial WHO the joined he 1998, In helminths. HIV,and for cancer,malaria drugs Supercourse whichinvolved 56,000facultiesfrom 174countries. Kelly the Developed NASA. Association. Diabetes and American the NIH, from Award Epidemiology DiabetesWest from projects international Childhood and national for Network, funded Health Numerous Project Global 1994. the Multinational of Developed WHO countries. 70 in the centers 155 of involving Diabetes, PI and Developer Epidemiology. of HIV and cancer biology. In the Pharmaceutical industry, he discovered new La Universita Sapienza, Rome, Italy. and Biomedical USA; research in tuberculosis, schistosomiasis, Bethesda, NCI, Health, of Institutes National The University; Harvard Research, Scientific for VenezuelanInstitute the at tenures Academic USA. Boston, in University Harvard from Biology the from (1970) degree Medical University PhD. of Carabobo, MD, Venezuela. Lazdins-Helds,Ph.D. (1978) K. in Cell Janis and Developmental Head, Novartis Vaccines Academy, Novartis Vaccines andDiagnostics zdins La Department Center, Collaborating WHO Monitoring Telecommunications, Disease Director, education. and in achievement time life for of Public Health, University of Pittsburgh, 1989. Lillienfeld Award, APHA Global Health, and Internet. First 1977; Distinguished Teacher, in Graduate School Psychology Cognitive in Masters degree Ph.D. in Epidemiology, 1981. 531 1975; publications in Epidemiology, in Psychology in MS of Pittsburgh UniversityHealth, Public of Epidemiology,School Graduateof Professor Laporte -Helds , Ronald , Janis K. Speakers’ Biographies &Abstracts by theUniversity ofFribourg (Switzerland). for his academic work in Business Ethics he was awarded a “Doctor Honoris Causa” in Theology “Pro engagement et Justitia” as sustained Pace well his as Anan. Kofi For Compact Global UN 2006, Klaus Leisinger as served Special Advisor of the United Nations Secretary General for the December and 2005 SeptemberBetween Council. Social and Economic UN the and (ECLA), World Bank (CGIAR), Asian Development Bank, the Economic Commission for Latin America the United Nations Global Compact, the United Nations Development Program (UNDP), the holds several advisory positions in a number of national and international organizations, such as He is a member of the European Academy of Sciences and Arts. Klaus Leisinger has held and still Paul University, the MIT Sloan School of Management (Cambridge), and at Harvard University. was a guest speaker at several Swiss and German Universities, the University of Notre Dame, De Leisinger Klaus Business. and HumanRights as well as ResponsibilitySocial Corporate Ethics, is Professor of Sociology at the University of Basel where he teaches Business and Economic Council of the United Nations. In addition, Klaus Leisinger Social the with status consultative has Trustees. of Foundation BoardThe the and of Executive Officer President Chief the is he whereDevelopment Sustainable for Foundation Novartis the at appointed is Leisinger Klaus Sustainable Development for Foundation Novartis Director, Executive and President Leisinger the and quantitative estimationofanthropogenicscale climatechangeimpactse.g.oninsurancebusiness. regional at risk climate the of understanding the on focused work ongoing the of basis the up build outcome scientific which CIRCE) ENSEMBLES, (MICE, projects EU skills in the realisation of interdisciplinary projects. He has contributed to previous and ongoing anthropogenic climate change impacts of meteorological extreme events. He achieved high level statistic-dynamical downscaling techniques. Actually, his research is focused on the estimation of scientific different time and spatial his scales, i.e. from paleo-climate conditions to regional modelling within on processes During meteorological of analysis importance. the in experience gained crucial he work of therefore is mechanisms large on physical underlying of understanding The processes. scale synoptic to scale impacts related and variability climate naturaland induced of anthropogenic thediagnosis on arefocused interests research main The Dr. Gregor C. Leckebusch is Associate Professor at Freie Universität Berlin. Associate Professor, freie Universität Berlin Leckebusch BioVisionAlexandria April 2010 , KlausM. , Gregor C.
79 BioVisionAlexandria 2010 80 BioVisionAlexandria 2010 and others. BritishMedicalthe reviewerfor Journalpeer Journala (BMJ), Medicalas of Internet Research, peer reviewed papers and chapters on cancer epidemiology and global health. Dr. Linkov served 40 over published She changes. premalignant detect to markers tumor biological of use the on women’sDr.reviewmechanisms. peer and health, Linkov’s current research focused is activities divide, digital health, global cancer, include interests Linkov’sDr.research world. developing to is developers the in members faculty to Supercoursematerials education health public deliver and the divide digital the close of goals main the of One countries. 174 from participants 58,000 over with Prevention Diseases and Health Public on lectures 4200 containing library in the Global Health Network Supercourse Project. Supercourse is an open access Internet based ilgcl netcds ee sud n i nm. rf Mdor uhrd 4 pe reviewed peer 140 authored scientific publications andcontributed withchaptersin7international textbooks. Madkour Prof. name. his in issued were insecticides biological for awards AOAD three received scientific excellence, and also the FAO He World Food Day 2007. recognition in 2001. Three in patents for Technologies novel Agricultural Advanced appreciation of in Award State the of recipient the as Egypt of President the from Medal Gold Egypt’swith decorated was He(Bioversity). IPGRI and Trusteesof ICARDA Board of the on (2001-2004). He served on the Technical Advisory Committee of the CGIAR (1996-2000), and Egypt) andappointed Vice President thenPresident oftheAgriculturalResearch Center, Egypt 1990). In 1990 he established the Agricultural Genetic Engineering Research Institute (AGERI- Pathology, Alexandria Plant Univ.of Prof. Egypt appointed (1982-1989), Pathology,Visiting was Prof.Plant Univ.Physiological in of California, UK Wales,Davis Univ.of (1989- the from past ten years, Dr. Linkov has been working with Professor Ronald Laporte Advanced Studies in Global Health from the University of Pittsburgh. In the Epidemiology,MPH inCommunityandBehavioral Health of Sciences,andaCertificate in PhD a holds Linkov Dr. Oncology. and Hematology of Division Medicine, of Department Medicine, of School Pittsburgh of Faina Linkov is a Research Assistant Professor of Medicine at the University of Medicine School Pittsburgh UniversityMedicine,of Professorof Assistant Research Linkov oprto, CRA 20-06. rf Mdor band i PhD International his obtained for Madkour Prof. General 2004-2006). ICARDA( Director Cooperation, Assistant the was He Alexandrina. Agric. (ARDF), Fund Bibliotheca to AdvisorSenior and Agriculture of Development Ministry Council, R&D for Research Agric. Committee, ResearchAgric. Inst.,Shams AinUniv., the of Egypt,Chairman Technical Professor Magdy Madkour, is the Head of Biotechnology at the Arid Lands Fund-ARDF Development for Chairman, TechnicalResearch Agricultural Committee, MADKOUR, Magdy , Faina Speakers’ Biographies &Abstracts Security (CSCANS)oftheNational Academy ofSciences. National and Communications Scientific on Committee and Biosecurity for Board Advisory Science National the of member a currently is Dr.Mahmoud Diseases. Infectious for Society Council and is a past president of the Central Society for Clinical Research and the International Diseases Society of America Infectiousin 1984. He served in the Nationalthe Advisory Allergy and Infectious Diseases of Award’ ‘Squibb the and 1983, in of HygieneSociety and American TropicalMedicinethe of Award’ Ashford K. ‘Bailey the received He 1987. in Sciences’ of 1971. He was elected for the membership of the ‘Institute of Medicine of the National Academy in 1963 and Ph.D from the University of London, School of Hygiene and Tropical Medicine in Cairo of University the from degree M.D. his receivedDr. Mahmoud vaccine. Papillomavirus Human and Shingles vaccine; Virus Rota Varicellavaccine; and Rubella Mumps, Measles, of their combination a for vaccines new four strategies developed Dr.MahmoudMerck, at and working While control. infections helminthic to resistance host of investigations on focused pursuits academic Mahmoud’s Dr. Physician-in-Chief. and Medicine Chairman of as Cleveland of Hospitals University and University Reserve post as President of Merck Vaccines. Prior to that, he served at Case Western Molecular Biology at Princeton University. He has recently retired from his of Public Department of The WilsonSchool and International Affairs and Adel A. F. Mahmoud, M.D., Ph.D is currently appointed at The Woodrow Former and President, Merck Vaccines University Princeton Biology, Molecular of Department Professor, MAHMOUD, Adel BioVisionAlexandria April 2010 pioneers of this new industry.pioneers ofthisnew company,his launch to time ‘Aldebaran the of one becoming Robotics’,thus 2005, in founded right the for waiting years, 25 past the for evolution its and market this following closely been has he years, for robotics by andFascinated Portugal) skills. management multicultural Poland his (Brazil, thus improving companies financial international of CEO successful became then He projects. multi-partners headed he where bank, a of manager DP became he until companies, tech high and banks various of manager IT robots. as years 10 humanoid for worked first He banks. of management and IT pillars: programmabletwo of sales on built was PolytechniqueTelecomand career from Graduated and his Paris, design company European in 1st the specialized Robotics, Aldebaran of founder and CEO CEO, AldebaranRobotics MAISONNIER, Bruno
81 BioVisionAlexandria 2010 82 BioVisionAlexandria 2010 Academy and Science. ofArt is a Fellow of the Royal Geographical Society of the GlobalUnited Kingdom and a Fellow nominated of the World was and Government Culture.Sheand Education Hungarianof MinisterHungarianthe Culture French for by Ambassador the by d’Honneur” Légion la de national l’Ordrede “Chevalier the awarded was she 2008, In Science. in Cooperation International for Award AAAS the received she 1999 In papers. and books numerous co-authored has Lefèvre Marton- J. France, and StatesUnited the in educated and Hungary in Born Prizes. Alcan and Andrew’sSaint the of jury the in and Century, 21st the for capacities technology and science Technologyin Developing Countries and (COSTED), the InterAcademyScience Council’son PanelCommittee ICSU’son promoting worldwide in served also has She Development. and Environment in Cooperation International for Council China the and International, Charter Development (IIED), the Board of Trustees of the Bibliotheca Alexandrina, the Council of Earth French the of member a Academy of is Technologies He andanofficerinthe French Order of Merit. France. HEC-Paris from MBA an holds Martin companies. sciences life several of boards the in member a Mymetics(Epalinges-Switzerland).also of is He the Board of GAVI (Global Alliance for Vaccines and Immunization). He is in Chairman membership his and facilitated CEO which countries, low-income to support program other immunization and vaccines lifesaving provide to fund’sefforts the lead He fund. vaccine the of CEO AIDS Vaccine Initiative (IAVI). From 2000 to January 2005, Martin was the first President and (SAGE). From November 1997 to June 2003 he was a member of the WHO Board of of Experts of the Group International Advisory Scientific the of member a was he such, As Associations. Manufacturers Pharmaceutical of FederationInternational the of Committee Biological the of French(the Chairman the Nationalas Health).Instituteof Fromserved Martin 1997, to 1994 Lyon,France. From September Septemberto 1996 Boarda was he 1999, INSERM of member of LEAD International, the International Institute for Environment and Environment for Institute International the International, LEAD of and boards Directors of of Board number the UPEACE, a of Council of the including member commissions a is Julia globe. the across spread governments, overmembers together of 1000 partnership world unique a in scientists and NGOs brings which (IUCN), Nature of Conservations for Union International the of General Director is Marton-Lefevre Julia Director General, The World Conservation Union (IUCN) MARTON-LEFEVRE, Julia in based company consulting biotech Parteurop,a up set Martin 1991, In the Government of Canada for the acquisition of Connaught Laboratories. Mérieux. He was nominated CEO, in 1988, and successfully of negotiated expansion international with the to contributed largely he where Marketing, Information. In 1976, Martin joined the Institut MérieuxBiographical as Parteurop VP of of Sales CEO and and Chairman Martin, Jacques-Francois President andCEO,Parteurop MARTIN, Jacques-François Speakers’ Biographies &Abstracts responses inchildhood,prediction andprevention ofallergyinchildhood IgE of impact (Berlin, clinical and evolution hypothesis, School hygiene interests: research current Medical Major D). Charité Paediatric the of at Dept. Immunology the and in Pneumology currently and CH) (Geneva, Health World Organization CH), (Lausanne, UNIL Institute, Biochemistry Rome), HeImmunology(1990). and Allergy Researchthe workedat (IAF, Center Rome in Graduated 1958. (1982), in trained in Allergology, Rome Clinical Immunology (1986), in Lab Medicine Born Matricardi. Maria Paolo University Medical Centre Professor, Department of Pediatric Pneumology and Immunology, Charité Matricardi BioVisionAlexandria April 2010 Peking University; andaMember oftheOrder oftheGolden Ark. Professorat AdjunctUniversity; an Cornell at Large Professorat White A.D. an Management; Academy of Art and Science; member of the UNEP International Panel for Sustainable Resource Worldthe of fellow of Conservation; BoardTrustees Environmental the Foundationfor the of of member a Europe; Earthwatch of Patron Science Council; Governance Risk International the of and Council Scientific Technical the of member Biology; Conservation for Society the positions: Chairman of the Board of Ecoagriculture Partners; Chair of the Policy Committee of IUCN interest such as species, protected areas, ecosystems, and economics. He also holds several agriculture, human health, biotechnology, climate change, energy, and more traditional fields of board of 14 international journals. His current work includes linking biodiversity to sustainable and technical articles on a wide range of environmental topics, as well as serving on the editorial specialists popular other 500 and books 40 over edited and and written has He conservation. biological scientists in working 10,000 and members institutional 1,000 over with network, conservation largest world’s the of work the overseeing for responsible is Advisor,he Science IUCN’sSenior As activities. management resource of Thailand, in years twelve spent Indonesia, he and Nepal, IUCN, where he conducted joining research and Before practical application 1980. since Jeffrey A. McNeely is Senior Science Advisor at IUCN, where he has worked (IUCN) Nature of Conservation for Union International Advisor, Science Senior MCNEEL Y, Jeffrey , Paolo
83 BioVisionAlexandria 2010 84 BioVisionAlexandria 2010 funded through theEUAfricaCaribbeanandPacific program (EU-ACP). Initiative in Science Regionaland Education (RISE); Carnegie and is responsible a for a Products), new project, ‘POL-SABINA’Natural for Informatics and Biochemistry African (Southern programSABINA the of establishment the Malariain African Initiative). Sheinstrumental was (South SAMI of committee steering the chairs MorrisProtocol. Cartagena the under building for the SIDA Bio-EARN program, and as a member of an international team evaluating capacity Committee Program Advisory the of member a as programs, international various of evaluator delegations thus establishing biotechnology links with other countries. She also served as external strongly is associated with Morris biotechnology and biosafety role. in Africa. current She her participated in on various SA taking government beforeTechnologies Chemical and Biological Strategicresponsiblethe was for she 1999, in CSIR TechnologyGroup Food,of division the in where she became manager of biotechnology R&D in an industrial environment. Rejoining the Alexandria: Bibliotheca Alexandrina/The Doyle Foundation. 2004’, BioVisionAlexandria of ‘AnF. Overview Erbisch,(2004); S., Soliman, R., Nakhla, C., Schneider, Forum’, Reform ‘Education Alexandrina’; Bibliotheca ‘Alexandria: Development’, Refai, A., Abdo, A., Nakhla, R. (2005); ‘Reform Issues in Continuous Education and Vocational Technology’, ControversialEgypt’,‘Alexandria: in Schools Alexandrina’,Bibliotheca ‘El Tayeb, a Mofty,El M., M., Eid, M., Secondary ‘Biotechnology in Curriculum (2004), ‘Biology (2003); R. R. Nakhla, Alexandrina’, Nakhla, Bibliotheca‘Alexandria: : are publications his of Some Excellence. Awardfor National the of Examiners of Board 2005 the of member a is He Forum. Reform Education the and Forum Reform Arab the of workshop conference pre the in Heparticipated 2004. BioVisionAlexandriain and 2003; in century 21st the in Science and and TechnologyScience of Responsibility2002; SocialTeaching in and Ethical 2002; in Math South the and North the of voices Biotechnology BA; in conferences international several in the Bibliotheca Alexandrina (BA). He is also the former Director of Personnel. He contributed of British Columbia in Canada. She later joined AECI Ltd in South Africa, PhD Andrews, Universitythe in and South Africa, in CSIR StAberdeen).the in She worked Hons (BSc Scotland in biochemistry in Trainingher obtained Morris bioscience. advanced in expertise of network a establish of the CSIR, University of Pretoria and University of the Witwatersrand to Director of the African Centre for Gene Technologies (ACGT), an initiative Director, AfricanCentre forGene Technologies MORRIS, Jane In October 2002 he became he Training2002 OctoberIn in HumanResourcesconsultant and AAGSB. the in lecturer visiting a and AUC the in Marketing and Sales in and experience in sales in the Pharmaceutical industry, he became a lecturer training of years five Wolverhampton,UniversityAfter of the (U.K.) from Projacs Management Quality in degree Master Administration, a holds pharmacist, Nakhla, Rafik and Resources Human International President, Vice NAKHL A, Rafik Speakers’ Biographies &Abstracts healthcare andhumancapacitydevelopment on focuses He Rwanda. of Republic the of President Kagame, Paul H.E. Presidentialof Council the Advisory as appointed been has Niyikiza Dr. 2007, September Since prevention. and governmentand (Federalacademia business, research,State)cancer treatmentand to dedicated from leaders senior of forum national UnitedStates a C-Change, for WalkerCommittee Bush on article Journal’ Street ‘Wall April 21, 2004. Since March 2006, page Dr. Niyikiza front serves on former US President George a Herbert in featured were Lilly landmark at His medicines. achievements Lilly scientific of many for indications drug new 10 of registration efficient and development effective in resulted that makers policy authority regulatory and investigators of network international strong a developing for and research groundbreaking for credited is the Lilly,he At project. genome of human the of leader completion following program worldwide pharmacogenomics Lilly’s became Niyikiza Dr. Lilly. company’s He Eli for 2009. the then to of and Syntex for 2005 first working 1991 in member industry from pharmaceutical the joined a Board Operations as Development and Medicine GlaxoSmithKline for Development Leader Medicine and President Vice as served Development Niyikiza Dr. this role, Medicine to Prior USA. of MA, Cambridge, President in Pharmaceuticals Merrimack Vice for Executive is Niyikiza Dr. Vice President ofGlaxoSmithkline NIYIKIZ these disorders. more complete understanding of the nature of the neurophysiological alterations associated with molecular,of integration cellular, the producinganimal, same a the in data behavioral and systems, allow will approach this that believes Nicolelis Dr. learning. and reward sleep, gustation, Deficit Disorder. He has also made fundamental contributions in the fields of plasticity, sensory Parkinson’sAttention including and Epilepsy,disordersSchizophrenia disease, psychiatric and and non-human primates, he has also developed an integrative approach to studying neurological Brainof studies pioneering Machine Interfaces Neuroprostheticsand (BMI) patients human in his for known best is Dr.Nicolelis a decade, past the for Paulo.Although Sao of University is from the Neurophysiology in Ph.D. Nicolelis and M.D. his Dr. received he where Natal. Brazil Paulo, Sao of of native Neuroscience for Institute Lily Safra International and Edmond the of Director Scientific and Co-Founder and Neuroengineering;for Center Duke University.of Co-Director also is He Professor of Neurobiology, Biomedical Engineering and Psychology at Duke Dr.Anne MiguelW.Nicolelisthe is ProfessorDeane Neuroscienceof and Duke Neuroengineering, for University Medical Center Center Co-Director, and Sciences Brain and Psychological and Engineering Biomedical Neurobiology Professor, NICOLEIS, Miguel BioVisionAlexandria April 2010 A, Clet
85 BioVisionAlexandria 2010 86 BioVisionAlexandria 2010 Board ofdirectors ofEuropean Membrane House. nuclear submarine. a on served also Navy. He U.S. the in officer medical a as service military by interrupted was residency neurosurgical His College. Medical University Jefferson Thomas from MD his and from honors Haverfordhigh College, his with MA degree in degree international relations BA from the Universityhis of receivedPennsylvania Nobel Dr. hospitals. and health of ministries device medical to policy telecommunications regulation, and has served as national a consultant to many federal, voluntary, from and international agencies, ranging legislation, proposed on Congress U.S. the before testified has Nobel Dr. continents. five the on projects different directed personally has He nations. Arabic the serve to Dubai in and region, Asia-Pacific the serve to Malaysia in Europe, serve to Kingdom the United in offices and Centre Collaborating (WHO) Organization WorldHealthrelated its programs, ECRI’sinternational developed He services. and publications ECRI other many and select system, comparison product healthcare 1987 to 1997. Fellow, Member Academy of Sciences of Sao Paulo, Brazil Paulo, Sao of Sciences of AcademyFellow, Member 1997. to 1987 for health devices, health devices alerts, the health devices sourcebook, the sourcebook, devices health the alerts, devices health devices, health for and technical assistance services. He created the concepts and operating plans productassessment, technology its including evaluation, management, risk ECRI’sprograms,developedHe and organization. researchoverallpolicies services health nonprofit based U.S. old 42-year a ECRI, founded Nobel Joel Institute. ECRI Emeritus, President and Founder M.D Nobel, J. Joel Founder andProfessor Emeritus, ECRIInstitute (ECRI) NOBEL, Joel 2009). Associate Professor, University of Campinas, Brazil Humboldt from (1997- Germany Association, Helmholtz GKSS, Energy, Sustainable for Saudi Arabia. Previous positions: Researcher (KAUST), Technologyand and Head of Science Dept. of Membranes University Abdullah King Center Research Membranes Scientist Research Principal 2009: September Since Principal Research Scientist,KAUST Membranes Research Center Nunes , Suzana Speakers’ Biographies &Abstracts projects inBrazil. BioFort and AgroSalud HarvestPlus, the for responsible is Network Biofortification Brazilian the areas of food safety, biosafety and labeling of genetically modified foods. Coordinator of the FoodTechnology, Embrapa in at researcherbeing researcha her Biosafety.is in she Nowadays Genetically Modified Foods of Plant Origin”, of ofthe roster ofexperts beingpart FAO/WHO (Japan) since 2000. She is a member of the FAO/WHO Expert Consultation, “Safety Aspects Biotechnologyof from (Canada) Derived Foods Taskon Alimentarius Force Labeling Codex the Food at and in 1997 since Committee Alimentarius Codex the at delegate Brazilian MSc. or PhD with researchers 40 including employees, 140 with unit FoodTechnology, research a of Foods for Special Dietary Uses. From 1996 to 2003, Nutti was General Manager of Embrapa R&D at oriented mainly researchers 40 of S.A., group a Nutricionais,leading e ProdutosDieteticos Nutricia of Director Technical theses. MSc several of committees (1983- examination of member a and courses several for responsible being Campinas 1987), of University State Planning, Food and Nutrition of of University the at Guelph, Canada studies (1985). consumer Full time in researcher and and (1980) lecturer at Belgium the Gent, Department of Brazil (1986). Post-Graduate course in nutritional planning at the University FoodEngineer, Foodin MSc State the at Science University Campinas, of Researcher, National Research CenteronFood Technology, Embrapa Marilia NUTTI, BioVisionAlexandria April 2010 Group on Biotechnology and Nanotechnology. Coordinating Internal OECD the of and chairman the bio-economy.is Mr.emerging Oborne risks the systemic new managing and monitoring issues), biosecurity (particularly economy the commercialization of space, the future investment needs for infrastructure, the new security on focused projects on working is Programme Futures International Currently,the China. of policy, innovation policy frameworks, information technology policy and the political economy biotechnology,science of areas the in extensively worked has OborneMr. China. of Republic People’sthe in issues investment foreigndirect and technology on articles and books published and Italy. In the 1980’s he worked on the political economies of the Pacific Basin countries, and senior Fulbright professor, he has taught at universities in the United States, Great Britain, France California, Berkeley, at Cambridge University, and at the Ecole Normale Supérieure in Paris. As of University the at PHD MA, BA, his received Mr.Oborne Forum. Science OECD’sGlobal the for Director the also is HeProgramme.OECD’sFutures International the of Director the At present he is the Director of Multidisciplinary Issues in OECD and also Director for Science, Technology Department of and the Industry OECD. Head of the Science was and he Previously,Technology Economic 1980. Policy for since Division of (OECD) OECD, Organization and Development Deputy and the Cooperation at working been has Oborne Michael Science Forum, OECD Global the and Programme Futures International the Director, OBORNE, Michael
87 BioVisionAlexandria 2010 88 BioVisionAlexandria 2010 Pediatrics ofMexico. (2006-2007). Finance of Minister (2004). forum STS the university;founded graduate interdisciplinary and enact the Fundamental Law of S&T (1995); created the to Okinawa role Institute central of a S&T, played He and (2001-02). international Science Policy Technology for Northern and TerritoriesAff. and Okinawa for Minister (1997-98), Planning Economic for Minister Sec.-Gen. Bureau; Chairman, Standing Comm. on Finance; LDP Dir.-Gen., Election Bureau; LDP Acting Ind.Policy& Comm. the of Gen. Bureau;Dir.-Gen. LDP & Science the of TechnologyPolicy Global Health Mexican Academy of Pediatrics National Confederation of PediatricsNationalConfederation of AcademyMexican Health Global Internet Epidemiology,Epidemiology,SupercourseHealthDeveloperon Global and and Internet on Supercourse Latinamerican of Coordinator Guanajuato. of University Salvatierra, Celaya Campus Engineering, and Sciences Health of Division Obstetrics, and Nursing of Department in C Associated Professor Epidemiology. in Dr Pediatrician, Doctor, Medical of University Celaya Obstetrics, and Guanajuato Nursing of School Professor, P Dir.-Finance;LDP for Parliamentary Vice-minister 1983; in Firstelected Science and Technology Agency; Dir.-Gen., Guidance Dept., SME Agency. Div.,Director,Admin. Agency; Enterprise Medium & Div.,PolicySmall Enterprise Small Director, Bureau;Div., TradePolicyEurope Eastern & Asia South Director,York; New Hitotsubashi in General Consulate from positions, several graduated he positions: several University and joined hold the Min. of Int’l he Trade and Industry 1956 (MITI); he holds In Founder andChairman,Science Technology inSociety (STS) Forum OMI, Koji adill a , Nicolas Speakers’ Biographies &Abstracts P BioVisionAlexandria April 2010 the 2002award forDistinguished Policy Contribution. Rosegrant, Mark and Economics Pinstrup-Andersen Per with Agricultural along Pandya-Lorch, American presented Association the achievements, her of recognition In 2004. April on 1-3, Uganda Kampala, in 2020”, by Africa in Security Nutrition and Food“Assuring (2) and 2001; September 4-6, on Germany Bonn, in 2020”, by All for SecurityFood “Sustainable (1) on conferences international major two Sub-Saharanfacilitated in Shehas development Africa. sustainable on emphasis particular with degradation, environmental and poverty,insecurity, on trends in and prospects for Global Food Security and on policies to alleviate and prevent food General, Per DirectorPinstrup-Andersen. An IFPRI former IFPRI’sstaff member since to 1987, she assistant has focused special her research was Pandya-Lorch position, as Chief of Staff in the Director General’s Office. Before taking her current reducingpoverty protectingand environment. the She concurrently serves initiative that seeks to identify solutions for meeting world food needs while 2020 Vision for Food, Agriculture, and the Environment Initiative, a global IFPRI’sof head is origin, Indian of citizen Kenyan Pandya-Lorch,a Rajul Initiative Environment the and Agriculture Food, for Vision 2020 IFPRI’S Head, P manages projects inbiotechnologyandelectro-electronic wasterecovery andrecycling. and managment general in consultant a is Biotechnology.Presently in and Electro-electronic in associations business of Director and member been Has managment. chemistry, plastics, electronics in and biotechnology, businesses in several the areas in of finance, possitions marketing and held general Has - Career at the Politecnical School of the Federal University of Rio de Janeiro, Brazil. USA, and now completing a Masters degree in Environmental Engineeering Education - MBA from Amos Tuck School of Business, Dartmouth College, Principal, BiznessBrazil aes andya
de -Lorch Carvalho , Rajul , Rajul , João
89 BioVisionAlexandria 2010 90 BioVisionAlexandria 2010 of theEuropean Union toEgypt. of 2008. She is currently working as the Science and Technology Coordinator at the Delegation Knowledge Studio, Royal Netherlands Academy of Arts and Science in Amsterdam in the spring Virtual the Fellow,at Research Postdoctoral Technology.a and was Science PapageorgiouDr. of Ethics of field the in Society.fellowshipDr. and UNESCO 2007, PapageorgioureceivedIn textbooks to theoretical monographs. clinical and manuals technical from ranging books several and articles scientific numerous of his two Magneto encephalography laboratories at the Houston Medical in Center.conducted Hefunctions, is cognitive the author of mechanisms brain the of imaging in and plasticity brain epilepsy,in research his disorders,for developmental foundations private and federal other and NSF NIH, from awards grant and distinctions several of recipient the and Scholar Fulbright a is He Athens. of UniversityNational the of Department Neurology the Neuropsychologyat the of Studies Advanced of Institute International SummerNeuropsychological Society. the directedSince 2008 he and directs the founded graduate program in he clinical 2006 2002- In of Linguistics of Rice of University and Departments the Department of the Psychology of the in University of Pediatrics, professorHouston. Neurosurgery and Neurology and he holds adjunct appointments a in the Department is He (www.uth.tmc.edu/clinicalneuro). Neurosciences f ea Mdcl col wee e iet te etr o Clinical for Center the directs he where School, Medical Texas of University the with been has he 1980 University.Since Illinois Southern Psychologyfrom in doctorate his received he 1978, in Greeceand Athens, of University National the of Philosophy of School the in Scholar Merit ProfessorAndrew PapanicolaouC. careeracademic his began Nationala as School Director, Center for Clinical Neurosciences, the University of Texas Medical P and a Graduate Student Fellowship from the Newkirk Center for Science for Center Newkirk the Fellowshipfrom StudentGraduate a and WritingDissertation RegentsFellowship the In Papageorgioureceived 2006, Cooperation. and Conflict Wenner-Gren Global for the Institute the Program, and the National Foundation, Society by and Science supported Foundation, was Science research field Her Doubt.” of the “Seeds from Anthropology in Ph.D. UniversityDr. Irvine. California, of Papageorgiou’s entitled is dissertation her received Papageorgiou Kyriaki Coordinator andAssistant,EUScienceCounsellor P apanicol apageorgiou aou , Andrew C. , Kyriaki Speakers’ Biographies &Abstracts Zeneca) Loughborough, 1977-1981. Postdoctoral MRC 1983-1991; Nottingham, of Researcher,University Nottingham,of Industrial1981-1983; Research UniversityFisonsScientist, (Astra- Sciences, Biological of School the School of Biological Sciences, University of Nottingham, 1991-1996; Lecturer in Immunology, for Centre Fellow,Immunology, in Reader Toxicity,Human1996-1998; Leicester, Researchof of MechanismsUniversity Senior Honorary Fellowship, Leave of of Pharmacy, University University of Nottingham, 1996-present; Immunology,Wellcome Research PhD Birmingham,Previous1977. 1974; Posts: Parasitein Chair Immunology,School Birmingham, of University BSc Zoology Upper Second, University of Wales, 1973; MSc Immunology, Chemistry, (Physics, passes level A 3 Zoology); level, O 11 Qualifications: of University Pharmacy, Nottingham of School Immunology, Parasite of Professor PRITCHARD, David Award forherachievements ininnovation andcreation ofvalue, amongmanyothers. field of agriculture and healthcare in November 2009 by iCONGO, the Adolfo Ibanez University received the prestigious ‘Karmaveer Puraskar’ as a ‘Corporate Citizen’ for her contribution in the of the National Order of Merit’ by the President of the French Republic in April 2008. She also ‘Officer the awarded was She work. her for felicitations and awards many with honoured also was She (ABLE). Enterprises Led Biotechnology of Association the of member founding and Karnataka of Government State the by Biotechnology,instituted for Group Vision and Force Taskthe of member key a is She bioPharmaceuticals. & bioNutrition bioAgriculture, as such Ltd. in 2000. Dr. Patell has given Avesthagen a strong focus in innovative R&D in diverse areas and principal investigator working from NCBS. She created Avesta Gengraine Technologies Pvt. mitochondrial genome. plant On her the return to of India, aspects she established Fundamental herself as on an France,independent scientist Strasbourg, Pasteur, Louis University at Biology Molecular Plant in PhD her completed Patell Dr. 1978. in Hyderabad at ICRISAT at career professional her started Patell model Dr.genetics. population and unique pharma food, of convergence the on focused a with company biology systems leading a as Managing recognized and Chairperson Founder, Director of AVESTHAGEN is LIMITED. AVESTHAGEN Morawala-Patell which is globally Villoo Dr. Founder andCMD,Avesthagen Limited P BioVisionAlexandria April 2010 atell, Villoo Morawala
91 BioVisionAlexandria 2010 92 BioVisionAlexandria 2010 launch new R&Drouteslaunch new inthisfield. to created entity legal a (EMH), HouseMembraneEuropean the of Chairman the currently is He Commission. European the of support the with Europe in area technology membrane the membrane Technologies”reorganize to aiming (NanoMemPro–FP6instrument large a NMP), “Nanoscale-based on Excellence of Network European the of coordinator former (EFCE). the was Engineering He Chemical of Federation European the of Member and (EMS) Society of several triadicpatentsinBiotechnology related tothefoodandbiomedicalindustries. productresearchdevelopment,agricultural author and breeding.the plant is and Rangel-Aldao biochemistry,biology,topics: molecular chemistry,physiology, food plant research, biomedical the third largest in Latin America. Prof. Rangel-Aldao has several publications in a wide range of and Innovation at Empresas Polar (1987-2005), the largest food conglomerate inVenezuela and Biotechnology at several major institutions in Venezuela (1979-2009), and Director of Research f hmcl nier (odn, ebr f h Erpa Membrane European the of Member (London), Engineers Chemical of he in a and lot of other tasks of scientific expertise. He is a journals, Fellow of the Institution international in published participated in more than papers 100 international conferences. He is 120 also involved than more of author the also is He technologies. membrane in expert an is (France).He Montpellier in engineering chemical of Professor a is Rios M. Dr.Gilbert Chairman European Membrane House (EMH) RIOS, Gilbert M. of Professor as Sector Academic the in served has Dr.Rangel-Aldao years, a thirty For Wellness. Net, and Health Summum Preventative of of company CEO Biotechnology and University, Bolivar Simon at Medicine Molecular Digital of Professor Invited an is HeYork. New Medicine, of and Ph.D. at the Department of Molecular Biology, Albert Einstein College Rafael Rangel-Aldao received his M.D. from University Central of Venezuela, Professor, Digital Molecular Medicine, Simon Bolivar University Rangel -Aldao , Rafael Speakers’ Biographies &Abstracts Doing Better whileDoing Better. for philosophy PepsiCo’sNooyi Indraechoing Purpose,CEO with Performance of champion a is and ProgramWellness and Health Saludable Vive PepsiCo renowned the of creation the Inc./CPC International. During her 23 years in several Divisions of PepisCo. She Technology has Canada, Hershey in firm Foods Corn Consulting Mexico, Products Confectionery championed Products/ New Company; Chocolate Azteca Oats-La Quaker Health, of Secretary Mexico in and Development, Nutrition, Marketing and General Management. Some of her contributions: Research Science, to related positions diverse very lead MIT.has and she Business 1976, Since BusinessNorthincludes training WesternUniversity, University,Columbia Other of School Wharton Mexico. IPADE, and from eq. Technology, Science Food MBA in Food specialized and Nutrition in Iberoamericana Universidad from graduated City,she Mexico of Native Region. America Latin for Strategy America, Central (Mexico, Wellnessand Health the coordinates and RegionAmerica), South and Caribbean America Latin Foods PepsiCo for Development and Research Presidentof Vice is Rivero Carmela Professor Foods, America Latin Development, and PepsiCo Research President, Vice Rivero BioVisionAlexandria April 2010 patents. 20 than more of co-inventor company, is biotech and a plc.’, co-founded Therapeutics ‘Silence can help developing countries avoid the same disease patterns as their economies developed. He treatmentsthat identify to sought disorders which allergic of field the in publications and trials clinical to led has This disorders. inflammatory chronic other and these of risk thus the system, increasing immune the of regulation faulty to contributing is history of evolutionary part human a were that microorganisms environmental to exposure rich, reduced In countries disease. developed bowel inflammatory and disease autoimmune allergies, of incidences the in increases rapid to leads countries developed rich, of lifestyle the why understand to trying thus Medicine, Darwinian is interest dominant G.R.’s Currently neuroscience. and microbiology immunology,endocrinology, with on interdisciplinary,publications in is resulting physiology approach integrative on His emphasis tuberculosis. of immunopathology the initially was research his of theme The chapters. book and reviews other 80 than more and publications peer-reviewed 290 than more Graham’syielded research London. College University at Microbiology Medical of professor of post medicine in the University of London. Since 1994 Prof. Rook has held the clinical in qualifying before UK, Cambridge, of University the at sciences Prof. Graham A. W. Rook, BA MB BChir MD FIBiol, studied basic natural Professor ofMedical Microbiology, University CollegeLondon ROOK, Graham , Carmela
93 BioVisionAlexandria 2010 94 BioVisionAlexandria 2010 including: British Medical Journal, Medicine Lancet,Military &Nature Medicine. Letters, Arts, journals peer-reviewed and in TechnologySciences articles 20 of Mexico.than Publishedmorein Athenaeum National of member Founding MA. Cambridge, MIT Society, Council Relations Dynamics System of Member International City Kansas. of Cross Red the American at Former.member Board of member Board University. Baker at member Board Global of developer and Health Network/Supercourse Pittsburgh, PA.founder Faculty memberofthe William Glasser Institute.Co the is He DEC. and NCR) (old Solution Information AT&T’sat worked Global he Preceding that, Airlines. Delta with AT&Tventure the joint for strategy expansion an developed he Transquest,At Inc., Europe. and Arabia, Saudi Malaysia, produces IT products applied in health industry in its different branches in Australia, Singapore, which International, Cerner of CEO the that before and incubator business a BCEC, of CEO technology andapplications. the author of 6 patents and more than 100 publications and presentations related to membrane IWA, NAMS, leader of the WssTP “Membrane Technology for Water Treatment” taskforce, and institutions. He is currently treasurer of the European Membrane Society, member of the EMS, public as well as companies, for advisor technical a as acted also has and projects development desalination applications. He has been involved in many national and international research and innovative membrane processes for drinking, waste, industrial water and water industrial waste, drinking, for processes membrane innovative of development the for responsible is he where Veolia(France), Company Waterthe of at DirectorCentreResearch R&D Membrane currently is he (UK), Bath Universityof the at Department Engineering Chemical the in expert with 17 years of experience in membrane membrane processes. and Previouslywater recognized a lecturer is SCHROTTER Christophe Dr.Jean R&D Manager, VEOLIA-Membrane House Schrotter between Mexico, Canada and the United States. Prior to this, he was the was he this, to Prior States.United the and Canada Mexico, between export and import promotes he where TAG,Group, TransAm of CEO positions: several holds He Behavior”. and Thought Conditioned Socially Adapt”. He wrote an essay titled, “To Integrate Creative Imagination With Spanish-American University, Mexico City. Author of “Relearn, Evolve and Harvard Business School program in Mexico City; and MS Systems Education: Analysis, MD with honors, University of Mexico, UNAM; MBA, IPADE, CEO, Trans AmGroup S auer , Francois , Jean-Christophe Speakers’ Biographies &Abstracts from Harvard University. In doctorates. additionhealsoreceived 26honorary PhD a and University,degree MastersCairo froma engineering in degree Science of Bachelor biotechnology,development,sustainability, rural society.to science valueof the and He a holds including topics of variety a on papers over200 and monographs and books over50 published Socially Sustainable Development (1992-1998), and for Special Programs (1998-2000). He has (1995- program microfinance 2000). Serageldin has a also served at the World (CGAP), Bank, as Vice PoorestPresident for Environmentally and the Assist to Group Consultative the and 2000), the Founder and former Chairman of the Global Water Partnership (GWP, 1996-2000) 1994- (CGIAR, Research Agricultural International on Group Consultative the of Chairman Academy of Agricultural Sciences and the European Academy of Sciences and Arts. He is former Science), TWAS(Third Indian the National Sciences), of Academy World of Academy (Egyptian d’Egypte Institut the includes which efforts society andcivil committees institutions advisory international and of scientific number research, academic, a for of Member and Chair as serves He Netherlands. the in UniversityWageningen at Professor Distinguished is Directors for each of the BA’s affiliated research institutes and museums and Ismail Serageldin, Director, Library of Alexandria, also chairs the Boards of Director, Bibliotheca Alexandrina Serageldin BioVisionAlexandria April 2010 years ofacademicandindustrialwork inbothmedicalandagricultural biotechnology. product in experience His over20 from stems products biotechnology agriculture of commercialization chapters. and development book several and abstracts numerous and publications referred many of author the respectively.is He1984, and 1988 in Nebraska of University the fromUniversitythe Minnesotaof Masterand 1992 Bachelorin and Science of from Science of Vip3-based insect resistant cotton. Frank Shotkoski earned his Ph.D. in Molecular Entomology of development the in resulted that program biotechnology cotton a built he where Syngenta Traitswith Cotton was Global Frank at University,TechnicalManager the Cornell joining Before Asia. and Africa in crops engineered genetically commercialize to mandate a with project funded USAID a is ABSPII University. Cornell at (ABSPII) II Project Support Biotechnology Agricultural the Directorof the is FrankPh.D., Shotkoski, of Agriculture andLifeSciences,CornellUniversity College II, (ABSP) Project Support Biotechnology Agricultural Director, Shotkoski , Frank , Ismail
95 BioVisionAlexandria 2010 96 BioVisionAlexandria 2010 School. He isaformer chairmanofBranksome Hall School. at University of Chicago, public health at Yale University, and management at Harvard Business Universityof Toronto,at ethics medicine medical internal studied He health. issues global to related on Inc. Pepsico and governments, African several Canada; of Government General’s the Secretary Office, UN the in advisor an also is He Initiative.Grand Health Foundation Global Gates for Melinda Challenges & Bill the of Board Advisory Scientific the of is member Singer a students. 70 over trained and grants, research over 270 research in million $50 over He haspublished received articles, World). the Developing for Sciences of Academy (The and NationalAcademies, TWASthe Medicineof of Institute US the Canada, of RoyalSociety the Fellowof a and Sciences, Health of Academy Canadian the of ForeignSecretary the is He SmithPrize Canada’sas Healththe Research Yearof Populationin HealthHealth Services. and from 2002.;theConsultantofBAScienceSupercourse from 2008. project Internet-Supercourse at Lectures of Library Free Global the of developer 2000; from in the frame of Supercourse Global Library Project in Public Health, Epidemiology and Internet Kazakhstan, 2005; moderator of internet prevention program for Former Soviet Union countries Central Asia, and “Building the Bridges Kazakhstan Between Organizations in in Central Asia”,Violence Domestic FSU and the of US Workshopteacher 2005; Lithuania, disasters, natural and manmade from threat of prevention the for supercourse health global the and networking Development Gateway, 2003; co-director of NATO Advanced Research and WorkshopInstitute WorldBank on Region, scientific Asia Central and Europe the of Gateways Country the for E-Development on course online of expert guest posts: several Heheld 2000. Epidemiologyin ActFellowship Universityat Pittsburgh,of Graduated Publicof School Health,of Department Support Freedom under LaPorte Professor of fellow a was He 1996. Congress, International the transition from “lab to village”. In 2007, Singer received the Michael the received Singer 2007, In village”. to “lab from transition the research is on Singer’sToronto.life sciences of and Universitythe developing world–how and technologies Networkmake Health University Health, in Chair Global for FinancialCentre Rotman ¬- Life McLaughlin the Sunat Director and Medicine, Bioethics of Professor is Singer A. Peter Joint Centre forBioethics Torontoof University Director, & Bioethics in Chair Financial Life Sun SINGER, Peter Circumpolar 10th “Diabetes”, section of Chair and Diabetes of study for the Association European the of member been has he 1992 Since 1985. MD- Novosibirsk, University, Medical Novosibirsk from graduated He 1986. Endocrine since Russia Novosibirsk, and Medicine, Internal Therapeutically of Institute diseases, of Studies Prevention Clinical, of and Laboratory Population the at scientist research a is Shubnikov Eugene Research Scientist,Institute ofInternal Medicine, Novosibirsk SHUBNIKOV, Eugene Speakers’ Biographies &Abstracts of thePresident ofEgypt, 1981. Agricultural Sciences, 1980, and offered the First Level Medallion of Science and Art by Decree Society of America; and Egyptian Society of Toxicology. He was awarded the National Award on and Toxicology;of Toxicology;Chemistry Society Environmental US of WeedSociety Science Memberin: organizations. UN and USEPAUS by other funded researchprojectsand through Toxicology,and UniversityChemistry Pesticide Alexandria of Department the at Laboratories monitoring and mode of actions in international journals. He constructed a number of Research metals heavy neurotoxicity, and of pesticides areas in papers scientific 70 than more published 1999. He1999–present. (IPCS/SGRA, WHO), Assessment SteeringVice-Chairman,GroupRisk on since JMPR, WHO/FAO Residues, Pesticide on Meeting Joint Member, 1992. since (FRBs), International Program on Boards Chemical Review Safety Final(IPCS), Member, World (1988–1994). Health Arabia Organization Saudi (WHO) , University Saud King Professor, Galveston, Texas,(UTMB), Branch,Medical Visiting (1987–1988). USA North Carolina, USA (1979–1982). Visiting Professor, University of Texas Visiting Agency,ProtectionResearchEnvironmental Triangle U.S. (1986–present). Park,Scientist, University Alexandria Agriculture, of Faculty Toxicology,and Chemistry Pesticide of Professor Soliman, Ahmed Salah Agriculture, Alexandria University of Toxicology, Faculty & Chemistry Pesticide of Professor Soliman BioVisionAlexandria April 2010 and bookchapters. SheontheEditorial Board serves oftheJournal ofNatural Products. numerous research reviews literature, scientific peer-reviewed in publications 160 than more of Tinker Foundation and the John D. and Catherine T. MacArthur Foundation. She is the author Foundation, the US Department of Agriculture, US Agency for International Development, the Science National the Health, of Institutes National the by provided been have funds Research products with potential utility in the treatment of cancer, infectious diseases. and inflammatory natural of investigation biological and discovery the on focuses Program.researchHer (ICBG) study Groups the Biodiversity Cooperative International American Latin for the and medicines researchbotanical of Phytomedicine for Center Arizona the established she funding, NIH biodiversity.plant With from discovery lead drug in program research a established and ranks professorial the ascended Arizona, Universityof the Facultyat the joined she 1981, In Austin. of University Universityof Texas,the at 1980 National in Ph.D. a and 1977, in M.S. the a 1970, in Argentina Cordoba, at B.S. a obtained Timmermann Professor Therapeutics. Experimental Cancer for Center the of Director current the an academic career of almost 25 years at the University of Arizona. She is also the Department of Medicinal Chemistry at the University of Barbara Timmermann is Kansas a University Distinguished Professor followingand Chair of School ofPharmacy, University ofKansas Chemistry,Medicinal of Department Chair, and Professor Distinguished TIMMERMANN, Barbara , Salah
97 BioVisionAlexandria 2010 98 BioVisionAlexandria 2010 Baron, he is member of several academies of science, agriculture and engineering and holds and engineering numerousand Doctor Honoris Causadegrees. agriculture science, of academies several of member is he Baron, of title the received he accomplishments, scientific his to due 1990, In Prize.Japan the others among awards, numerous received the has of He (PRRI). President Initiative Regulation also and Research is Public He countries. less-developed of needs the towards oriented research (IPBO) at Ghent University. Its mission friendly is training, technology transfer Countries environmentally and Developing plant for biotechnology Biotechnology more Plant of Institute to the created he tolerant 2000 In herbicides. or insects to resistant plants as such agriculture, biotech for innovationsdrovefront-line he PGS, At CropDesign. and (PGS), Systems Genetic Plant spin-offs: two raised laboratory His classification). (ISI Science Animal & Plant of fields in plant growth, development and flowering. He ranks among the 10 most cited scientists in the physiological processes. He has made major contributions to the identification of genes involved a Consultantforthe World Bank, FAO, USAIDandotherorganizationsover fourdecades. 102 contributors from 28 countries (foreword by Dr. M.S. Swaminathan). Uphoff has served as Approaches To Sustainable Soil Systems’, (CRC Press, 2006), for which he was chief editor with ‘Biologicalvolume, edited an Madagascar.is yearsin recent developed in publication Hismain Intensification Rice of System the about learning after reoriented was career agroecology.His and development sustainable of issues with engaged CIIFAD, more Uphoffof became director (Cornell University Press, 1992; paperback, Intermediate Technology Publications, 1996). While From Gal Oya: Possibilities For Participatory Development And Post-Newtonian Social Science’, ‘Learning is period this from book Hisfavoriteresource management. natural and irrigation in interest special with development, participatory and institutions local on focused advising and research with , Committee Development Rural the of chair-man was he years, 20 next the of study gene regulation and to discover the molecular basis of several plant several of basis molecular the discover to to and newtechnology regulation gene this study used Van Montagu genes. plant chimerical first the constructed and ofDNA plants, to tumefaciens themechanism Agrobacterium from he discovered transfer Schell, Jeff colleague, his With European the of President Federation of Biotechnology (EFB), Montagu,is a pioneer in plant molecular Vanbiology. Baron Marc Prof. Emeritus Elected andActing president, theEuropean Federation of Technology VAN MONTAGU, Marc most For science. political in Berkeley California, of University the from 2005. to 1990 from Uphoff joined the Cornell University faculty in 1970 after receiving a PhD Development and Agriculture Food, for Institute University,Cornell at InternationalDirectorCornell as the of served USA, Agriculture International and Government of Professor Uphoff, Norman for Food, Agriculture andDevelopment (CIIFAD) Program Leader for Sustainable Rice Systems, Cornell International Institute UPHOFF, Norman Speakers’ Biographies &Abstracts the European Institute of Technology (EIT). and honourable memberships. In September 2008, he was appointed in the Governing Board of His achievements have been acknowledged by prestigious industrial awards and academic prizes professional several of member organizations is and serves on the boards of HeBiotech enterprises, including TVM Stockholm.Capital, Munich. Institute, Karolinska the at professorship adjunct foreign a Perutzand MaxVienna, Laboratories, the at Microbiology of professorship a more than published 100 publications and book chapters has and currently holds numerous He patents. immunology.He holds and interactions, host-parasite expression, gene microbial of the of Member was Executive Management Board he and CSO of the Company. 2009 His research interests to are in the fields 2005 From 2005. in successfully Exchange was Stock it Vienna the until on CEO floated as company the led and AG Intercell co-founded he 1998 In was Chair of Microbiology at the University of Vienna at the Campus Vienna Biocenter, Austria. AdvisorBiotechPharmaceuticaland Fromto companies. he 1998 to 1992 Universitythe Umeåof KarolinskaInstitute,the and Sweden, an wellas as at Professor a was he 1990s and 1980s the University.StanfordIn the at in Ph.D. his obtained Gabain Genetics at the University von of Heidelberg and held a post-doctorate Alexander position AG, Intercell of Boards Alexander von Gabain Strategic Advisor to the Management and Supervisory Professor, Max F. Perutz Laboratories,University of Vienna V Organs (INFA). He isMember of the Academic Leibniz-Sozietät inBerlin, Germany. the at Germany), in Danube University in (all Krems, Austria, and Idstein as a Professor in at the International “EFF” Faculty of Artificial Sciences Applied for University European private the at Ilmenau, the Technicaland at Aachen lecturer Universitiesof honorary an as serves also He (IFAO). Organs Artificial for Federation International the of President as serves currently dedicated to Biomaterials, Artificial Organs and Medical Device Technology. journals scientific Prof. several Jörg of Board Vienken Editorial the of member is He Organs. Artificial on as well as nephrology issues, and biocompatibility biomaterials, membranes, artificial and biological to subject with books 5 and publications 250 in than more authored/co-authoredGermany. has both JörgVienken Wuppertal, Membrana, Nobel Akzo at Services Scientific of Department as the of Head was position he Homburg, Bad in hisrecent Care FreseniusMedical “BioSciences”Presidentat Vice to moving Until medical organs. on artificial and focus biomaterials with technology, device years the 25 than in more working for industry now device Institute is medical the he University, at Würzburg Professor at Associate Biotechnology an for as and working both After Biophysics (RWTH), Germany. Aachen in in of Degree University Technical Doctoral the from a Engineering and Darmstadt of University Technicalthe from Engineering Chemical in degree a hold VienkenJoerg Vice-President, BioSciences-Fresenius Vienken BioVisionAlexandria April 2010 on Gabain , Jorg , Alexander
99 BioVisionAlexandria 2010 100 BioVisionAlexandria 2010 left arm to link his nervous systemdirectly withacomputer.left armtolinkhisnervous pioneering experiment which involves a neurosurgical implantation into the median nerve of his his renownedfor is though, Kevin, around. robots drive to networks neural cultured of use the brain stimulator to counteract the effects of Parkinson Disease tremors. Another project involves deep intelligent an of invention the involves research Kevin’srecent Lectures. most Christmas Award in MIT, and also the Mountbatten Medal. In 2000 Kevin presented the Royal Institution UniversityAston University.fromCoventry and He received The of Future Health Technology by the Imperial College and the Czech Academy of Sciences and received Honorary Doctorates Planning andBuilding. optimized energetically of Promotion the for Association non-profit e.V.–a ClimaDesign of his featuring on the cover stories of US magazines. Kevin was awarded DScs Kevin’sresearchpapers, 500 promoted technology implant in experiments followed by a PhD at Imperial College, London. As well as publishing over Telecom, at British the age join of 16. to At 22 school he took left his firstand degree atCoventry Aston in University,born was Kevin cyborgs. and robotics intelligence, artificial in research out carries he where England, Reading, of University the at Cybernetics of Professor is WarwickKevin Professor ofCybernetics, University ofReading WARWICK ,Kevin - 1999-2006; Weihenstephan Center Member a Architecture,Technische Founder.is MünchenUniversitätHe Science Ecology, Engineering and Planning Environmental studies: University 2006-2008. München Universität Technische Services, Building and Climatology Department Building Planning, of Utilisation Energy in associate, Research 2008. since supply energy Sustainable planning, Environmental planning, building and efficient Energy Profile: (TUM). Univ. Diploma-Ing. Degree: Research Associate, Technische Universität München W agner , Tobias Speakers’ Biographies &Abstracts throughout theworld. presentations on toxicology informatics and conducted continuing education courses at meetings Project, covering the basic principles of toxicology for general audiences. He has made numerous Tox-Learnthe TutorialEducational Toxicology,oversees He of Health. Environmental Safety, Library and WorldChemical the of development the spearheaded also He and databases. IRIS ITER LactMed, the for manager file as serves and system, TOXNETthe enhancing developingand in instrumental been has he NLM, At Foundation. ToxicologyEducation the of section. specialty vice-president Issues is HeAward. Social Communications Public SOT 2010 and the of recipient Legal, the is Ethical, Philip SOT’s of President the currently is and served as Chair of the US Society of Toxicology (SOT), World Wide Web Advisory Committee, Evolving Informatics Framework”, a major review for article Critical Reviews in “Toxicology:An Toxicology.preparing currently He is and articles, numerous published has He Perspective. Management Global A Health: Environment, Chemicals, titled, book a on working currently is He 2005). ed, Toxicology(2nd of Encyclopedia the and 2009) ed, Toxicologyin (4th Resources Elsevier’sInformation of Editor-in-Chief is He Program. Information an Health Environmental had and has (MLS), University Rutger’s extensive career at the of US National Library of Medicine (NLM) Toxicology graduate a Wexler, Philip Technology Information Specialist, National ofMedicine Library Wexler BioVisionAlexandria April 2010 energy issues. energy and environmental matters, and addresses many conferences on national on and extensively written international also Point.Worthingtonhas Center as known now PowerCompany,& Lighting Houston with that to prior and Foundation September, since Edison Alva Thomas Previously,Presidentthe 1988. Vicea of as served he post this in served has He activities. international and domestic Association’s the directs he where (USEA) Association Energy Barry K. Worthington serves as the Executive Director of the United States Executive Director, United States Energy Association W orthington , Philip Barry , Barry
101 BioVisionAlexandria 2010 102 BioVisionAlexandria 2010 2008 of fellow a TWASand 2007, in Sciences of Academy Chinese of Academician an and 2006, World Academy of Sciences (TWAS in 2006. He was elected as a foreign member of EMBO in Researchthe of YearLeader and 2002 in American byScientific Award Third in the Biology by including honors, and awards many received has YangDr. metagenoms. gut human recently in 2000. Dr. Zerhouni was elected by the Institute of Medicine of the US National Academy of Sciences Science-Translational of Scientific Advisor the of Science. publication Journal sister a Medicine Science and Technology Adviser for Sanofi-Aventis a global pharmaceutical company and Chief Technology and serves as chair of the Maryland Economic Development Commission. He is the and Lasker UniversityScience Abdullah of King the Clinic, Mayo the Foundation,the America, Research of board the by elected been has Zerhouni or Dr. companies. founded up and start patents 5 several co-founded holds also He publications. 212 of author the is He disease. Magnetic Resonance Imaging (MRI) used for diagnosing cancer, cardiovascular and pulmonary Axial Computerized for novelmethods imaging quantitativeTomography (CAT and scanning) His2002. developingto researchon from1995 focused Science Radiological and Radiology of Johns Hopkins University School of Medicine and chair of the Russell H. Morgan Department Dr.NIH, the as ExecutiveResearch then Vicefor Deanand served Zerhouni Vice-Deanthe of led to the successful passage of the NIH reform Act of 2006 by the US Congress. Prior to joining a yearly budget of $29.5 billion. He led a series of reforms at the NIH that NIH reformsthe of at Heseries billion. a $29.5 led of yearlybudget a and Research and employees 27,000 than more with Biomedical world the in Agency Development largest the Health, of Institutes National US the of Director 15th the was Dr.Zerhouni leadership. administrative scientific, and clinical, providing career his of much spent has Zerhouni Dr. Melinda Gates Foundation FormerDirector,Fellow,Senior and Health of NationalInstitutes and Bill Zerhouni the first Asian genome, human pan-genome, human ancient genome, and genome, ancient human pan-genome, human genome, Asian first the published collaborators and BGI microorganisms. many and cucumber, sequencing and analysing genomes of rice, chicken, silkworm, giant panda, to as well as projects, HapMap and HGP the to contribution significant a made have collaborators his and he BGI, of co-founders the As 1988. in Denmark, Copenhagen, of University from Ph.D. his received YangDr. Director, Huada Genomics Research Center and Sciences of Academy Chinese Institute, Genomics Beijing Director, Y ang , Huanming , Elias Speakers’ Biographies &Abstracts BioVisionAlexandria April 2010 and Exhibitors Partners, Sponsors
103 BioVisionAlexandria 2010 104 BioVisionAlexandria 2010 Partners, Sponsors &Exhibitors BioVisionAlexandria April 2010
105 BioVisionAlexandria 2010 106 BioVisionAlexandria 2010 education, researchandcommunitywelfare. progressive Qatarcentersdevotedto people,networkof potentialthroughadevelopthat Foundationto its aims of potential the is resource greatest nation’s a that principle the by Guided Emir of Qatar. non-profit organization, founded in 1995 by His Highness Sheikh Hamad Bin Khalifa Al-Thani, Foundationprivate,Education,QatarCommunitycharteredforScienceDevelopmentanda is information, seewww.twas.org. scientistsinstitutionsdevelopingAcademyandbycountries.additionalin the submittedFor to members, peer review proposals free-of-charge for research grants, fellowships and awards that are training and exchange programs. More than 2,000 eminent scientists worldwide,TWAS hasincluding supported TWASscientific research in 100 developing countries through a variety of research, promotescientific capacity and excellence for sustainable development in the South. Since 1986, to developingprincipalistheworld. Itsscienceaimcountries), in ofrepresents bestTWAS the comprised of more than 900 eminent scientists (more thanSouth 80 under percentthe leadershipof whom of arethethe scientistsfromlate from of distinguished groupNobel adeveloping bylaureate 1983 in AbdusItalyTrieste, organization,in Salamfounded international autonomous of Pakistan. an is With World, Developing a membership the for Sciences of Academy the TWAS, on BioVisioncanbefoundwww.biovision.org. Join them at the next edition of BioVision scientistson have recognized internationally 27-29already participated and March in etc) BioVision Frontières,2011 debates. Sans in Médecins (WWF,Lyon, leaders France. NGO More 24 etc),information multinational groups, 18 executive directors of international organizations (WHO, FAO, UNOP,13 ministers, 33 Nobel Prize laureates, 9 European commissioners, 47 CEOs or directors of large offering networking opportunities during Forumthe beyond,and through Internet.the Around Programme;fosterdiscussionandcollaborationand communities fourbetween the involved by build tomorrow’s life science community with NGOs;young and agenciesscientists UN throughof directors commissioners,itsCEOs,environment:European BioVision.Nxtthe and Fellows’ nutritionhealth,to related issues”“global on viewstheirconfront andinsights share toleaders industrialists, scientists, stakeholders: national alland international with policymakers implications ethical and civil societies; and engage societal key international their discuss and discoveries internationalforum,taking placeLyon,explaineveryyearsFrance. twoinaimstolifescience It ofprogress in life sciences and biotechnology into contemporary society. BioVision is a three-day and NGO leaders from all over the world years in an endeavour ten to improve last the harmonious the integration During BioVision, society. the serve World they Life unlessSciences meaningless Forum, are has technology brought and togetherScience scientists, industries, policymakers Partners The AcademyofSciencesfortheDevelopingWorld(TWAS) ...... BioVision -The World LifeSciences Forum Qatar Foundation Partners, Sponsors &Exhibitors and havereached morethan6,000people. be distributed worldwide. It is a “gift that is meant to be given”. The DVDs are widely distributed performance. Therefore, the Science Supercourse DVD containing more than 3,600 lectures is to amelioratetheirdevelopingcountries tofromscholars educatorsquality-improvedand assist to most updated source that is accessible online for free and continuously the provide to is goal Supercourse primary Science Department.The BA-ICT the bydesigned agriculture,engineering and environment. These lectures are collected through crawlinga system archive of PowerPoint lectures in four main scientific disciplines, namely:Science the medicineSupercourse launched Pittsburgh, (publicProject Centre, health), Collaborating in January WHO 2009. The the Science and Supercourse Alexandrina Bibliotheca intendsThe to build an internet prosperous societies. developingthebuildhealthier,meanstheir tosearchtheworldinfor equitable,more more and CanadianaIDRC isCrown corporation thatworkscloseincollaboration withresearchers from is availableatwww.asrt.sci.eg. for ethics and a national network for information (ENSTINET). More information about ASRT magazineforthe public, national committees, scientific societies, patenta office, a regional office developmentcenters, virtual research consortia and networks, aTV channel, amonthly scientific specializedimplementsmentionedaboveASRTthrough15thescientific councils, regional five knowledge-based economy.towards factor key a as culture, and research scientific and science with concerned authorities relevant and the innovation and society encourage civil to the technology with collaboration in inventions, and science of culture the of dissemination the to attention great pays which ASRT, of roles main the of scientificexchangingone researchthe is counterpart societies organizationsand the and and academy scientific agreementsthe between prominentscientistsresearchers.toprizesprograms,and Implementationhonors,andgrants of applicationsitsscienceimplementationdevelopmentand throughfellowshipthethe theand of basic and applied research, and future and strategic planning. ASRT has to value the excellence in The mission of ASRT is to conduct studies in the fields of advanced and interdisciplinary sciences,tank acting as a house of expertise that provides scientific advice to serve the Egyptianwith community.the mission of the counterpart international academies, ASRT Accordingis consideredto as the a latestnational thinkrestructuring of the science and technology system in Egypt and in conformity BioVisionAlexandria April 2010 Kyoto, Japan. in October 2010 3-5 during held be will forum STS the meeting annual of next program.The participants,countries,800internationalOver85regions andfrom organizations, attendedthe October,2009.4-6 on Kyoto in heldwas forumSociety(STS)Technology Scienceand in the andtechnology while keeping inherent risks under proper control. The Sixth Annual Meeting of LightsandShadows ofScience andTechnology” seeks ways toensure further progress “The ofscience on Discussion humankind. of future the ofstandpoint the fromtechnology and science creating a global human network based on trust to discuss, on an equal footing, how to deal with at meeting aims Kyoto,Japan.The inyear,every Octoberof annualmeeting initsholds 2004, November in Omi Koji by established Forum, (STS) Society in Technology and Science The Egyptian AcademyofScientificResearchandTechnology(ASRT) ...... The InternationalDevelopmentResearchCenter(IDRC) The ScienceandTechnologyinSociety(STS)Forum Science Supercourse
107 BioVisionAlexandria 2010 Official Airline EGYPTAIR
EGYPTAIR is the world-renowned national airline of Egypt, based in the cosmopolitan city of Cairo. During more than 76 years, EGYPTAIR has experienced extraordinary growth, taken the lead to be the first airline in the Middle East and Africa and the seventh in the world to join IATA and become a name worthy of trust. Throughout its 76 years of service and as a result of continuous investments, EGYPTAIR has successfully extended its network over the years to reach more than 1,624 weekly departures to 69 cities in 44 countries, carrying more than 7.2 million passengers in 2008/2009, with an increase of 20% compared to the same period last year. Currently, EGYPTAIR has one of the most modern fleets, with an average age of eight years, consisting of 51 aircraft, and aimimg to reach 75 aircrafts in 2013. In 2004, EGYPTAIR demonstrated the scale of its commitment to the highest standards of safety by being the first IOSA certified airline in the Middle East and Africa. In July 2008, EGYPTAIR became a member in Star Alliance, the biggest and the most prestigious alliance in the world, to offer to its customers more than 975 destinations around the globe through the Star Alliance network......
Official Hotel Radisson Hotel Located in the exciting new development area of Alex West, the brand new Radisson BLU Hotel, Alexandria, promises to be the most sought after hotel in the city. It is a minutes-drive from all locations, i.e. 10 minutes from Borg El Arab Airport, 35 minutes from El Nozha Airport, 40 minutes from the main train station in Alexandria, 25 minutes from Alexandria City Center shopping mall, 35-40 minutes from Alexandria`s tempting historical sites. The hotel offers 262 luxurious rooms, out of which 39 are Business Class rooms, 21 Junior Suites, and one extremely luxurious Royal Suite. The standard room area is 55 m2, with a 21 m2 terrace overlooking the marvelous lake. There are also 6 fabulous outlets offering varieties of food to match all tastes. Moreover, the extensive meeting rooms can accommodate up to 400 persons moreover, in addition to many more entertainment options. insght.pdf 1 2/22/10 8:35 PM
Discover Research in Germany www.research-in-germany.de
© Auswärtiges Amt © Dt. Tourismuszentrale © Auswärtiges Amt © Dt. Tourismuszentrale © Auswärtiges Amt
© Werner Baumann © Novaled © Hochtief AG
Find out about • Research institutions • Latest research findings © CARL ZEISS • Funding opportunities • Practical hints for your research stay … and much more.
™ FlexPen® TRUSTED BY MILLIONS 6,7 ELSEVIER ™ LOW RISK OF HYPOS 3,4 ™ 40% LESS Since 1580 Elsevier has WEIGHT GAIN 5 published content for the higher education and research community, making it available ™ via platforms such as ONCE- ScienceDirect, known globally for DAILY its reliability and innovative DOSING 1,3 approach to science.
Elsevier offers a journal collection of over 2,500 current titles consisting of more than 10 million articles, including a historical archive (backfiles) ™ of 4 million articles prior to 1995 directly to your OPTIMAL desktop, back to Volume 1, Issue 1. In addition we offer quality online Reference HbA1c Works, Book Series, Handbooks, eBooks which 1,2 enable fast and efficient access to the latest materials CONTROL available for teaching and research purposes and Scopus, our navigational tool covering the world’s largest collection of abstracts, references and indexes of STM literature. These services significantly contribute to the research-productivity of the scientists and enrich No other basal insulin is more effective.1,2 Initiate with Levemir,® from the world leader in diabetes care. their collections, whilst saving space and time References: 1. Blonde L. et al. Patient directed titration for achieving insulin delivery device in a randomized, open-label, crossover handling Levemir® in FlexPen®. Contraindications: Hypoglycaemia, hypersensitivity glycaemic goals using a once-daily basal insulin analogue: an study in patients with type 2 diabetes. Clin Ther 2008;20 (12):2252-62. to insulin detemir or any of the excipients. No data is available on the searching for suitable content. Elsevier provides you assessment of two different fasting plasma glucose targets – the Abbreviated prescribing information: Levemir ® 100 U/ml clinical use of insulin detemir during pregnancy or when breastfeeding. TITRATE™ Study. Diabetes, Obesity and Metabolism 2009; 11: 623-631. solution for injection in a cartridge (Penfill®). Levemir ® 100 U/ Caution is recommended when using this product during pregnancy or 2. Hermansen K. et al. A 26-week, randomized, parallel, treat-to-target ml solution for injection in a pre-filled pen (FlexPen®). Active when breastfeeding. Undesirable effects: Hypoglycaemia, visual trial comparing insulin detemir with NPH insulin as add-on therapy to substance: Insulin detemir. Composition: Active pharmaceutical disturbances or oedema upon initiation of treatment. Reactions at the with the necessary tools allowing you to teach At Novo Nordisk, we are changing diabetes. oral glucose-lowering drugs in insulin-naive people with type 2 ingredient: 100 U/ml insulin detemir, genetically produced from injection site (pain, redness, swelling, hives, inflammation, itching and In our approach to developing treatments, diabetes. Diabetes Care 2006;29(6):1269-74. 3. Levemir® EU Summary recombinant DNA in Saccharomyces cerevisiae. Excipients: Glycerol, bruising). Lipodystrophy at the injection site if injected too frequently in our commitment to operate profitably and of Product of Characteristics. 4. Philis-Tsimikas A. et al. Comparison of phenol, metacresol, zinc acetate, disodium phosphate dihydrate, into the same place. Allergic reactions, potentially allergic reactions, students at the highest possible level, making the ethically and in our search for a cure. We know once-daily insulin detemir with NPH insulin added to a regimen of oral sodium chloride, hydrochloric acid, sodium hydroxide, water for urticaria and rashes; very rarely, generalised hypersensitivity reactions, antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther injections. Therapeutic indications: Diabetes mellitus. Method of which may be life-threatening. Rarely, neuropathy in the arms and legs we are not simply treating diabetes, we are 2006;28(10):1569-81. 5. Rosenstock J. et al. A randomised, 52-week, administration: In combination with oral antidiabetic medicines it is during fast improvement of blood glucose control. Prescription-only institute an attractive place to study, whilst steadily helping real people live better. That understanding treat-to-target trial comparing insulin detemir with insulin glargine recommended to use Levemir® once daily, initially at a dose of 10 U or medicine. Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd, ® is behind every decision or action we take, when added to glucose-lowering drugs in insulin-naive people with 0.1-0.2 U/kg. Levemir 100 U/ml solution for injection has been Denmark. Text last revised: April 2009. Summary of Product type 2 diabetes. Diabetologia 2008; 51: 408–416. 6. IMS Worldwide developed for use with the Novo Nordisk insulin delivery systems and Characteristics can be obtained from Novo Nordisk. FlexPen®, and fuels our passion to change the treatment, Data Q4 2008. 7. Reimer T. et al. Intuitiveness, instruction time, and NovoFine® or NovoTwistTM injection needles. NovoFine® or NovoTwistTM Levemir® and &™ are trademarks owned by Novo Nordisk A/S. moving up the University World Rankings! perception and future of diabetes for good. patient acceptance of a prefilled insulin delivery device and a reusable injection needles 8 mm in length or shorter are provided for use with APROM ID#1124; approval date: July 2009.
Visit us at: www.elsevier.com EMH: The one-stop place for membrane expertise and partnerships
The European Membrane House is a not-for-profit international association set up in 2008 by universities and research institutes in 10 European countries. The European Membrane Society is also an EMH founding member. The European Membrane House is a not-for-profit international association set up in 2008 by universities and research institutes in 10 European countries. The European Membrane Society is also an EMH founding member. EMH, what for? • to enhance industrial implementation of membrane-based technologies. • to help develop a coherent and structured European system for membrane research and technological innovation.
This we achieve thanks to: • Research and industry partnerships • Institutional Lobbying
EMH Clusters Links with industry are developed by EMH clusters, chaired by 1 academic and 1 industrialist. EMH Energy Cluster – Food Cluster – Health Cluster – Water Cluster
For more information, please visit: http://www.euromemhouse.com 122 BioVisionAlexandria 2010 publications. and ensure good nutrition for all. The Bibliotheca Alexandrina is a Depository Library for FAO and countries in transition to modernize and improve agriculture, forestry and fisheries practices countries developing assists FAO information. and knowledge debate of source and a agreements also is negotiate FAO policy. to equals as meet nations all where forum neutral a as acts FAO countries, developing and developed both Serving hunger. defeat to efforts international The United Nations Food and Agriculture Organization (FAO) was established in 1945 to lead Depository LibraryforWHOpublications. a is Alexandrina Bibliotheca social The infirmity. or disease of absence and the merely not and well-being mental physical, complete of state a as Constitution WHO’s in defined is Health health. of level possible highest the of peoples all by attainment the is Constitution, its in out within the United Nations system. It was established on 7 April 1948. WHO’s objective, as set The World Health Organization (WHO) is the directing and coordinating authority for health is to be distributed worldwide. It is a “gift that is meant to be given”. The DVDs are widely are DVDs distributed andhavereachedmorethan6,000people. The given”. be to meant is that “gift a is It worldwide. distributed be to is lectures 3,600 than more containing DVD Supercourse Science the Therefore, performance. their ameliorate to countries developing from scholars and educators assist to quality-improved continuously and free for online accessible is primary that source updated Supercourse most the Science provide to The is goal Department. BA-ICT the by designed system crawling a through collected are lectures These environment. medicine and engineering agriculture, health), (public namely: disciplines, scientific main four in build an lectures to PowerPoint of archive intends internet Supercourse Science The 2009. January in Project Supercourse Science the launched Pittsburgh, Centre, Collaborating WHO the and Alexandrina Bibliotheca The Food andAgricultureOrganization WorldHealthOrganization Exhibitors Guide Science Supercourse www.who.int www.fao.org West ExhibitionPlan West ExhibitionPlan West ExhibitionPlan Partners, Sponsors &Exhibitors Booth #12 Booth #13 Booth #2
a DepositoryLibraryforUNEPpublications. quality of life without compromising that of future generations. The Bibliotheca Alexandrina is their improve to peoples and nations enabling and informing, inspiring, by environment the Human Environment. the UNEP’s mission is to provide leadership and encourage on partnership in caring for Conference UN after 1972 in established was It system. Nations United the The United Nations Environment Programme (UNEP) is the voice for the environment within BioVisionAlexandria April 2010 publications initsmoderndistributionfacilityJordan. latest the of range stock extensive an holding to addition in Publishing Express and Learning such as S. Karger AG, Focus Medica, Ausmed, John Wiley & Sons, Pearson Education, Cengage Islamic Republic of Iran. In order to achieve this, KaSha partners with international publishers, a distribution in publications, world-class multimedia cost-effective and and timely providing manner, to teaching customers in the language to Middle East, North English Africa, Turkey committed and periodicals, the books, venture of services joint international an is KaSha Visit springer.comtofindoutmore! economics. and sciences physics, social sciences, medicine, human sciences, clinical computer mathematics, sciences, engineering, life and biomedicine including subjects of range wide a over 1,900 publishing journals and more than 4,000 companies, new books, both in publishing print and online. Its publications scientific cover international leading the of one is Springer re t ahee omn ol. ih edures n emr, oo ods employees Nordisk Novo more than29,000 employeesin81countries, andmarketsitsproducts in179countries. Denmark, in headquarters With goals. common achieve to order in system healthcare the in parties all between collaboration promote to actively work to and treatment and detection prevention, diabetes of methods better by diabetes defeat to is vision Nordisk’s Novo society. and profession medical the patients, to difference significant a make that services and products pharmaceutical markets and manufactures Nordisk Novo therapy. replacement hormone and therapy hormone growth management, homeostasis as such areas within position leading a has Nordisk Novo addition, In systems. delivery insulin of area, the broadest diabetes product portfolio in the industry, including the most advanced products within Novo Nordisk is a healthcare company and the world leader in diabetes care. The Company has the United NationsEnvironmentProgramme www.springer.com Novo Nordisk www.unep.org Springer KaSha Middle HallOutsidePlan Middle HallOutsidePlan Middle HallOutsidePlan West ExhibitionPlan Booth #11 Booth #5 Booth #1 Booth #8
123 BioVisionAlexandria 2010 124 BioVisionAlexandria 2010 Association (ESIA).Currently,theChairmanofFSIisalsoESIA. Industry Seed Egyptian the of member active an is and employees full-time 55 has FSI insects. resist to Bt with Monsanto, endowed corn hybrid 2000, year the since developing, been had Company the with Along herbicides. imports and Europe to seeds Brassica hybrid quality high exports Company The varieties. rice and under wheat produces also It established agriculture. Egyptian to corn company shareholders selling and private processing multiplying, breeding, in active a is company The 1995. in is law Egyptian (FSI) SAE International Seeds Fine n gntc ehooy ltom, nldn boehooy bedn ad eois The lawn-and-garden herbicideproducts,andtheCompany’s dairybusiness. residential products, genomics. protection crop and of primarily breeding consists segment biotechnology, Productivity Agricultural including platforms, technology genetic and business, traits and seeds global Company’s the of consists segment Genomics and Seeds The Our business is structured in two segments: Seeds and Genomics, and Agricultural Productivity. Roundup®, and other herbicides used by farmers, consumers and lawn-and-garden professionals. addition to our seeds and traits business, we also manufacture the world’s best-selling herbicide, In farm. their to appropriate most the are that varieties the in products our access can farmers seed and trait technologies to other companies throughout the world. This approach ensures that healthier foods and better animal feed. As a produce company, we and are crops committed their to broadly protect licensing Today, them our help seed. to products each seed-based of innovative our out use farmers more obtain can farmers so it, protect to used technology the and costs. We are constantly seeking ways to maximize the potential of seed, both its yield potential on-farm their reducing and efficiency on-farm their supporting yield, their protecting at aim who farmers to technologies trait in-the-seed leading produce also We vegetables. as such crops in large-acre crops such as corn, cotton and oilseeds (soybeans and canola), as well as small-acre and to the farmers that feed, clothe and fuel our growing world. We produce leading seed agriculture brands to commitment our support we biology, modern of tools the Through succeed. we Monsanto is an agricultural company with 17,000 employees worldwide. When farmers succeed, Fine SeedsInternational Monsanto West ExhibitionPlan West ExhibitionPlan Partners, Sponsors &Exhibitors Booth #14 Booth #17 BioVisionAlexandria April 2010 it comprises. the Ancient Library, as well as the fascinating building of the Bibliotheca Alexandrina and what of history great the of reminder perfect a offers It heritage. national our of uniqueness the and Our Bookshop contains a rich variety of books and gifts that reflect the wonders of our civilization irr ad h Nbl eto, ih h ojcie t ipoe wrns, nweg and knowledge awareness, improve to objectives dialogue betweenculturesandattainstandardsofexcellenceinscientificresearch. the with Section, Nobel the and Library Multimedia & Arts the Library, People’s Young the Taha Library, the Children’s the libraries: Library, specialized Hussein its and Library Main the through users its to services offers It Ancient Library of Alexandria and to ensure an international center of excellence in Alexandria. The Bibliotheca Alexandrina Library Sector is a public-research library; established to revive the hm n ilge n ta wr, n pooig erig n kolde ciiis by activities knowledge and learning promoting and work, team self-learning anddistantlearningmethods. and dialogue in engaging them by peers their with knowledge and ideas exchange of to skills youth social encourage They and youth. personal and work team crisis constructive research, aim scientific They develop environment. to the to related scientific programs and toencourage activities in youth seek engage and also thinking They youth. among concepts management to environmental aim preventative promote programs and problems These global old). and local years about awareness (19-25 environmental people increase (League young LYM to and directed old) is special years Masters) (13-18 a Young students for is young to Understanding) directed Better and by and operated program Sustainability Environmental for (Youth YESBU The BibliothecaAlexandrina YESBU andLYMPrograms Library SectorResources Bibliotheca Alexandrina Bibliotheca Alexandrina www.bibalex.org/yesbu www.bibalex.org www.bibalex.org Bookshop West ExhibitionPlan Main Entrance Main Entrance Booth #2 Booth #1 Booth #4
125 BioVisionAlexandria 2010 126 BioVisionAlexandria 2010 elwhp ad wrs ht r sbitd o h Aaey y cetss n isiuin in institutions and scientists by developing countries.Foradditionalinformation, see www.twas.org. Academy the to submitted are that awards and fellowships scientists eminent 2,000 than More worldwide, including TWAS members, peer programs. review proposals free-of-charge for research grants, exchange and training research, of variety a South. Since 1986, TWAS has supported scientific research in 100 developing countries through principal aim is to promote scientific capacity and excellence for sustainable development in the are from developing countries), TWAS represents the best of science whom in of the percent developing 80 world. Its than a (more scientists With eminent 900 Pakistan. than more of of comprised Salam membership Abdus laureate Nobel from late the scientists of of leadership group the under distinguished South a the by 1983 in Italy Trieste, in founded organization, international autonomous an is World, Developing the for Sciences of Academy the TWAS, and socialsciences. versions of journals, monographs, textbooks and reference works and cover health, life, physical printed and electronic include services and products Our Sciences. Health and Technology & increase them their productivity and effectiveness. Elsevier’shelp operations are organized in two divisions:we Science worldwide, practitioners and educators students, researchers, to tools to the advancement of these critical fields. By delivering world-class information and innovative contribute to and communities health and science global the in role essential an play to proud is Elsevier worldwide. professionals information and health and students, scientists, million 30 than more serves Elsevier information, health and science of publisher leading world’s the As in thefermentationprocess.Availableforresearchersofanyauthoritytousetheirprojects. change which specifications, product the Optimizing instruments. tech high unit the operating for courses training specialized highly Arranging private bio-products. any the of and production for researchers sectors with Co-operating is BGEU NRC. the within located is BGEU TheAcademyofSciencesfortheDevelopingWorld(TWAS) Biotechnology &GeneticEngineeringUnit(BGEU) National ResearchCenter(NRC) www.elsevier.com ELSEVIER Middle HallOutsidePlan West ExhibitionPlan West ExhibitionPlan Partners, Sponsors &Exhibitors Booth #10 Booth #1 Booth #4 BioVisionAlexandria April 2010 initiated toestablishefficienthighereducationsystemsintheThirdWorld. programs regional long-term the to vice-chancellors university foreign of information delegations by from visits countries, developing from graduates for years several lasting scholarships doctoral to purposes teaching or research for exchanges short-term from range objectives these pursues DAAD which with programs more and 200 The abroad. experience able valuable gain been to have DAAD, by supported scientists, and researchers teachers, students, of Scores field. its in organizations intermediary respected most and largest world’s the of one is DAAD website: www.rdi.eg.net our visit please Programme, RDI the about information further For and performance. innovation development research, its improving through competitiveness international and economic growth Egypt’s of enhancement the to contributing of objective overarching Programme RDI the achieve to aim activities above The innovation. and initiatives science of culture the various promote to implementing been also has Programme RDI with The cooperation partners. scientific European fruitful the on embark to aiming institutes research and universities cross-cutting 51 financing through industry the projects to date. The RDI Programme established a wide network within the public and private and sector development and research the Research, the Research, Scientific between link the strengthening and in succeeded Programme (RDI) Innovation Education and Development Higher of Ministry the by managed and years three of period a over million €11 of grant a with Commission European the by Funded Research,DevelopmentandInnovation(RDI)Programme TheGermanAcademicExchangeService(DAAD) West ExhibitionPlan West ExhibitionPlan Booth #16 Booth #5
127 BioVisionAlexandria 2010